Patent Application
20150140612
This application contains a Sequence Listing, which is incorporated herein by reference.
1. Field of the Invention
The present invention relates to methods for increasing hydrolysis of cellulosic material with an enzyme composition and processes including a method of the invention. The invention also relates to a blend composition for use in a method or process of the invention.
2. Description of the Related Art
Cellulose is a polymer of the simple sugar glucose linked by beta-1,4-bonds. Many microorganisms produce enzymes that hydrolyze beta-linked glucans. These enzymes include endoglucanases, cellobiohydrolases, and beta-glucosidases. Endoglucanases digest the cellulose polymer at random locations, opening it to attack by cellobiohydrolases. Cellobiohydrolases sequentially release molecules of cellobiose from the ends of the cellulose polymer. Cellobiose is a water-soluble beta-1,4-linked dimer of glucose. Beta-glucosidases hydrolyze cellobiose to glucose.
WO 2005/067531 discloses a method for degrading a lignocellulosic material with cellulolytic enzymes in the presence of at least one surfactant selected from the group consisting of a secondary alcohol ethoxylate, fatty alcohol ethoxylate, nonylphenol ethoxylate, tridecyl ethoxylate, and polyoxyethylene ether.
WO 2010/080408 concerns methods for degrading or converting a cellulosic material by treating said cellulosic material with an enzyme composition in the presence of a polypeptide having peroxidase activity.
The present invention provides methods for improving hydrolysis of pretreated cellulosic material using a cellulolytic enzyme composition and processes for producing fermentation product from hydrolyzate.
Described herein are methods for degrading/hydrolyzing pretreated cellulosic material, comprising subjecting the pretreated cellulosic material to:
a cellulolytic enzyme composition;
a polypeptide having cellulolytic enhancing activity;
a peroxidase; and
a nonionic surfactant and/or a cationic surfactant,
at conditions suitable for hydrolyzing the pretreated lignocellulosic material.
Methods of the present invention can be used to hydrolyze/saccharify pretreated cellulosic material to fermentable sugars. The fermentable sugars may be converted to many useful desired substances, e.g., fuel, potable ethanol, and/or fermentation products (e.g., acids, alcohols, ketones, gases, and the like).
The degraded/hydrolyzed pretreated cellulosic material may be or may contain sugars that can be used in processes for producing syrups (e.g., High Fructose Corn Syrups (HFCS) and/or plastics (e.g., polyethylene, polystyrene, and polypropylene), polylactic acid (e.g., for producing PET).
The present invention also relates to processes for producing fermentation products, comprising
(a) hydrolyzing a pretreated cellulosic material according to the method of the invention;
(b) fermenting the material with one or more (several) fermenting microorganisms to produce the fermentation product; and
(c) optionally recovering the fermentation product from the fermentation.
Finally the present invention relates to compositions comprising or consisting of:
i) polypeptide having cellulolytic enhancing activity;
ii) a peroxidase;
iii) a nonionic surfactant and/or a cationic surfactant.
In an embodiment the composition also comprises a cellulolytic enzyme composition.
Peroxidase: The term “Peroxidase” is defined herein includes enzymes having peroxidase activity and Peroxide-decomposing enzymes.
Peroxidase activity: The term “peroxidase activity” is defined herein as an enzyme activity that converts a peroxide, e.g., hydrogen peroxide, to a less oxidative species, e.g., water. It is understood herein that a polypeptide having peroxidase activity encompasses a peroxide-decomposing enzyme (defined below).
Peroxide-decomposing enzyme: The term “peroxide-decomposing enzyme” is defined herein as an donor:peroxide oxidoreductase (E.C. number 1.11.1.x) that catalyzes the reaction reduced substrate (2e−)+ROOR′→oxidized substrate+ROH+R′OH; such as horseradish peroxidase that catalyzes the reaction phenol+H2O2→quinone+H2O, and catalase that catalyzes the reaction H2O2+H2O2→O2+2H2O. In addition to hydrogen peroxide, other peroxides may also be decomposed by these enzymes.
Cellulolytic activity: The term “cellulolytic activity” is defined herein as a biological activity that hydrolyzes a cellulosic material. The two basic approaches for measuring cellulolytic activity include: (1) measuring the total cellulolytic activity, and (2) measuring the individual cellulolytic activities (endoglucanases, cellobiohydrolases, and beta-glucosidases) as reviewed in Zhang et al., 2006, Outlook for cellulase improvement: Screening and selection strategies, Biotechnology Advances 24: 452-481. Total cellulolytic activity is usually measured using insoluble substrates, including Whatman No 1 filter paper, microcrystalline cellulose, bacterial cellulose, algal cellulose, cotton, pretreated lignocellulose, etc. The most common total cellulolytic activity assay is the filter paper assay using Whatman No 1 filter paper as the substrate. The assay was established by the International Union of Pure and Applied Chemistry (IUPAC) (Ghose, 1987, Measurement of cellulase activities, Pure Appl. Chem. 59: 257-68).
For purposes of the present invention, cellulolytic activity is determined by measuring the increase in hydrolysis of a cellulosic material by cellulolytic enzyme(s) under the following conditions: 1-20 mg of cellulolytic protein/g of cellulose in PCS for 3-7 days at 50-65° C. compared to a control hydrolysis without addition of cellulolytic protein. Typical conditions are 1 ml reactions, washed or unwashed PCS, 5% insoluble solids, 50 mM sodium acetate pH 5, 1 mM MnSO4, 50-65° C., 72 hours, sugar analysis by AMINEX® HPX-87H column (Bio-Rad Laboratories, Inc., Hercules, Calif., USA).
Endoglucanase: The term “endoglucanase” is defined herein as an endo-1,4-(1,3;1,4)-beta-D-glucan 4-glucanohydrolase (E.C. 3.2.1.4), which catalyses endohydrolysis of 1,4-beta-D-glycosidic linkages in cellulose, cellulose derivatives (such as carboxymethyl cellulose and hydroxyethyl cellulose), lichenin, beta-1,4 bonds in mixed beta-1,3 glucans such as cereal beta-D-glucans or xyloglucans, and other plant material containing cellulosic components. Endoglucanase activity can be determined based on a reduction in substrate viscosity or increase in reducing ends determined by a reducing sugar assay (Zhang et al., 2006, Biotechnology Advances 24: 452-481). For purposes of the present invention, endoglucanase activity is determined using carboxymethyl cellulose (CMC) hydrolysis according to the procedure of Ghose, 1987, Pure and Appl. Chem. 59: 257-268.
Cellobiohydrolase: The term “cellobiohydrolase” is defined herein as a 1,4-beta-D-glucan cellobiohydrolase (E.C. 3.2.1.91), which catalyzes the hydrolysis of 1,4-beta-D-glucosidic linkages in cellulose, cellooligosaccharides, or any beta-1,4-linked glucose containing polymer, releasing cellobiose from the reducing or non-reducing ends of the chain (Teeri, 1997, Crystalline cellulose degradation: New insight into the function of cellobiohydrolases, Trends in Biotechnology 15: 160-167; Teeri et al., 1998, Trichoderma reesei cellobiohydrolases: why so efficient on crystalline cellulose?, Biochem. Soc. Trans. 26: 173-178). For purposes of the present invention, cellobiohydrolase activity is determined using a fluorescent disaccharide derivative 4-methylumbelliferyl-β-D-lactoside according to the procedures described by van Tilbeurgh et al., 1982, FEBS Letters 149: 152-156 and van Tilbeurgh and Claeyssens, 1985, FEBS Letters 187: 283-288.
Beta-glucosidase: The term “beta-glucosidase” is defined herein as a beta-D-glucoside glucohydrolase (E.C. 3.2.1.21), which catalyzes the hydrolysis of terminal non-reducing beta-D-glucose residues with the release of beta-D-glucose. For purposes of the present invention, beta-glucosidase activity is determined according to the basic procedure described by Venturi et al., 2002, Extracellular beta-D-glucosidase from Chaetomium thermophilum var. coprophilum: production, purification and some biochemical properties, J. Basic Microbiol. 42: 55-66. One unit of beta-glucosidase activity is defined as 1.0 μmole of p-nitrophenol produced per minute at 40° C., pH 5 from 1 mM p-nitrophenyl-beta-D-glucopyranoside as substrate in 100 mM sodium citrate containing 0.01% TWEEN® 20.
Cellulolytic enhancing activity: The term “cellulolytic enhancing activity” is defined herein as a biological activity that enhances the hydrolysis of a cellulosic material by polypeptides having cellulolytic activity. For purposes of the present invention, cellulolytic enhancing activity is determined by measuring the increase in reducing sugars or the increase of the total of cellobiose and glucose from the hydrolysis of a cellulosic material by cellulolytic protein under the following conditions: 1-50 mg of total protein/g of cellulose in PCS, wherein total protein is comprised of 50-99.5% w/w cellulolytic protein and 0.5-50% w/w protein of cellulolytic enhancing activity for 1-7 day at 50-65° C. compared to a control hydrolysis with equal total protein loading without cellulolytic enhancing activity (1-50 mg of cellulolytic protein/g of cellulose in PCS). In a preferred aspect, a mixture of CELLUCLAST® 1.5L (Novozymes A/S, Bagsværd, Denmark) in the presence of 3% of total protein weight Aspergillus oryzae beta-glucosidase (recombinantly produced in Aspergillus oryzae according to WO 02/095014) or 3% of total protein weight Aspergillus fumigatus beta-glucosidase (recombinantly produced in Aspergillus oryzae as described in WO 02/095014) of cellulase protein loading is used as the source of the cellulolytic activity.
The polypeptides having cellulolytic enhancing activity enhance the hydrolysis of a cellulosic material catalyzed by proteins having cellulolytic activity by reducing the amount of cellulolytic enzyme required to reach the same degree of hydrolysis preferably at least 1.01-fold, more preferably at least 1.05-fold, more preferably at least 1.10-fold, more preferably at least 1.25-fold, more preferably at least 1.5-fold, more preferably at least 2-fold, more preferably at least 3-fold, more preferably at least 4-fold, more preferably at least 5-fold, even more preferably at least 10-fold, and most preferably at least 20-fold.
Family 61 glycoside hydrolase: The term “Family 61 glycoside hydrolase” or “GH 61” or “Family GH61” is defined herein as a polypeptide falling into the glycoside hydrolase Family 61 according to Henrissat, 1991, A classification of glycosyl hydrolases based on amino-acid sequence similarities, Biochem. J. 280: 309-316, and Henrissat and Bairoch, 1996, Updating the sequence-based classification of glycosyl hydrolases, Biochem. J. 316: 695-696. Presently, Henrissat lists the GH61 Family as unclassified indicating that properties such as mechanism, catalytic nucleophile/base, and catalytic proton donors are not known for polypeptides belonging to this family.
Xylan degrading activity: The terms “xylan degrading activity” or “xylanolytic activity” are defined herein as a biological activity that hydrolyzes xylan-containing material. The two basic approaches for measuring xylanolytic activity include: (1) measuring the total xylanolytic activity, and (2) measuring the individual xylanolytic activities (endoxylanases, beta-xylosidases, arabinofuranosidases, alpha-glucuronidases, acetylxylan esterases, feruloyl esterases, and alpha-glucuronyl esterases). Recent progress in assays of xylanolytic enzymes was summarized in several publications including Biely and Puchard, 2006, Recent progress in the assays of xylanolytic enzymes, Journal of the Science of Food and Agriculture 86(11): 1636-1647; Spanikova and Biely, 2006, Glucuronoyl esterase—Novel carbohydrate esterase produced by Schizophyllum commune, FEBS Letters 580(19): 4597-4601; Herrmann et al., 1997, The beta-D-xylosidase of Trichoderma reesei is a multifunctional beta-D-xylan xylohydrolase, Biochemical Journal 321: 375-381.
Total xylan degrading activity can be measured by determining the reducing sugars formed from various types of xylan, including oat spelt, beechwood, and larchwood xylans, or by photometric determination of dyed xylan fragments released from various covalently dyed xylans. The most common total xylanolytic activity assay is based on production of reducing sugars from polymeric 4-O-methyl glucuronoxylan as described in Bailey, Biely, Poutanen, 1992, Interlaboratory testing of methods for assay of xylanase activity, Journal of Biotechnology 23(3): 257-270.
For purposes of the present invention, xylan degrading activity is determined by measuring the increase in hydrolysis of birchwood xylan (Sigma Chemical Co., Inc., St. Louis, Mo., USA) by xylan-degrading enzyme(s) under the following typical conditions: 1 ml reactions, 5 mg/ml substrate (total solids), 5 mg of xylanolytic protein/g of substrate, 50 mM sodium acetate pH 5, 50° C., 24 hours, sugar analysis using p-hydroxybenzoic acid hydrazide (PHBAH) assay as described by Lever, 1972, A new reaction for colorimetric determination of carbohydrates, Anal. Biochem 47: 273-279.
Xylanase activity: The term “xylanase activity” is defined herein as a 1,4-beta-D-xylan-xylohydrolase activity (E.C. 3.2.1.8) that catalyzes the endo-hydrolysis of 1,4-beta-D-xylosidic linkages in xylans. For purposes of the present invention, xylanase activity is determined using birchwood xylan as substrate. One unit of xylanase activity is defined as 1.0 μmole of reducing sugar (measured in glucose equivalents as described by Lever, 1972, A new reaction for colorimetric determination of carbohydrates, Anal. Biochem 47: 273-279) produced per minute during the initial period of hydrolysis at 50° C., pH 5 from 2 g of birchwood xylan per liter as substrate in 50 mM sodium acetate containing 0.01% TWEEN® 20.
Beta-xylosidase activity: The term “beta-xylosidase activity” is defined herein as a beta-D-xyloside xylohydrolase (E.C. 3.2.1.37) that catalyzes the exo-hydrolysis of short beta (1→4)-xylooligosaccharides, to remove successive D-xylose residues from the non-reducing termini. For purposes of the present invention, one unit of beta-xylosidase activity is defined as 1.0 μmole of p-nitrophenol produced per minute at 40° C., pH 5 from 1 mM p-nitrophenyl-beta-D-xyloside as substrate in 100 mM sodium citrate containing 0.01% TWEEN® 20.
Acetylxylan esterase activity: The term “acetylxylan esterase activity” is defined herein as a carboxylesterase activity (EC 3.1.1.72) that catalyses the hydrolysis of acetyl groups from polymeric xylan, acetylated xylose, acetylated glucose, alpha-napthyl acetate, and p-nitrophenyl acetate. For purposes of the present invention, acetylxylan esterase activity is determined using 0.5 mM p-nitrophenylacetate as substrate in 50 mM sodium acetate pH 5.0 containing 0.01% TWEEN™ 20. One unit of acetylxylan esterase activity is defined as the amount of enzyme capable of releasing 1 μmole of p-nitrophenolate anion per minute at pH 5, 25° C.
Feruloyl esterase activity: The term “feruloyl esterase activity” is defined herein as a 4-hydroxy-3-methoxycinnamoyl-sugar hydrolase activity (EC 3.1.1.73) that catalyzes the hydrolysis of the 4-hydroxy-3-methoxycinnamoyl (feruloyl) group from an esterified sugar, which is usually arabinose in “natural” substrates, to produce ferulate (4-hydroxy-3-methoxycinnamate). Feruloyl esterase is also known as ferulic acid esterase, hydroxycinnamoyl esterase, FAE-III, cinnamoyl ester hydrolase, FAEA, cinnAE, FAE-I, or FAE-II. For purposes of the present invention, feruloyl esterase activity is determined using 0.5 mM p-nitrophenylferulate as substrate in 50 mM sodium acetate pH 5.0. One unit of feruloyl esterase activity equals the amount of enzyme capable of releasing 1 μmole of p-nitrophenolate anion per minute at pH 5, 25° C.
Alpha-glucuronidase activity: The term “alpha-glucuronidase activity” is defined herein as an alpha-D-glucosiduronate glucuronohydrolase activity (EC 3.2.1.139) that catalyzes the hydrolysis of an alpha-D-glucuronoside to D-glucuronate and an alcohol. For purposes of the present invention, alpha-glucuronidase activity is determined according to de Vries, 1998, J. Bacteriol. 180: 243-249. One unit of alpha-glucuronidase activity equals the amount of enzyme capable of releasing 1 μmole of glucuronic or 4-O-methylglucuronic acid per minute at pH 5, 40° C.
Alpha-L-arabinofuranosidase activity: The term “alpha-L-arabinofuranosidase activity” is defined herein as an alpha-L-arabinofuranoside arabinofuranohydrolase activity (EC 3.2.1.55) that catalyzes the hydrolysis of terminal non-reducing alpha-L-arabinofuranoside residues in alpha-L-arabinosides. The enzyme activity acts on alpha-L-arabinofuranosides, alpha-L-arabinans containing (1,3)- and/or (1,5)-linkages, arabinoxylans, and arabinogalactans. Alpha-L-arabinofuranosidase is also known as arabinosidase, alpha-arabinosidase, alpha-L-arabinosidase, alpha-arabinofuranosidase, polysaccharide alpha-L-arabinofuranosidase, alpha-L-arabinofuranoside hydrolase, L-arabinosidase, or alpha-L-arabinanase. For purposes of the present invention, alpha-L-arabinofuranosidase activity is determined using 5 mg of medium viscosity wheat arabinoxylan (Megazyme International Ireland, Ltd., Bray, Co. Wicklow, Ireland) per ml of 100 mM sodium acetate pH 5 in a total volume of 200 μl for 30 minutes at 40° C. followed by arabinose analysis by AMINEX® HPX-87H column chromatography (Bio-Rad Laboratories, Inc., Hercules, Calif., USA).
Xylan-containing material: The term “xylan-containing material” is defined herein as any material comprising a plant cell wall polysaccharide containing a backbone of beta-(1-4)-linked xylose residues. Xylans of terrestrial plants are heteropolymers possessing a beta-(1-4)-D-xylopyranose backbone, which is branched by short carbohydrate chains. They comprise D-glucuronic acid or its 4-O-methyl ether, L-arabinose, and/or various oligosaccharides, composed of D-xylose, L-arabinose, D- or L-galactose, and D-glucose. Xylan-type polysaccharides can be divided into homoxylans and heteroxylans, which include glucuronoxylans, (arabino)glucuronoxylans, (glucurono)arabinoxylans, arabinoxylans, and complex heteroxylans. See, for example, Ebringerova et al., 2005, Adv. Polym. Sci. 186: 1-67.
In the methods of the present invention, any material containing xylan may be used. In a preferred aspect, the xylan-containing material is lignocellulose.
Xylan-containing material: The term “xylan-containing material” is defined herein as any material comprising a plant cell wall polysaccharide containing a backbone of beta-(1-4)-linked xylose residues. Xylans of terrestrial plants are heteropolymers possessing a beta-(1-4)-D-xylopyranose backbone, which is branched by short carbohydrate chains. They comprise D-glucuronic acid or its 4-O-methyl ether, L-arabinose, and/or various oligosaccharides, composed of D-xylose, L-arabinose, D- or L-galactose, and D-glucose. Xylan-type polysaccharides can be divided into homoxylans and heteroxylans, which include glucuronoxylans, (arabino)glucuronoxylans, (glucurono)arabinoxylans, arabinoxylans, and complex heteroxylans. See, for example, Ebringerova et al., 2005, Adv. Polym. Sci. 186: 1-67.
In the methods of the present invention, any material containing xylan may be used. In a preferred aspect, the xylan-containing material is lignocellulose.
Isolated polypeptide: The term “isolated polypeptide” as used herein refers to a polypeptide that is isolated from a source. In a preferred aspect, the polypeptide is at least 1% pure, preferably at least 5% pure, more preferably at least 10% pure, more preferably at least 20% pure, more preferably at least 40% pure, more preferably at least 60% pure, even more preferably at least 80% pure, and most preferably at least 90% pure, as determined by SDS-PAGE.
Substantially pure polypeptide: The term “substantially pure polypeptide” denotes herein a polypeptide preparation that contains at most 10%, preferably at most 8%, more preferably at most 6%, more preferably at most 5%, more preferably at most 4%, more preferably at most 3%, even more preferably at most 2%, most preferably at most 1%, and even most preferably at most 0.5% by weight of other polypeptide material with which it is natively or recombinantly associated. It is, therefore, preferred that the substantially pure polypeptide is at least 92% pure, preferably at least 94% pure, more preferably at least 95% pure, more preferably at least 96% pure, more preferably at least 97% pure, more preferably at least 98% pure, even more preferably at least 99% pure, most preferably at least 99.5% pure, and even most preferably 100% pure by weight of the total polypeptide material present in the preparation. The polypeptides are preferably in a substantially pure form, i.e., that the polypeptide preparation is essentially free of other polypeptide material with which it is natively or recombinantly associated. This can be accomplished, for example, by preparing the polypeptide by well-known recombinant methods or by classical purification methods.
Mature polypeptide: The term “mature polypeptide” is defined herein as a polypeptide in its final form following translation and any post-translational modifications, such as N-terminal processing, C-terminal truncation, glycosylation, phosphorylation, etc.
Mature polypeptide coding sequence: The term “mature polypeptide coding sequence” is defined herein as a nucleotide sequence that encodes a mature polypeptide.
Identity: The relatedness between two amino acid sequences or between two nucleotide sequences is described by the parameter “identity”.
For purposes of the present invention, the degree of identity between two amino acid sequences is determined using the Needleman-Wunsch algorithm (Needleman and Wunsch, 1970, J. Mol. Biol. 48: 443-453) as implemented in the Needle program of the EMBOSS package (EMBOSS: The European Molecular Biology Open Software Suite, Rice et al., 2000, Trends in Genetics 16: 276-277), preferably version 3.0.0 or later. The optional parameters used are gap open penalty of 10, gap extension penalty of 0.5, and the EBLOSUM62 (EMBOSS version of BLOSUM62) substitution matrix. The output of Needle labeled “longest identity” (obtained using the—nobrief option) is used as the percent identity and is calculated as follows:
(Identical Residues×100)/(Length of Alignment−Total Number of Gaps in Alignment)
For purposes of the present invention, the degree of identity between two deoxyribonucleotide sequences is determined using the Needleman-Wunsch algorithm (Needleman and Wunsch, 1970, supra) as implemented in the Needle program of the EMBOSS package (EMBOSS: The European Molecular Biology Open Software Suite, Rice et al., 2000, supra), preferably version 3.0.0 or later. The optional parameters used are gap open penalty of 10, gap extension penalty of 0.5, and the EDNAFULL (EMBOSS version of NCBI NUC4.4) substitution matrix. The output of Needle labeled “longest identity” (obtained using the—nobrief option) is used as the percent identity and is calculated as follows:
(Identical Deoxyribonucleotides×100)/(Length of Alignment−Total Number of Gaps in Alignment)
Homologous sequence: The term “homologous sequence” is defined herein as a predicted protein having an E value (or expectancy score) of less than 0.001 in a tfasty search (Pearson, W. R., 1999, in Bioinformatics Methods and Protocols, S. Misener and S. A. Krawetz, ed., pp. 185-219) with a polypeptide of interest.
Polypeptide fragment: The term “polypeptide fragment” is defined herein as a polypeptide having one or more (several) amino acids deleted from the amino and/or carboxyl terminus of a mature polypeptide or a homologous sequence thereof, wherein the fragment has biological activity.
Subsequence: The term “subsequence” is defined herein as a nucleotide sequence having one or more (several) nucleotides deleted from the 5′ and/or 3′ end of a mature polypeptide coding sequence or a homologous sequence thereof, wherein the subsequence encodes a polypeptide fragment having biological activity.
Allelic variant: The term “allelic variant” denotes herein any of two or more alternative forms of a gene occupying the same chromosomal locus. Allelic variation arises naturally through mutation, and may result in polymorphism within populations. Gene mutations can be silent (no change in the encoded polypeptide) or may encode polypeptides having altered amino acid sequences. An allelic variant of a polypeptide is a polypeptide encoded by an allelic variant of a gene.
Isolated polynucleotide: The term “isolated polynucleotide” as used herein refers to a polynucleotide that is isolated from a source. In a preferred aspect, the polynucleotide is at least 1% pure, preferably at least 5% pure, more preferably at least 10% pure, more preferably at least 20% pure, more preferably at least 40% pure, more preferably at least 60% pure, even more preferably at least 80% pure, and most preferably at least 90% pure, as determined by agarose electrophoresis.
Substantially pure polynucleotide: The term “substantially pure polynucleotide” as used herein refers to a polynucleotide preparation free of other extraneous or unwanted nucleotides and in a form suitable for use within genetically engineered protein production systems. Thus, a substantially pure polynucleotide contains at most 10%, preferably at most 8%, more preferably at most 6%, more preferably at most 5%, more preferably at most 4%, more preferably at most 3%, even more preferably at most 2%, most preferably at most 1%, and even most preferably at most 0.5% by weight of other polynucleotide material with which it is natively or recombinantly associated. A substantially pure polynucleotide may, however, include naturally occurring 5′ and 3′ untranslated regions, such as promoters and terminators. It is preferred that the substantially pure polynucleotide is at least 90% pure, preferably at least 92% pure, more preferably at least 94% pure, more preferably at least 95% pure, more preferably at least 96% pure, more preferably at least 97% pure, even more preferably at least 98% pure, most preferably at least 99% pure, and even most preferably at least 99.5% pure by weight. The polynucleotides are preferably in a substantially pure form, i.e., that the polynucleotide preparation is essentially free of other polynucleotide material with which it is natively or recombinantly associated. The polynucleotides may be of genomic, cDNA, RNA, semisynthetic, synthetic origin, or any combinations thereof.
Coding sequence: When used herein the term “coding sequence” means a nucleotide sequence, which directly specifies the amino acid sequence of its protein product. The boundaries of the coding sequence are generally determined by an open reading frame, which usually begins with the ATG start codon or alternative start codons such as GTG and TTG and ends with a stop codon such as TAA, TAG, and TGA. The coding sequence may be a DNA, cDNA, synthetic, or recombinant nucleotide sequence.
cDNA: The term “cDNA” is defined herein as a DNA molecule that can be prepared by reverse transcription from a mature, spliced, mRNA molecule obtained from a eukaryotic cell. cDNA lacks intron sequences that may be present in the corresponding genomic DNA. The initial, primary RNA transcript is a precursor to mRNA that is processed through a series of steps before appearing as mature spliced mRNA. These steps include the removal of intron sequences by a process called splicing. cDNA derived from mRNA lacks, therefore, any intron sequences.
Nucleic acid construct: The term “nucleic acid construct” as used herein refers to a nucleic acid molecule, either single- or double-stranded, which is isolated from a naturally occurring gene or which is modified to contain segments of nucleic acids in a manner that would not otherwise exist in nature or which is synthetic. The term nucleic acid construct is synonymous with the term “expression cassette” when the nucleic acid construct contains the control sequences required for expression of a coding sequence.
Control sequences: The term “control sequences” is defined herein to include all components necessary for the expression of a polynucleotide encoding a polypeptide. Each control sequence may be native or foreign to the nucleotide sequence encoding the polypeptide or native or foreign to each other. Such control sequences include, but are not limited to, a leader, polyadenylation sequence, propeptide sequence, promoter, signal peptide sequence, and transcription terminator. At a minimum, the control sequences include a promoter, and transcriptional and translational stop signals. The control sequences may be provided with linkers for the purpose of introducing specific restriction sites facilitating ligation of the control sequences with the coding region of the nucleotide sequence encoding a polypeptide.
Operably linked: The term “operably linked” denotes herein a configuration in which a control sequence is placed at an appropriate position relative to the coding sequence of the polynucleotide sequence such that the control sequence directs the expression of the coding sequence of a polypeptide.
Expression: The term “expression” includes any step involved in the production of a polypeptide including, but not limited to, transcription, post-transcriptional modification, translation, post-translational modification, and secretion.
Expression vector: The term “expression vector” is defined herein as a linear or circular DNA molecule that comprises a polynucleotide encoding a polypeptide and is operably linked to additional nucleotides that provide for its expression.
Host cell: The term “host cell”, as used herein, includes any cell type that is susceptible to transformation, transfection, transduction, and the like with a nucleic acid construct or expression vector comprising a polynucleotide of the present invention.
Modification: The term “modification” means herein any chemical modification of a polypeptide, as well as genetic manipulation of the DNA encoding the polypeptide. The modification can be a substitution, a deletion and/or an insertion of one or more (several) amino acids as well as replacements of one or more (several) amino acid side chains.
Artificial variant: When used herein, the term “artificial variant” means a polypeptide produced by an organism expressing a modified polynucleotide sequence encoding a polypeptide variant. The modified nucleotide sequence is obtained through human intervention by modification of the polynucleotide sequence.
The present invention relates to improved methods for degrading/hydrolyzing pretreated cellulosic material into sugars by hydrolyzing the pretreated cellulosic material. The present invention also relates to processes for producing a fermentation product from pretreated cellulosic material.
In the first aspect the invention relates to methods for degrading/hydrolyzing pretreated cellulosic material comprising subjecting the pretreated cellulosic material to:
a cellulolytic enzyme composition;
a polypeptide having cellulolytic enhancing activity;
a peroxidase; and
a nonionic surfactant and/or a cationic surfactant,
at conditions suitable for hydrolyzing the pretreated lignocellulosic material.
The component may be present of added to the method of the invention. According to the invention the components added during degradation/hydrolysis may be added as one composition, but may also be added as two or more single or multiple component compositions. For instance the cellulolytic enzyme composition and the polypeptide may be added as one composition while the peroxidase and the surfactant(s) may be added separately. In one embodiment the cellulolytic enzyme composition, the polypeptide having cellulolytic enhancing activity and the peroxidase is added a one composition while the surfactant(s) is(are) added separately. Any combination is contemplated according to the invention. It is also contemplated to add one or more of the components before degradation/hydrolysis.
The degraded/hydrolyzed pretreated cellulosic material comprises sugars. The sugars can be used in processes for producing syrups (e.g., High Fructose Corn Syrups (HFCS)) and/or plastics (e.g., polyethylene, polystyrene, and polypropylene), polylactic acid (e.g., for producing PET). The sugars may also be fermented into a fermentation product, such as ethanol, by a fermenting microorganism, such as yeast, e.g., from a strain of Saccharomyces, such as a strain of Saccharomyces cerevisiae capable of converting C5 sugars (pentose sugars) and/or C6 sugars (hexose sugars) into a desired end-product, such as ethanol. A non-exhaustive list of contemplated products, including fermentation products are described below. Examples of suitable fermenting microorganisms are also described below.
According to the invention the pretreated cellulosic material may be agricultural residues, herbaceous material (including energy crops), municipal solid waste, pulp and paper mill residue, waste paper, or wood (including forestry residue), or arundo, bagasse, bamboo, corn cob, corn fiber, corn stover, miscanthus, orange peel, rice straw, switchgrass or wheat straw. According to the invention the degraded pretreated cellulosic material, such as sugars or sugars converted into fermentation products, may be recovered after hydrolysis and/or fermentation.
The sugars may be one from the group consisting of glucose, xylose, mannose, galactose, and arabinose. When the end-product is a fermentation product it may be an alcohol, such as especially ethanol, an organic acid, a ketone, an amino acid, or a gas.
The pretreated cellulosic material may according to the invention be pretreated in any suitable way. Pretreatment of the cellulosic material may preferably be carried out as chemical pretreatment, physical pretreatment, or chemical pretreatment and a physical pretreatment. Pretreatment methods and pretreatment conditions are well-known in the art.
In an embodiment the cellulosic material is pretreated with an acid, such as dilute acid pretreatment. In a preferred embodiment the pretreatment of the cellulosic material is done by pretreating at high temperature, high pressure with an acid, such as dilute acid.
In an embodiment acid pretreatment is carried out using acetic acid or sulfuric acid.
In an embodiment pretreatment is an alkaline pretreatment, such as ammonium pretreatment, such as mild ammonium pretreatment of the cellulosic material.
In another embodiment the pretreatment is thermomechemically pretreatment.
In a further embodiment the cellulosic material is pretreated using organosolv pretreatment, such as Acetosolv and Acetocell processes.
In a preferred embodiment the material is dilute acid pretreated corn stover. In another embodiment the pretreated material is dilute acid pretreated corn cobs.
In context of the invention degrading pretreated cellulosic material is the same a hydrolysing pretreated cellulosic material.
Suitable method conditions are well-known to the skilled person in the art or can easily be determined by the skilled person in the art. In one embodiment hydrolysis may be carried out at 10-50% (w/w) TS (Total Solids), such as at 15-40% TS, such as at 15-30% TS, such as at around 20% TS. The hydrolysis may be carried out for 12-240 hours, such as for 24-192 hours, such as for 48-144 hours, such as for around 96 hours. The temperature during hydrolysis may be between 30-70° C., such as 40-60° C., such as 45-55° C., such as around 50° C. The pH during hydrolysis may be between 4-7, such as pH 4.5-6, such as around pH 5.
In a more specific embodiment the invention relates to methods for degrading pretreated cellulosic material comprising subjecting the pretreated cellulosic material to:
a cellulolytic enzyme composition;
polypeptide having cellulolytic enhancing activity, preferably the one derived from Thermoascus aurantiacus shown as SEQ ID NO: 14 herein, and/or the one derived from Penicillium emersonii shown in SEQ ID NO: 72 herein, or a polypeptide having cellulolytic enhancing activity having at least 60%, at least 70%, at least 80%, at least 90%, at least 95%, at least 97%, at least 99% sequence identity to SEQ ID NO: 14 herein or SEQ ID NO: 72 herein:
a peroxidase classified as EC 1.11.1.7 peroxidase, preferably the one derived from Coprinus cinereus shown in SEQ ID NO: 71 herein (CiP); or a polypeptide having peroxidase activity having at least 60%, at least 70%, at least 80%, at least 90%, at least 95%, at least 97%, at least 99% identity to SEQ ID NO: 71 herein:
a nonionic surfactant and/or a cationic surfactant;
at conditions suitable for hydrolyzing the pretreated lignocellulosic material.
A non-exhaustive disclosure of cellulolytic enzyme compositions, enzymes and polypeptides which may suitably be used in a method for degrading pretreated cellulosic material of the invention or in a process for producing a fermentation product of the invention is disclosed in the “Enzymes” section below. According to the invention at least a cellulolytic enzyme composition; a polypeptide having cellulolytic enhancing activity; a Peroxidase; and a nonionic surfactant and/or a cationic surfactant are present or added before and/or during hydrolysis.
The optimal amounts of cellulolytic enzyme composition, enzymes, and polypeptides having cellulolytic enhancing activity, Peroxidase and nonionic and/or cationic surfactant depend on several factors including, but not limited to, the cellulolytic enzymes, the cellulosic substrate, the concentration of cellulosic substrate, the pretreatment(s) of the cellulosic substrate/material, temperature, time, pH, and inclusion of fermenting microorganism.
According to the invention any cellulolytic enzyme composition may be used for hydrolysis. An effective amount of cellulolytic enzyme composition or total enzyme and polypeptide loading during hydrolysis may be between about 0.1 to about 25 mg, such as about 1-10 mg, such as about 2 to about 8 mg, such as around 4 mg protein per g cellulosic material.
In an embodiment the amount of polypeptide having cellulolytic enhancing activity to cellulosic material is about 0.01 to about 20 mg, such as about 0.01 to about 10 mg, such as about 0.01 to about 5 mg, such as about 0.025 to about 1.5 mg, such as about 0.05 to about 1.25 mg, such as about 0.075 to about 1.25 mg, such as about 0.1 to about 1.25 mg, such as about 0.15 to about 1.25 mg, and such as about 0.25 to about 1.0 mg per g of cellulosic material.
In an embodiment amount of peroxidase to cellulosic material is about 0.001 to about 20 mg, such as about 0.01 to about 15 mg, such as about 0.02 to about 10 mg, such as about 0.05 to about 5 mg per g of cellulosic material.
The cellulolytic enzyme composition may comprise one or more (several) enzymes selected from the group consisting of endoglucanase, cellobiohydrolase (CBH), and beta-glucosidase. The cellulolytic enzyme composition may also include other enzymes and/or polypeptides native or foreign to the cellulolytic enzyme producing donor or host cell. For instance, the cellulolytic enzyme composition may be produced by a host cell producing cellulolytic enzymes and further one or more additional recombinant enzymes, such as, e.g., a GH61 polypeptide having cellulolytic enhancing activity foreign to the host cell and other enzymes such as a beta-glucosidase foreign to the host cell.
The cellulolytic enzyme composition used during hydrolysis may be derived from or produced by a strain of Trichoderma, preferably a strain of Trichoderma reesei; or a strain of Humicola, such as a strain of Humicola insolens; or a strain of Chrysosporium, such as a strain of Chrysosporium lucknowense; or a strain of Myceliophthora, such as a strain of Myceliophthora thermophila.
According to the invention a polypeptide having cellulolytic enhancing activity may be present or added during hydrolysis. The polypeptide having cellulolytic enhancing activity may be added separately (e.g., a recombinant or mono-component polypeptide) from the cellulolytic enzyme composition, but may also be part of said composition (e.g., produced recombinantly in a cellulolytic enzyme producing production/host cell). The polypeptide having cellulolytic enhancing activity may be a GH61 polypeptide. In one preferred embodiment the GH61 polypeptide may be derived from the genus Thermoascus, such as a strain of Thermoascus aurantiacus, such as the one described in, e.g., WO 2005/074656 as SEQ ID NO: 2 or SEQ ID NO: 14 herein ; or one derived from the genus Thielavia, such as a strain of Thielavia terrestris, such as the one described in, e.g., WO 2005/074647 as SEQ ID NO: 7 (DNA) and SEQ ID NO: 8 (amino acids) or SEQ ID NO: 8 herein; or one derived from a strain of Aspergillus, such as a strain of Aspergillus fumigatus, such as the one described in, e.g., WO 2010/138754 as SEQ ID NO: 1 and SEQ ID NO: 2; or one derived from a strain derived from Penicillium, such as a strain of Penicillium emersonii, such as the one disclosed in, e.g., WO 2011/041397 as SEQ ID NO: 2 or SEQ ID NO: 72 herein.
In an embodiment the polypeptide having cellulolytic enhancing activity has at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 14 herein.
In an embodiment the polypeptide having cellulolytic enhancing activity has at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 72 herein.
In an embodiment of the invention a beta-glucosidase may be present or added during hydrolysis. The beta-glucosidase may be added to hydrolysis as a separate enzyme (e.g., a recombinant or mono-component enzyme) or as part of the cellulolytic enzyme composition (e.g., produced recombinantly in a cellulolytic enzyme producing production/host cell). In an embodiment the beta-glucosidase may be one derived from a strain of the genus Aspergillus, such as Aspergillus oryzae, such as the one disclosed in, e.g., WO 02/095014 or the fusion protein having beta-glucosidase activity disclosed in, e.g., WO 2008/057637, or Aspergillus fumigatus, such as one disclosed as SEQ ID NO: 2 in WO 2005/047499 or SEQ ID NO: 78 herein, or an Aspergillus fumigatus beta-glucosidase variant disclosed in, e.g., WO 2012/044915, e.g., having the following mutations: F100D, S283G, N456E, F512Y using SEQ ID NO: 78 herein for numbering; or a strain of Aspergillus aculeatus (e.g., WO 2012/030845) or a strain of the genus a strain Penicillium, such as a strain of the Penicillium brasilianum disclosed in, e.g., WO 2007/019442 or SEQ ID NO: 62 herein, or a strain of the genus Trichoderma, such as a strain of Trichoderma reesei.
In an embodiment the beta-glucosidase is from a strain of Aspergillus, such as a strain of Aspergillus fumigatus, such as Aspergillus fumigatus beta-glucosidase (SEQ ID NO: 78 herein), which comprises one or more substitutions selected from the group consisting of L89M, G91L, F100D, I140V, I186V, S283G, N456E, and F512Y; such as a variant thereof with the following substitutions:
F100D+S283G+N456E+F512Y;
L89M+G91L+I186V+I140V;
I186V+L89M+G91L+I140V+F100D+S283G+N456E+F512Y (using SEQ ID NO: 78 herein for numbering.
In an embodiment the number of substitutions is between 1 and 10, such 1 and 8, such as 1 and 6, such as 1 and 4, such as 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10 substitutions.
In an embodiment the beta-glucosidase is one having at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 78 herein.
In an embodiment the beta-glucosidase variant is one having at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 78 herein.
In an embodiment of the invention a xylanase may be present or added during hydrolysis. The xylanase may be added to hydrolysis as a separate enzyme (e.g., a recombinant or mono-component enzyme) or as part of the cellulolytic enzyme composition (e.g., produced recombinantly in a cellulolytic enzyme producing production/host cell). In a preferred embodiment the xylanase is a GH10 xylanase. In an embodiment the xylanase is derived from a strain of the genus Aspergillus, such as a strain from Aspergillus fumigatus, such as the one disclosed as SEQ ID NO: 6 (Xyl III) in WO 2006/078256 or SEQ ID NO: 75 here, or Aspergillus aculeatus, such as the one disclosed in WO 94/21785, e.g., as SEQ ID NO: 5 (Xyl II) or SEQ ID NO: 74 herein.
In an embodiment the xylanase is one having at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 74 herein.
In an embodiment the xylanase is one having at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 75 herein.
In an embodiment of the invention a beta-xylosidase may be present or added during hydrolysis. The beta-xylosidase may be added to hydrolysis as a separate enzyme (e.g., a recombinant or mono-component enzyme) or as part of the cellulolytic enzyme composition (e.g., produced recombinantly in a cellulolytic enzyme producing production/host cell). In an embodiment the beta-xylosidase is one derived from a strain of the genus Aspergillus, such as a strain of Aspergillus fumigatus, such as the one disclosed in co-pending U.S. provisional No. 61/526,833 or WO 2013/028928 (Examples 16 and 17) (hereby incorporated by reference) or SEQ ID NO: 73 herein, or derived from a strain of Trichoderma, such as a strain of Trichoderma reesei, such as the mature polypeptide of SEQ ID NO: 58 in WO 2011/057140.
In an embodiment the beta-xylosidase is one having at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 73 herein.
In an embodiment of the invention a cellobiohydrolase I (CBH I) may be present or added during hydrolysis. The cellobiohydrolase I (CBH I) may be added to hydrolysis as a separate enzyme (e.g., a recombinant or mono-component enzyme) or as part of the cellulolytic enzyme composition (e.g., produced recombinantly in a cellulolytic enzyme producing production/host cell). In an embodiment cellobiohydrolase I (CBH I) is one derived from a strain of the genus Aspergillus, such as a strain of Aspergillus fumigatus, such as the Cel7a CBH I disclosed in, e.g., SEQ ID NO: 6 in WO 2011/057140 or SEQ ID NO: 76 herein, or a strain of the genus Trichoderma, such as a strain of Trichoderma reesei.
In an embodiment the CBH I is one having at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 76 herein.
In an embodiment of the invention a cellobiohydrolase II (CBH II) may be present or added during hydrolysis. The cellobiohydrolase II (CBH II) may be added to hydrolysis as a separate enzyme (e.g., a recombinant or mono-component enzyme) or as part of the cellulolytic enzyme composition (e.g., produced recombinantly in a cellulolytic enzyme producing production/host cell). In an embodiment the cellobiohydrolase II (CBH II) is one derived from a strain of the genus Aspergillus, such as a strain of Aspergillus fumigatus, such as the one shown as SEQ ID NO: 18 in WO 2011/057140 or SEQ ID NO: 77 herein; or a strain of the genus Trichoderma, such as Trichoderma reesei, or a strain of the genus Thielavia, such as a strain of Thielavia terrestris, such as cellobiohydrolase II CEL6A from Thielavia terrestris.
In an embodiment the CBH II is one having at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 77 herein.
In an embodiment of the invention the cellulolytic enzyme composition may be a Trichoderma reesei cellulolytic enzyme composition and the polypeptide having cellulolytic enhancing activity is Thermoascus aurantiacus GH61A (e.g., SEQ ID NO: 2 in WO 2005/074656 or SEQ ID NO: 14 herein). In an embodiment a beta-glucosidase is also present or added during hydrolysis. The beta-glucosidase may preferably be an Aspergillus oryzae beta-glucosidase fusion protein (e.g., SEQ ID NO: 74 or 76 in WO 2008/057637 or SEQ ID NO: 68 or 70 herein. In an embodiment the beta-glucosidase may preferably be an Aspergillus aculeatus beta-glucosidase, such as the one disclosed in SEQ ID NO: 66 herein.
In an embodiment the cellulolytic enzyme composition is a Trichoderma reesei cellulolytic enzyme composition and the polypeptide having cellulolytic enhancing activity is the Penicillium emersonii GH61A polypeptide disclosed in WO 2011/041397 as SEQ ID NO: 2 (SEQ ID NO: 72 herein). In an embodiment a beta-glucosidase may also be present or added during hydrolysis. The beta-glucosidase may be an Aspergillus fumigatus beta-glucosidase (e.g., SEQ ID NO: 2 of WO 2005/047499 or SEQ ID NO: 78 herein) or a variant thereof with the following substitutions: F100D, S283G, N456E, F512Y using SEQ ID NO>78 for numbering (see WO 2012/044915).
In a preferred embodiment the cellulolytic enzyme composition used according to the method of the invention for degrading pretreated cellulosic material may be a Trichoderma reesei cellulolytic enzyme composition and wherein one or more of the following components are present or added:
(i) an Aspergillus fumigatus cellobiohydrolase I;
(ii) an Aspergillus fumigatus cellobiohydrolase II;
(iii) an Aspergillus fumigatus beta-glucosidase or variant thereof, e.g., with one or more of the following substitutions: F100D, S283G, N456E, F512Y using SEQ ID NO: 78 herein for numbering (see WO 2012/044915); and
(iv) a Penicillium (emersonii) sp. GH61 polypeptide having cellulolytic enhancing activity; or homologs thereof.
In an embodiment a xylanase (e.g., derived from Aspergillus fumigatus and disclosed as SEQ ID NO: 6 (Xyl III) in WO 2006/078256 or SEQ ID NO: 75 herein, or Aspergillus aculeatus disclosed in WO 94/21785 as SEQ ID NO: 5 (Xyl II) (SEQ ID NO: 74 herein), and/or a beta-xylosidase (e.g., derived from Aspergillus fumigatus and disclosed in co-pending U.S. provisional No. 61/526,833 or WO 2013/028928 or SEQ ID NO: 73 herein) is(are) present or added as well.
According to the method of the invention the cellulolytic enzyme composition may be added or present together with one or more (several) enzymes selected from the group consisting of hemicellulase, esterase, protease, and laccase.
According to the invention the cellulolytic enzyme composition added or present may further comprise one or more (several) enzymes selected from the group consisting of a xylanase, an acetyxylan esterase, a feruloyl esterase, an arabinofuranosidase, a xylosidase, a glucuronidase, and combinations thereof.
A peroxidase is present or added during hydrolysis in a method of degrading pretreated cellulosic material of the invention together with a cellulolytic enzyme composition; a polypeptide having cellulolytic enhancing activity; and a nonionic surfactant and/or a cationic surfactant.
The term “Peroxidase” is according to the invention a peroxidase or peroxide-decomposing enzyme. The peroxidase may be selected from the group comprising peroxidase or peroxide-decomposing enzymes including, but are not limited to, the following: E.C. 1.11.1.1 NADH peroxidase; E.C. 1.11.1.2 NADPH peroxidase; E.C. 1.11.1.3 fatty-acid peroxidase; E.C. 1.11.1.5 cytochrome-c peroxidase; E.C. 1.11.1.5; E.C. 1.11.1.6 catalase; E.C. 1.11.1.7 peroxidase; E.C. 1.11.1.8 iodide peroxidase; E.C. 1.11.1.9 glutathione peroxidase; E.C. 1.11.1.10 chloride peroxidase; E.C. 1.11.1.11 L-ascorbate peroxidase; E.C. 1.11.1.12 Phospholipid-hydroperoxide glutathione peroxidase; E.C. 1.11.1.13 manganese peroxidase; E.C. 1.11.1.14 lignin peroxidase; E.C. 1.11.1.15 peroxiredoxin; E.C. 1.11.1.16 versatile peroxidase; E.C. 1.11.1.B2 chloride peroxidase; E.C. 1.11.1.B6 iodide peroxidase (vanadium-containing); E.C. 1.11.1.B7 bromide peroxidase; E.C. 1.11.1.B8 iodide peroxidase.
In a preferred embodiment the peroxidase is an E.C. 1.11.1.7 peroxidase.
The peroxidase may be derived from any microorganism, such as a fungal organism, such as yeast or filamentous fungi, or a bacterium; or a plant.
In a preferred embodiment the peroxidase is a peroxidase (E.C. 1.11.1.7) derived from a strain of Coprinus, such as strain of Coprinus cinereus, such as one shown as SEQ ID NO: 71 herein (CiP). In an embodiment the peroxidase has at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 71 herein.
A nonionic surfactant, a cationic surfactant, or a mixture thereof, may be present or added during hydrolysis in a method for degrading pretreated cellulosic material of the invention together with a cellulolytic enzyme composition; a polypeptide having cellulolytic enhancing activity; and a Peroxidase.
Nonionic surfactants are surfactants well-known in the art. According to the invention any nonionic surfactant may be used. The nonionic surfactant may be an alkyl or an aryl. Examples of nonionic surfactants include glycerol ethers, glycol ethers, ethanolamides, sulfoanylamides, alcohols, amides, alcohol ethoxylates, glycerol esters, glycol esters, ethoxylates of glycerol ester and glycol esters, sugar-based alkyl polyglycosides, polyoxyethylenated fatty acids, alkanolamine condensates, alkanolamides, tertiary acetylenic glycols, polyoxyethylenated mercaptans, carboxylic acid esters, and polyoxyethylenated polyoxyproylene glycols, such as EO/PO block copolymers (EO is ethylene oxide, PO is propylene oxide), EO polymers and copolymers, polyamines, and polyvinylpynolidones.
In an embodiment the nonionic surfactant is a linear primary, or secondary or branched alcohol ethoxylate having the formula: RO(CH2CH2O)nH, wherein R is the hydrocarbon chain length and n is the average number of moles of ethylene oxide, such as where R is linear primary or branched secondary hydrocarbon chain length in the range from C9 to C16 and n ranges from 6 to 13, such as alcohol ethoxylate where R is linear C9-C11 hydrocarbon chain length, and n is 6.
In a preferred embodiment the nonionic surfactant is nonylphenol ethoxylate. In an preferred embodiment the nonionic surfactant is C14H22O(C2H4O)n. In a preferred embodiment the nonionic surfactant is C13-alcohol polyethylene glycol ethers (10 EO). In a preferred embodiment the nonionic surfactant is EO, PO copolymer. In a preferred embodiment the nonionic surfactant is alkylpolyglycolether. In a preferred embodiment the nonionic surfactant is RO(EO)5H. In a preferred embodiment the nonionic surfactant is HOCH2(EO)nCH2OH. In a preferred embodiment the nonionic surfactant is HOCH2(EO)nCH2OH.
Cationic surfactants are surfactants well-known in the art. According to the invention any cationic surfactant may be used. In an embodiment the cationic surfactant is a primary, secondary, or tertiary amine, such as octenidine dihydrochloride; alkyltrimethylammonium salts, such as cetyl trimethylammonium bromide (CTAB) a.k.a. hexadecyl trimethyl ammonium bromide, cetyl trimethylammonium chloride (CTAC), cetylpyridinium chloride (CPC), benzalkonium chloride (BAC), benzethonium chloride (BZT), 5-bromo-5-nitro-1,3-dioxane, dimethyldioctadecylammonium chloride, dioctadecyldimethylammonium bromide (DODAB) and hexadecyltrimethylammonium bromide.
In a preferred embodiment the cationic surfactant is C21H38NCl. In a preferred embodiment the cationic surfactant is CH3(CH2)15N(CH3)3Br
In this aspect, the invention relates to processes for producing a fermentation product, comprising
(a) hydrolyzing pretreated cellulosic material in accordance with a method of the invention;
(b) fermenting the material with one or more (several) fermenting microorganisms to produce the fermentation product; and
(c) optionally recovering the fermentation product from the fermentation.
In the hydrolyzing step, also known as saccharification, the pretreated cellulosic material is hydrolyzed to break down cellulose and alternatively also hemicellulose to fermentable sugars, such as glucose, cellobiose, xylose, xylulose, arabinose, mannose, galactose, and/or soluble oligosaccharides. Hydrolysis is carried out in a suitable aqueous environment under conditions that can be readily determined by one skilled in the art. In a preferred aspect, hydrolysis is performed under conditions suitable for the activity of the enzyme(s), i.e., optimal for the enzyme(s). The hydrolysis can be carried out as a fed batch or continuous process where the pretreated cellulosic material (substrate) is fed gradually to, for example, an enzyme containing hydrolysis solution. The hydrolysis may be performed in stirred-tank reactors or fermentors under controlled pH, temperature, and mixing conditions. Suitable process time, temperature and pH conditions can readily be determined by one skilled in the art. Examples of suitable hydrolysis conditions can be found above in the “Hydrolysis Method Conditions” section.
In an embodiment hydrolysis step (a) and fermentation step (b) are carried out sequentially or simultaneously. In an embodiment hydrolysis step (a) and fermentation step (b) are carried out as separate hydrolysis and fermentation (SHF). In an embodiment hydrolysis step (a) and fermentation step (b) are carried out as simultaneous saccharification and fermentation (SSF). In an embodiment hydrolysis step (a) and fermentation step (b) are carried out as simultaneous saccharification and co-fermentation (SSCF). In an embodiment hydrolysis step (a) and fermentation step (b) are carried out as hybrid hydrolysis and fermentation (HHF). In an embodiment hydrolysis step (a) and fermentation step (b) are carried out as separate hydrolysis and co-fermentation (SHCF). In an embodiment hydrolysis step (a) and fermentation step (b) are carried out as hybrid hydrolysis and co-fermentation (HHCF). In an embodiment hydrolysis step (a) and fermentation step (b) are carried out as direct microbial conversion (DMC), also sometimes called consolidated bioprocessing (CBP). SHF uses separate process steps to first enzymatically hydrolyze cellulosic material to fermentable sugars, e.g., glucose, cellobiose, cellotriose, and pentose sugars, and then ferment the fermentable sugars to ethanol. In SSF, the enzymatic hydrolysis of cellulosic material and the fermentation of sugars to, e.g., ethanol are combined in one step (Philippidis, G. P., 1996, Cellulose bioconversion technology, in Handbook on Bioethanol: Production and Utilization, Wyman, C. E., ed., Taylor & Francis, Washington, D.C., 179-212). SSCF involves the cofermentation of multiple sugars (Sheehan and Himmel, 1999, Enzymes, energy and the environment: A strategic perspective on the U.S. Department of Energy's research and development activities for bioethanol, Biotechnol. Prog. 15: 817-827). HHF involves a separate hydrolysis step, and in addition a simultaneous saccharification and hydrolysis step, which can be carried out in the same reactor. The steps in an HHF process can be carried out at different temperatures, i.e., high temperature enzymatic saccharification followed by SSF at a lower temperature that the fermentation strain can tolerate. DMC combines all three processes (enzyme production, hydrolysis, and fermentation) in one or more (several) steps where the same microorganism is used to produce the enzymes for conversion of the cellulosic material to fermentable sugars and to convert the fermentable sugars into a final product (Lynd et al., 2002, Microbial cellulose utilization: Fundamentals and biotechnology, Microbiol. Mol. Biol. Reviews 66: 506-577). It is understood herein that any method known in the art comprising pretreatment, enzymatic hydrolysis (saccharification), fermentation, or a combination thereof, can be used in the practicing the methods of the present invention.
Conventional apparatus used includes a fed-batch stirred reactor, a batch stirred reactor, a continuous flow stirred reactor with ultrafiltration, and/or a continuous plug-flow column reactor (Fernanda de Castilhos Corazza et al., 2003, Optimal control in fed-batch reactor for the cellobiose hydrolysis, Acta Scientiarum. Technology 25: 33-38; Gusakov and Sinitsyn, 1985, Kinetics of the enzymatic hydrolysis of cellulose: 1. A mathematical model for a batch reactor process, Enz. Microb. Technol. 7: 346-352), an attrition reactor (Ryu and Lee, 1983, Bioconversion of waste cellulose by using an attrition bioreactor, Biotechnol. Bioeng. 25: 53-65), or a reactor with intensive stirring induced by an electromagnetic field (Gusakov et al., 1996, Enhancement of enzymatic cellulose hydrolysis using a novel type of bioreactor with intensive stirring induced by electromagnetic field, Appl. Biochem. Biotechnol. 56: 141-153). Additional reactor types include: fluidized bed, upflow blanket, immobilized, and extruder type reactors for hydrolysis and/or fermentation.
According to the invention fermentation may be carried out using a microorganism, such as yeast or a bacterium. In an embodiment the fermenting microorganism is capable of fermenting hexose and/or pentose sugars into a desired fermentation product. In a preferred embodiment the fermenting microorganism is yeast, such as strain of the genus Saccharomyces, such as a strain of Saccharomyces cerevisiae. Examples of suitable fermenting microorganisms can be found in the “Fermenting Microorganisms” section below.
In an embodiment fermentation is carried out at a temperature between about 26° C. to about 60° C., e.g., about 32° C. or 50° C., and about pH 3 to about pH 8, e.g., pH 4-5, 6, or 7.
When the fermenting microorganism is yeast, such as a strain of the genus Saccharomyces, in particular a strain of Saccharomyces cerevisiae, fermentation may be carried out at a temperature from 20-40° C., e.g., 26-34° C., preferably around 32° C., especially, when the desired fermentation product is ethanol. In an embodiment fermentation is carried out at pH 3-7, e.g., pH 4-6. In an embodiment fermentation is performed for about 12 to about 96 hours, such as typically 24-60 hours. In a preferred embodiment the fermentation product is an alcohol, e.g., ethanol.
The cellulosic material used in a method or process of the invention can be any material containing cellulose. The predominant polysaccharide in the primary cell wall of biomass is cellulose, the second most abundant is hemicellulose, and the third is pectin. The secondary cell wall, produced after the cell has stopped growing, also contains polysaccharides and is strengthened by polymeric lignin covalently cross-linked to hemicellulose. Cellulose is a homopolymer of anhydrocellobiose and thus a linear beta-(1-4)-D-glucan, while hemicelluloses include a variety of compounds, such as xylans, xyloglucans, arabinoxylans, and mannans in complex branched structures with a spectrum of substituents. Although generally polymorphous, cellulose is found in plant tissue primarily as an insoluble crystalline matrix of parallel glucan chains. Hemicelluloses usually hydrogen bond to cellulose, as well as to other hemicelluloses, which help stabilize the cell wall matrix.
Cellulose is generally found, for example, in the stems, leaves, hulls, husks, and cobs of plants or leaves, branches, and wood of trees. The cellulosic material can be, but is not limited to, herbaceous material, agricultural residue, forestry residue, municipal solid waste, waste paper, and pulp and paper mill residue (see, for example, Wiselogel et al., 1995, in Handbook on Bioethanol (Charles E. Wyman, editor), pp. 105-118, Taylor & Francis, Washington D.C.; Wyman, 1994, Bioresource Technology 50: 3-16; Lynd, 1990, Applied Biochemistry and Biotechnology 24/25: 695-719; Mosier et al., 1999, Recent Progress in Bioconversion of Lignocellulosics, in Advances in Biochemical Engineering/Biotechnology, T. Scheper, managing editor, Volume 65, pp. 23-40, Springer-Verlag, New York). It is understood herein that the cellulose may be in the form of lignocellulose, a plant cell wall material containing lignin, cellulose, and hemicellulose in a mixed matrix. In a preferred aspect, the cellulosic material is lignocellulose.
In one aspect, the cellulosic material is herbaceous material. In another aspect, the cellulosic material is agricultural residue. In another aspect, the cellulosic material is forestry residue. In another aspect, the cellulosic material is municipal solid waste. In another aspect, the cellulosic material is waste paper. In another aspect, the cellulosic material is pulp and paper mill residue.
In another aspect, the cellulosic material is corn stover. In another aspect, the cellulosic material is corn fiber. In another aspect, the cellulosic material is corn cob. In another aspect, the cellulosic material is orange peel. In another aspect, the cellulosic material is rice straw. In another aspect, the cellulosic material is wheat straw. In another aspect, the cellulosic material is switch grass. In another aspect, the cellulosic material is miscanthus. In another aspect, the cellulosic material is bagasse.
In another aspect, the cellulosic material is microcrystalline cellulose. In another aspect, the cellulosic material is bacterial cellulose. In another aspect, the cellulosic material is algal cellulose. In another aspect, the cellulosic material is cotton linter. In another aspect, the cellulosic material is amorphous phosphoric-acid treated cellulose. In another aspect, the cellulosic material is filter paper.
The cellulosic material may be used as is or may be subjected to pretreatment, using conventional methods known in the art, as described herein. In a preferred aspect, the cellulosic material is pretreated.
In a preferred embodiment the pretreated cellulosic material is pretreated corn stover or “PCS” which is corn stover treatment with heat and dilute sulfuric acid.
In practicing the methods or processes of the present invention, preparing the pretreated cellulosic material, any pretreatment process known in the art can be used to disrupt plant cell wall components of cellulosic material (Chandra et al., 2007, Substrate pretreatment: The key to effective enzymatic hydrolysis of lignocellulosics? Adv. Biochem. Engin./Biotechnol. 108: 67-93; Galbe and Zacchi, 2007, Pretreatment of lignocellulosic materials for efficient bioethanol production, Adv. Biochem. Engin./Biotechnol. 108: 41-65; Hendriks and Zeeman, 2009, Pretreatments to enhance the digestibility of lignocellulosic biomass, Bioresource Technol. 100: 10-18; Mosier et al., 2005, Features of promising technologies for pretreatment of lignocellulosic biomass, Bioresource Technol. 96: 673-686; Taherzadeh and Karimi, 2008, Pretreatment of lignocellulosic wastes to improve ethanol and biogas production: A review, Int. J. of Mol. Sci. 9: 1621-1651; Yang and Wyman, 2008, Pretreatment: the key to unlocking low-cost cellulosic ethanol, Biofuels Bioproducts and Biorefining-Biofpr. 2: 26-40).
The cellulosic material can also be subjected to particle size reduction, pre-soaking, wetting, washing, or conditioning prior to pretreatment using methods known in the art.
Conventional pretreatments include, but are not limited to, steam pretreatment (with or without explosion), dilute acid pretreatment, hot water pretreatment, alkaline pretreatment, lime pretreatment, wet oxidation, wet explosion, ammonia fiber explosion, organosolv pretreatment, and biological pretreatment. Additional pretreatments include ammonia percolation, ultrasound, electroporation, microwave, supercritical CO2, supercritical H2O, ozone, and gamma irradiation pretreatments.
The cellulosic material can be pretreated before hydrolysis and/or fermentation. Pretreatment is preferably performed prior to the hydrolysis. Alternatively, the pretreatment can be carried out simultaneously with enzyme hydrolysis to release fermentable sugars, such as glucose, xylose, and/or cellobiose. In most cases the pretreatment step itself results in some conversion of biomass to fermentable sugars (even in absence of enzymes).
In steam pretreatment, cellulosic material is heated to disrupt the plant cell wall components, including lignin, hemicellulose, and cellulose to make the cellulose and other fractions, e.g., hemicellulose, accessible to enzymes. Cellulosic material is passed to or through a reaction vessel where steam is injected to increase the temperature to the required temperature and pressure and is retained therein for the desired reaction time. Steam pretreatment is preferably done at 140-230° C., more preferably 160-200° C., and most preferably 170-190° C., where the optimal temperature range depends on any addition of a chemical catalyst. Residence time for the steam pretreatment is preferably 1-15 minutes, more preferably 3-12 minutes, and most preferably 4-10 minutes, where the optimal residence time depends on temperature range and any addition of a chemical catalyst. Steam pretreatment allows for relatively high solids loadings, so that cellulosic material is generally only moist during the pretreatment. The steam pretreatment is often combined with an explosive discharge of the material after the pretreatment, which is known as steam explosion, that is, rapid flashing to atmospheric pressure and turbulent flow of the material to increase the accessible surface area by fragmentation (Duff and Murray, 1996, Bioresource Technology 855: 1-33; Galbe and Zacchi, 2002, Appl. Microbiol. Biotechnol. 59: 618-628; U.S. Patent Application No. 2002/0164730). During steam pretreatment, hemicellulose acetyl groups are cleaved and the resulting acid autocatalyzes partial hydrolysis of the hemicellulose to monosaccharides and oligosaccharides. Lignin is removed to only a limited extent.
A catalyst such as H2SO4 or SO2 (typically 0.3 to 3% w/w) is often added prior to steam pretreatment, which decreases the time and temperature, increases the recovery, and improves enzymatic hydrolysis (Ballesteros et al., 2006, Appl. Biochem. Biotechnol. 129-132: 496-508; Varga et al., 2004, Appl. Biochem. Biotechnol. 113-116: 509-523; Sassner et al., 2006, Enzyme Microb. Technol. 39: 756-762).
The term “chemical treatment” refers to any chemical pretreatment that promotes the separation and/or release of cellulose, hemicellulose, and/or lignin. Examples of suitable chemical pretreatment processes include, for example, dilute acid pretreatment, lime pretreatment, wet oxidation, ammonia fiber/freeze explosion (AFEX), ammonia percolation (APR), and organosolv pretreatments.
In dilute acid pretreatment, cellulosic material is mixed with dilute acid, typically H2SO4, and water to form a slurry, heated by steam to the desired temperature, and after a residence time flashed to atmospheric pressure. The dilute acid pretreatment can be performed with a number of reactor designs, e.g., plug-flow reactors, counter-current reactors, or continuous counter-current shrinking bed reactors (Duff and Murray, 1996, supra; Schell et al., 2004, Bioresource Technol. 91: 179-188; Lee et al., 1999, Adv. Biochem. Eng. Biotechnol. 65: 93-115).
Several methods of pretreatment under alkaline conditions can also be used. These alkaline pretreatments include, but are not limited to, lime pretreatment, wet oxidation, ammonia percolation (APR), and ammonia fiber/freeze explosion (AFEX).
Lime pretreatment is performed with calcium carbonate, sodium hydroxide, or ammonia at low temperatures of 85-150° C. and residence times from 1 hour to several days (Wyman et al., 2005, Bioresource Technol. 96: 1959-1966; Mosier et al., 2005, Bioresource Technol. 96: 673-686). WO 2006/110891, WO 2006/110899, WO 2006/110900, and WO 2006/110901 disclose pretreatment methods using ammonia.
Wet oxidation is a thermal pretreatment performed typically at 180-200° C. for 5-15 minutes with addition of an oxidative agent such as hydrogen peroxide or over-pressure of oxygen (Schmidt and Thomsen, 1998, Bioresource Technol. 64: 139-151; Palonen et al., 2004, Appl. Biochem. Biotechnol. 117: 1-17; Varga et al., 2004, Biotechnol. Bioeng. 88: 567-574; Martin et al., 2006, J. Chem. Technol. Biotechnol. 81: 1669-1677). The pretreatment is performed at preferably 1-40% dry matter, more preferably 2-30% dry matter, and most preferably 5-20% dry matter, and often the initial pH is increased by the addition of alkali such as sodium carbonate.
A modification of the wet oxidation pretreatment method, known as wet explosion (combination of wet oxidation and steam explosion), can handle dry matter up to 30%. In wet explosion, the oxidizing agent is introduced during pretreatment after a certain residence time. The pretreatment is then ended by flashing to atmospheric pressure (WO 2006/032282).
Ammonia fiber explosion (AFEX) involves treating cellulosic material with liquid or gaseous ammonia at moderate temperatures such as 90-100° C. and high pressure such as 17-20 bar for 5-10 minutes, where the dry matter content can be as high as 60% (Gollapalli et al., 2002, Appl. Biochem. Biotechnol. 98: 23-35; Chundawat et al., 2007, Biotechnol. Bioeng. 96: 219-231; Alizadeh et al., 2005, Appl. Biochem. Biotechnol. 121: 1133-1141; Teymouri et al., 2005, Bioresource Technol. 96: 2014-2018). AFEX pretreatment results in the depolymerization of cellulose and partial hydrolysis of hemicellulose. Lignin-carbohydrate complexes are cleaved.
Organosolv pretreatment delignifies cellulosic material by extraction using aqueous ethanol (40-60% ethanol) at 160-200° C. for 30-60 minutes (Pan et al., 2005, Biotechnol. Bioeng. 90: 473-481; Pan et al., 2006, Biotechnol. Bioeng. 94: 851-861; Kurabi et al., 2005, Appl. Biochem. Biotechnol. 121: 219-230). Sulphuric acid is usually added as a catalyst. In organosolv pretreatment, the majority of hemicellulose is removed.
Other examples of suitable pretreatment methods are described by Schell et al., 2003, Appl. Biochem. and Biotechnol. 105-108: 69-85, and Mosier et al., 2005, Bioresource Technology 96: 673-686, and U.S. Published Application 2002/0164730.
In one aspect, the chemical pretreatment is preferably carried out as an acid treatment, and more preferably as a continuous dilute and/or mild acid treatment. The acid is typically sulfuric acid, but other acids can also be used, such as acetic acid, citric acid, nitric acid, phosphoric acid, tartaric acid, succinic acid, hydrogen chloride, or mixtures thereof. Mild acid treatment is conducted in the pH range of preferably 1-5, more preferably 1-4, and most preferably 1-3. In one aspect, the acid concentration is in the range from preferably 0.01 to 20 wt % acid, more preferably 0.05 to 10 wt. % acid, even more preferably 0.1 to 5 wt. % acid, and most preferably 0.2 to 2.0 wt. % acid. The acid is contacted with cellulosic material and held at a temperature in the range of preferably 160-220° C., and more preferably 165-195° C., for periods ranging from seconds to minutes to, e.g., 1 second to 60 minutes.
In another aspect, pretreatment is carried out as an ammonia fiber explosion step (AFEX pretreatment step).
In another aspect, pretreatment takes place in an aqueous slurry. In preferred aspects, cellulosic material is present during pretreatment in amounts preferably between 10-80 wt. %, more preferably between 20-70 wt. %, and most preferably between 30-60 wt. %, such as around 50 wt. %. The pretreated cellulosic material can be unwashed or washed using any method known in the art, e.g., washed with water.
The term “mechanical pretreatment” refers to various types of grinding or milling (e.g., dry milling, wet milling, or vibratory ball milling).
The term “physical pretreatment” refers to any pretreatment that promotes the separation and/or release of cellulose, hemicellulose, and/or lignin from cellulosic material. For example, physical pretreatment can involve irradiation (e.g., microwave irradiation), steaming/steam explosion, hydrothermolysis, and combinations thereof.
Physical pretreatment can involve high pressure and/or high temperature (steam explosion). In one aspect, high pressure means pressure in the range of preferably about 300 to about 600 psi, more preferably about 350 to about 550 psi, and most preferably about 400 to about 500 psi, such as around 450 psi. In another aspect, high temperature means temperatures in the range of about 100 to about 300° C., preferably about 140 to about 235° C. In a preferred aspect, mechanical pretreatment is performed in a batch-process, steam gun hydrolyzer system that uses high pressure and high temperature as defined above, e.g., a Sunds Hydrolyzer available from Sunds Defibrator AB, Sweden.
Cellulosic material can be pretreated both physically and chemically. For instance, the pretreatment step can involve dilute or mild acid treatment and high temperature and/or pressure treatment. The physical and chemical pretreatments can be carried out sequentially or simultaneously, as desired. A mechanical pretreatment can also be included.
Accordingly, in a preferred aspect, cellulosic material is subjected to mechanical, chemical, or physical pretreatment, or any combination thereof, to promote the separation and/or release of cellulose, hemicellulose, and/or lignin.
The term “biological pretreatment” refers to any biological pretreatment that promotes the separation and/or release of cellulose, hemicellulose, and/or lignin from cellulosic material. Biological pretreatment techniques can involve applying lignin-solubilizing microorganisms (see, for example, Hsu, T.-A., 1996, Pretreatment of biomass, in Handbook on Bioethanol: Production and Utilization, Wyman, C. E., ed., Taylor & Francis, Washington, D.C., 179-212; Ghosh and Singh, 1993, Physicochemical and biological treatments for enzymatic/microbial conversion of cellulosic biomass, Adv. Appl. Microbiol. 39: 295-333; McMillan, J. D., 1994, Pretreating lignocellulosic biomass: a review, in Enzymatic Conversion of Biomass for Fuels Production, Himmel, M. E., Baker, J. O., and Overend, R. P., eds., ACS Symposium Series 566, American Chemical Society, Washington, D.C., chapter 15; Gong, C. S., Cao, N. J., Du, J., and Tsao, G. T., 1999, Ethanol production from renewable resources, in Advances in Biochemical Engineering/Biotechnology, Scheper, T., ed., Springer-Verlag Berlin Heidelberg, Germany, 65: 207-241; Olsson and Hahn-Hagerdal, 1996, Fermentation of lignocellulosic hydrolysates for ethanol production, Enz. Microb. Tech. 18: 312-331; and Vallander and Eriksson, 1990, Production of ethanol from lignocellulosic materials: State of the art, Adv. Biochem. Eng./Biotechnol. 42: 63-95).
According to the method and process of the invention fermentable sugars are obtained from hydrolyzing pretreated cellulosic material. Said sugars can be fermented by one or more (several) fermenting microorganisms capable of fermenting/converting the sugars directly or indirectly into a desired fermentation product. The term “Fermentation” refers to any process comprising a fermentation step. The fermentation conditions depend on the desired fermentation product and fermenting microorganism. Fermentation conditions can easily be determined by one skilled in the art.
In the fermentation step, sugars, released from the pretreated cellulosic material as a result of the hydrolysis, are fermented to a desired product, e.g., ethanol, by a fermenting microorganism, such as yeast. Hydrolysis (saccharification) and fermentation can be separate (SHF) or simultaneous (SSF), or as described above.
Any suitable hydrolyzed pretreated cellulosic material can be used in fermentation in practicing the present invention. The material is generally selected based on the desired fermentation product.
The term “fermentation medium” is understood herein to refer to a medium before the fermenting microorganism is added, such as, a medium resulting from a hydrolysis, as well as a medium used in a simultaneous saccharification and fermentation (SSF).
According to the process of the invention, one or more fermenting microorganisms are used to ferment/convert sugars produced by hydrolyzing pretreated cellulosic material in accordance with the method of the invention. The term “fermenting microorganism” refers to any microorganism, including bacterial and fungal organisms, suitable for use in a process of the invention. The fermenting microorganism can be C6 or C5 fermenting microorganism, or a combination thereof. Both C6 and C5 fermenting microorganisms are well-known in the art. Suitable fermenting microorganisms are able to ferment, i.e., convert, sugars, such as glucose, xylose, xylulose, arabinose, maltose, mannose, galactose, or oligosaccharides, directly or indirectly into the desired fermentation product.
Examples of bacterial and fungal fermenting microorganisms producing ethanol are described by Lin et al., 2006, Appl. Microbiol. Biotechnol. 69: 627-642.
Examples of fermenting microorganisms that can ferment C6 sugars include bacterial and fungal organisms, such as yeast. Preferred yeast includes strains of the Saccharomyces spp., preferably Saccharomyces cerevisiae.
Examples of fermenting microorganisms that can ferment C5 sugars include bacterial and fungal organisms, such as yeast. Preferred C5 fermenting yeast include strains of Pichia, preferably Pichia stipitis, such as Pichia stipitis CBS 5773; strains of Candida, preferably Candida boidinii, Candida brassicae, Candida sheatae, Candida diddensii, Candida pseudotropicalis, or Candida utilis.
Other fermenting microorganisms include strains of Zymomonas, such as Zymomonas mobilis; Hansenula, such as Hansenula anomala; Kluyveromyces, such as K. fragilis; Schizosaccharomyces, such as S. pombe; and E. coli, especially E. coli strains that have been genetically modified to improve the yield of ethanol.
In a preferred aspect, the yeast is a Saccharomyces spp. In a more preferred aspect, the yeast is Saccharomyces cerevisiae. In another more preferred aspect, the yeast is Saccharomyces distaticus. In another more preferred aspect, the yeast is Saccharomyces uvarum. In another preferred aspect, the yeast is a Kluyveromyces. In another more preferred aspect, the yeast is Kluyveromyces marxianus. In another more preferred aspect, the yeast is Kluyveromyces fragilis. In another preferred aspect, the yeast is a Candida. In another more preferred aspect, the yeast is Candida boidinii. In another more preferred aspect, the yeast is Candida brassicae. In another more preferred aspect, the yeast is Candida diddensii. In another more preferred aspect, the yeast is Candida pseudotropicalis. In another more preferred aspect, the yeast is Candida utilis. In another preferred aspect, the yeast is a Clavispora. In another more preferred aspect, the yeast is Clavispora lusitaniae. In another more preferred aspect, the yeast is Clavispora opuntiae. In another preferred aspect, the yeast is a Pachysolen. In another more preferred aspect, the yeast is Pachysolen tannophilus. In another preferred aspect, the yeast is a Pichia. In another more preferred aspect, the yeast is a Pichia stipitis. In another preferred aspect, the yeast is a Bretannomyces. In another more preferred aspect, the yeast is Bretannomyces clausenii (Philippidis, G. P., 1996, Cellulose bioconversion technology, in Handbook on Bioethanol: Production and Utilization, Wyman, C. E., ed., Taylor & Francis, Washington, D.C., 179-212).
Bacteria that can efficiently ferment hexose and pentose to ethanol include, for example, Zymomonas mobilis and Clostridium thermocellum (Philippidis, 1996, supra).
In a preferred aspect, the bacterium is a Zymomonas. In a more preferred aspect, the bacterium is Zymomonas mobilis. In another preferred aspect, the bacterium is a Clostridium. In another more preferred aspect, the bacterium is Clostridium thermocellum.
Commercially available yeast suitable for ethanol production includes, e.g., ETHANOL RED™ yeast (available from Fermentis/Lesaffre, USA), FALI™ (available from Fleischmann's Yeast, USA), SUPERSTART™ and THERMOSACC™ fresh yeast (available from Ethanol Technology, WI, USA), BIOFERM™ AFT and XR (available from NABC—North American Bioproducts Corporation, GA, USA), GERT STRAND™ (available from Gert Strand AB, Sweden), and FERMIOL™ (available from DSM Specialties).
In a preferred aspect, the fermenting microorganism has been genetically modified to provide the ability to ferment pentose sugars, such as xylose utilizing, arabinose utilizing, and xylose and arabinose co-utilizing microorganisms.
The cloning of heterologous genes into various fermenting microorganisms has led to the construction of microorganisms capable of converting hexoses and pentoses to ethanol (cofermentation) (Chen and Ho, 1993, Cloning and improving the expression of Pichia stipitis xylose reductase gene in Saccharomyces cerevisiae, Appl. Biochem. Biotechnol. 39-40: 135-147; Ho et al., 1998, Genetically engineered Saccharomyces yeast capable of effectively cofermenting glucose and xylose, Appl. Environ. Microbiol. 64: 1852-1859; Kotter and Ciriacy, 1993, Xylose fermentation by Saccharomyces cerevisiae, Appl. Microbiol. Biotechnol. 38: 776-783; Walfridsson et al., 1995, Xylose-metabolizing Saccharomyces cerevisiae strains overexpressing the TKL1 and TAL1 genes encoding the pentose phosphate pathway enzymes transketolase and transaldolase, Appl. Environ. Microbiol. 61: 4184-4190; Kuyper et al., 2004, Minimal metabolic engineering of Saccharomyces cerevisiae for efficient anaerobic xylose fermentation: a proof of principle, FEMS Yeast Research 4: 655-664; Beall et al., 1991, Parametric studies of ethanol production from xylose and other sugars by recombinant Escherichia coli, Biotech. Bioeng. 38: 296-303; Ingram et al., 1998, Metabolic engineering of bacteria for ethanol production, Biotechnol. Bioeng. 58: 204-214; Zhang et al., 1995, Metabolic engineering of a pentose metabolism pathway in ethanologenic Zymomonas mobilis, Science 267: 240-243; Deanda et al., 1996, Development of an arabinose-fermenting Zymomonas mobilis strain by metabolic pathway engineering, Appl. Environ. Microbiol. 62: 4465-4470; WO 03/062430, xylose isomerase).
In an embodiment the C5 fermenting microorganism is a modified strain of Saccharomyces cerevisiae comprising a xylose isomerase gene as disclosed in WO 03/062340, WO 2004/099381 or WO 2006/009434.
In a preferred aspect, the genetically modified fermenting microorganism is Saccharomyces cerevisiae. In another preferred aspect, the genetically modified fermenting microorganism is Zymomonas mobilis. In another preferred aspect, the genetically modified fermenting microorganism is Escherichia coli. In another preferred aspect, the genetically modified fermenting microorganism is Klebsiella oxytoca. In another preferred aspect, the genetically modified fermenting microorganism is Kluyveromyces sp.
It is well-known in the art that the microorganisms described above can also be used to produce other substances, as described herein.
The fermenting microorganism is typically added to the degraded pretreated cellulosic material or hydrolysate and the fermentation is performed for about 12 to about 96 hours, such as about 24 to about 60 hours. The temperature is typically between about 26° C. to about 60° C., in particular about 32° C. or 50° C., and at about pH 3 to about pH 8, such as around pH 4-5, 6, or 7.
In a preferred aspect, the yeast and/or another microorganism is applied to the degraded pretreated cellulosic material and the fermentation is performed as described above for about 12 to about 96 hours, such as typically 24-60 hours. In a preferred aspect, the temperature is preferably between about 20° C. to about 60° C., more preferably about 25° C. to about 50° C., and most preferably about 32° C. to about 50° C., in particular about 32° C. or 50° C., and the pH is generally from about pH 3 to about pH 7, preferably around pH 4-7. However, some fermenting microorganisms, e.g., bacteria, have higher fermentation temperature optima.
Yeast or another microorganism is preferably applied in amounts of approximately 105 to 1012, preferably from approximately 107 to 1010, especially approximately 2×108 viable cell count per ml of fermentation broth. Further guidance in respect of using yeast for fermentation can be found in, e.g., “The Alcohol Textbook” (Editors K. Jacques, T. P. Lyons and D. R. Kelsall, Nottingham University Press, United Kingdom 1999), which is hereby incorporated by reference.
For ethanol production, following the fermentation the fermented slurry is distilled to extract the ethanol. The ethanol obtained according to the processes of the invention can be used as, e.g., fuel ethanol, drinking ethanol, i.e., potable neutral spirits, or industrial ethanol.
A fermentation stimulator can be used in combination with any of the processes described herein to further improve the fermentation, and in particular, the performance of the fermenting microorganism, such as, rate enhancement and product yield. A “fermentation stimulator” refers to stimulators for growth of the fermenting microorganisms, in particular, yeast. Preferred fermentation stimulators for growth include vitamins and minerals. Examples of vitamins include multivitamins, biotin, pantothenate, nicotinic acid, meso-inositol, thiamine, pyridoxine, para-aminobenzoic acid, folic acid, riboflavin, and Vitamins A, B, C, D, and E. See, for example, Alfenore et al., Improving ethanol production and viability of Saccharomyces cerevisiae by a vitamin feeding strategy during fed-batch process, Springer-Verlag (2002), which is hereby incorporated by reference. Examples of minerals include minerals and mineral salts that can supply nutrients comprising P, K, Mg, S, Ca, Fe, Zn, Mn, and Cu.
A (desired) fermentation product can be any substance derived from process of the invention, which include a fermentation step. The fermentation product can be, without limitation, an alcohol (e.g., arabinitol, butanol, ethanol, glycerol, methanol, 1,3-propanediol, sorbitol, and xylitol); an organic acid (e.g., acetic acid, acetonic acid, adipic acid, ascorbic acid, citric acid, 2,5-diketo-D-gluconic acid, formic acid, fumaric acid, glucaric acid, gluconic acid, glucuronic acid, glutaric acid, 3-hydroxypropionic acid, itaconic acid, lactic acid, malic acid, malonic acid, oxalic acid, oxaloacetic acid, propionic acid, succinic acid, and xylonic acid); a ketone (e.g., acetone); an amino acid (e.g., aspartic acid, glutamic acid, glycine, lysine, serine, and threonine); and a gas (e.g., methane, hydrogen (H2), carbon dioxide (CO2), and carbon monoxide (CO)). The fermentation product can also be protein as a high value product.
In a preferred embodiment, the fermentation product is an alcohol. It will be understood that the term “alcohol” encompasses a substance that contains one or more hydroxyl moieties. In a more preferred aspect, the alcohol is arabinitol. In another more preferred aspect, the alcohol is butanol. In another more preferred aspect, the alcohol is ethanol. In another embodiment, the alcohol is glycerol. In another preferred embodiment, the alcohol is methanol. In another more preferred aspect, the alcohol is 1,3-propanediol. In another more preferred aspect, the alcohol is sorbitol. In another more preferred aspect, the alcohol is xylitol. See, for example, Gong, C. S., Cao, N. J., Du, J., and Tsao, G. T., 1999, Ethanol production from renewable resources, in Advances in Biochemical Engineering/Biotechnology, Scheper, T., ed., Springer-Verlag Berlin Heidelberg, Germany, 65: 207-241; Silveira and Jonas, 2002, The biotechnological production of sorbitol, Appl. Microbiol. Biotechnol. 59: 400-408; Nigam and Singh, 1995, Processes for fermentative production of xylitol—a sugar substitute, Process Biochemistry 30(2): 117-124; Ezeji et al., 2003, Production of acetone, butanol and ethanol by Clostridium beijerinckii BA101 and in situ recovery by gas stripping, World Journal of Microbiology and Biotechnology 19(6): 595-603.
In another preferred embodiment, the fermentation product is an organic acid. In another more preferred embodiment, the organic acid is acetic acid. In another more preferred embodiment, the organic acid is acetonic acid. In another more preferred embodiment, the organic acid is adipic acid. In another more preferred embodiment, the organic acid is ascorbic acid. In another more preferred embodiment, the organic acid is citric acid. In another more preferred embodiment, the organic acid is 2,5-diketo-D-gluconic acid. In another more preferred embodiment, the organic acid is formic acid. In another more preferred embodiment, the organic acid is fumaric acid. In another more preferred embodiment, the organic acid is glucaric acid. In another more preferred embodiment, the organic acid is gluconic acid. In another more preferred embodiment, the organic acid is glucuronic acid. In another more preferred embodiment, the organic acid is glutaric acid. In another preferred embodiment, the organic acid is 3-hydroxypropionic acid. In another more preferred embodiment, the organic acid is itaconic acid. In another more preferred embodiment, the organic acid is lactic acid. In another more preferred embodiment, the organic acid is malic acid. In another more preferred embodiment, the organic acid is malonic acid. In another more preferred embodiment, the organic acid is oxalic acid. In another more preferred embodiment, the organic acid is propionic acid. In another more preferred embodiment, the organic acid is succinic acid. In another more preferred embodiment, the organic acid is xylonic acid. See, for example, Chen and Lee, 1997, Membrane-mediated extractive fermentation for lactic acid production from cellulosic biomass, Appl. Biochem. Biotechnol. 63-65: 435-448.
In another preferred embodiment, the fermentation product is a ketone. It will be understood that the term “ketone” encompasses a substance that contains one or more ketone moieties. In another more preferred aspect, the ketone is acetone. See, for example, Qureshi and Blaschek, 2003, supra.
In another preferred embodiment, the fermentation product is an amino acid. In another more preferred embodiment, the organic acid is aspartic acid. In another more preferred embodiment, the amino acid is glutamic acid. In another more preferred embodiment, the amino acid is glycine. In another more preferred embodiment, the amino acid is lysine. In another more preferred embodiment, the amino acid is serine. In another more preferred embodiment, the amino acid is threonine. See, for example, Richard and Margaritis, 2004, Empirical modeling of batch fermentation kinetics for poly(glutamic acid) production and other microbial biopolymers, Biotechnology and Bioengineering 87(4): 501-515.
In another preferred embodiment, the fermentation product is a gas. In another more preferred embodiment, the gas is methane. In another more preferred embodiment, the gas is H2. In another more preferred embodiment, the gas is CO2. In another more preferred embodiment, the gas is CO. See, for example, Kataoka et al., 1997, Studies on hydrogen production by continuous culture system of hydrogen-producing anaerobic bacteria, Water Science and Technology 36(6-7): 41-47; and Gunaseelan, 1997, Anaerobic digestion of biomass for methane production: A review, Biomass and Bioenergy 13(1-2): 83-114.
The fermentation product can optionally be recovered from the fermentation using any method known in the art including, but not limited to, chromatography, electrophoretic procedures, differential solubility, distillation, or extraction. For example, an alcohol, e.g., ethanol, may be separated from the cellulosic material hydrolyzed and fermented in accordance with the present invention and optionally purified by conventional methods of distillation. Ethanol with a purity of up to about 96 vol. % can be obtained, which can be used as, for example, fuel ethanol, drinking ethanol, i.e., potable neutral spirits, or industrial ethanol.
A polypeptide having cellulolytic enhancing activity is present or added during hydrolysis in a method for degrading pretreated cellulosic material of the invention together with a cellulolytic enzyme composition; a Peroxidase; and a nonionic surfactant and/or a cationic surfactant.
In an embodiment the polypeptide having cellulolytic enhancing activity comprises the following motifs:
wherein X is any amino acid, X(4,5) is any amino acid at 4 or 5 contiguous positions, and X(4) is any amino acid at 4 contiguous positions.
The polypeptide comprising the above-noted motifs may further comprise:
wherein X is any amino acid, X(1,2) is any amino acid at 1 position or 2 contiguous positions, X(3) is any amino acid at 3 contiguous positions, and X(2) is any amino acid at 2 contiguous positions. In the above motifs, the accepted IUPAC single letter amino acid abbreviation is employed.
In a preferred embodiment the polypeptide having cellulolytic enhancing activity further comprises H—X(1,2)-G-P—X(3)-[YW]-[AILMV]. In another preferred aspect, the isolated polypeptide having cellulolytic enhancing activity further comprises [EQ]-X—Y—X(2)-C—X-[EHQN]-[FILV]-X-[ILV]. In another preferred embodiment the polypeptide having cellulolytic enhancing activity further comprises H—X(1,2)-G-P—X(3)-[YW]-[AILMV] and [EQ]-X—Y—X(2)-C—X[EHQN]-[FILV]-X-[ILV].
In another embodiment the polypeptide having cellulolytic enhancing activity comprises the following motif:
wherein x is any amino acid, x(4,5) is any amino acid at 4 or 5 contiguous positions, and x(3) is any amino acid at 3 contiguous positions. In the above motif, the accepted IUPAC single letter amino acid abbreviation is employed.
In an embodiment the polypeptide having cellulolytic enhancing activity comprises an amino acid sequence that has a degree of identity to the mature polypeptide of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, or SEQ ID NO: 16 of preferably at least 60%, more preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99%. In a preferred aspect, the mature polypeptide sequence is amino acids 20 to 326 of SEQ ID NO: 2, amino acids 18 to 239 of SEQ ID NO: 4, amino acids 20 to 258 of SEQ ID NO: 6, amino acids 19 to 226 of SEQ ID NO: 8, amino acids 20 to 304 of SEQ ID NO: 10, amino acids 16 to 317 of SEQ ID NO: 12, amino acids 23 to 250 of SEQ ID NO: 14, or amino acids 20 to 249 of SEQ ID NO: 16.
A polypeptide having cellulolytic enhancing activity preferably comprises the amino acid sequence of SEQ ID NO: 2 or an allelic variant thereof; or a fragment thereof that has cellulolytic enhancing activity. In a preferred aspect, the polypeptide comprises the amino acid sequence of SEQ ID NO: 2. In another preferred aspect, the polypeptide comprises the mature polypeptide of SEQ ID NO: 2. In another preferred aspect, the polypeptide comprises amino acids 20 to 326 of SEQ ID NO: 2, or an allelic variant thereof; or a fragment thereof that has cellulolytic enhancing activity. In another preferred aspect, the polypeptide comprises amino acids 20 to 326 of SEQ ID NO: 2. In another preferred aspect, the polypeptide consists of the amino acid sequence of SEQ ID NO: 2 or an allelic variant thereof; or a fragment thereof that has cellulolytic enhancing activity. In another preferred aspect, the polypeptide consists of the amino acid sequence of SEQ ID NO: 2. In another preferred aspect, the polypeptide consists of the mature polypeptide of SEQ ID NO: 2. In another preferred aspect, the polypeptide consists of amino acids 20 to 326 of SEQ ID NO: 2 or an allelic variant thereof; or a fragment thereof that has cellulolytic enhancing activity. In another preferred aspect, the polypeptide consists of amino acids 20 to 326 of SEQ ID NO: 2.
A polypeptide having cellulolytic enhancing activity preferably comprises the amino acid sequence of SEQ ID NO: 4 or an allelic variant thereof; or a fragment thereof that has cellulolytic enhancing activity. In a preferred aspect, the polypeptide comprises the amino acid sequence of SEQ ID NO: 4. In another preferred aspect, the polypeptide comprises the mature polypeptide of SEQ ID NO: 4. In another preferred aspect, the polypeptide comprises amino acids 18 to 239 of SEQ ID NO: 4, or an allelic variant thereof; or a fragment thereof that has cellulolytic enhancing activity. In another preferred aspect, the polypeptide comprises amino acids 18 to 239 of SEQ ID NO: 4. In another preferred aspect, the polypeptide consists of the amino acid sequence of SEQ ID NO: 4 or an allelic variant thereof; or a fragment thereof that has cellulolytic enhancing activity. In another preferred aspect, the polypeptide consists of the amino acid sequence of SEQ ID NO: 4. In another preferred aspect, the polypeptide consists of the mature polypeptide of SEQ ID NO: 4. In another preferred aspect, the polypeptide consists of amino acids 18 to 239 of SEQ ID NO: 4 or an allelic variant thereof; or a fragment thereof that has cellulolytic enhancing activity. In another preferred aspect, the polypeptide consists of amino acids 18 to 239 of SEQ ID NO: 4.
A polypeptide having cellulolytic enhancing activity preferably comprises the amino acid sequence of SEQ ID NO: 6 or an allelic variant thereof; or a fragment thereof that has cellulolytic enhancing activity. In a preferred aspect, the polypeptide comprises the amino acid sequence of SEQ ID NO: 6. In another preferred aspect, the polypeptide comprises the mature polypeptide of SEQ ID NO: 6. In another preferred aspect, the polypeptide comprises amino acids 20 to 258 of SEQ ID NO: 6, or an allelic variant thereof; or a fragment thereof that has cellulolytic enhancing activity. In another preferred aspect, the polypeptide comprises amino acids 20 to 258 of SEQ ID NO: 6. In another preferred aspect, the polypeptide consists of the amino acid sequence of SEQ ID NO: 6 or an allelic variant thereof; or a fragment thereof that has cellulolytic enhancing activity. In another preferred aspect, the polypeptide consists of the amino acid sequence of SEQ ID NO: 6. In another preferred aspect, the polypeptide consists of the mature polypeptide of SEQ ID NO: 6. In another preferred aspect, the polypeptide consists of amino acids 20 to 258 of SEQ ID NO: 6 or an allelic variant thereof; or a fragment thereof that has cellulolytic enhancing activity. In another preferred aspect, the polypeptide consists of amino acids 20 to 258 of SEQ ID NO: 6.
A polypeptide having cellulolytic enhancing activity preferably comprises the amino acid sequence of SEQ ID NO: 8 or an allelic variant thereof; or a fragment thereof that has cellulolytic enhancing activity. In a preferred aspect, the polypeptide comprises the amino acid sequence of SEQ ID NO: 8. In another preferred aspect, the polypeptide comprises the mature polypeptide of SEQ ID NO: 8. In another preferred aspect, the polypeptide comprises amino acids 19 to 226 of SEQ ID NO: 8, or an allelic variant thereof; or a fragment thereof that has cellulolytic enhancing activity. In another preferred aspect, the polypeptide comprises amino acids 19 to 226 of SEQ ID NO: 8. In another preferred aspect, the polypeptide consists of the amino acid sequence of SEQ ID NO: 8 or an allelic variant thereof; or a fragment thereof that has cellulolytic enhancing activity. In another preferred aspect, the polypeptide consists of the amino acid sequence of SEQ ID NO: 8. In another preferred aspect, the polypeptide consists of the mature polypeptide of SEQ ID NO: 8. In another preferred aspect, the polypeptide consists of amino acids 19 to 226 of SEQ ID NO: 8 or an allelic variant thereof; or a fragment thereof that has cellulolytic enhancing activity. In another preferred aspect, the polypeptide consists of amino acids 19 to 226 of SEQ ID NO: 8.
A polypeptide having cellulolytic enhancing activity preferably comprises the amino acid sequence of SEQ ID NO: 10 or an allelic variant thereof; or a fragment thereof that has cellulolytic enhancing activity. In a preferred aspect, the polypeptide comprises the amino acid sequence of SEQ ID NO: 10. In another preferred aspect, the polypeptide comprises the mature polypeptide of SEQ ID NO: 10. In another preferred aspect, the polypeptide comprises amino acids 20 to 304 of SEQ ID NO: 10, or an allelic variant thereof; or a fragment thereof that has cellulolytic enhancing activity. In another preferred aspect, the polypeptide comprises amino acids 20 to 304 of SEQ ID NO: 10. In another preferred aspect, the polypeptide consists of the amino acid sequence of SEQ ID NO: 10 or an allelic variant thereof; or a fragment thereof that has cellulolytic enhancing activity. In another preferred aspect, the polypeptide consists of the amino acid sequence of SEQ ID NO: 10. In another preferred aspect, the polypeptide consists of the mature polypeptide of SEQ ID NO: 10. In another preferred aspect, the polypeptide consists of amino acids 20 to 304 of SEQ ID NO: 10 or an allelic variant thereof; or a fragment thereof that has cellulolytic enhancing activity. In another preferred aspect, the polypeptide consists of amino acids 20 to 304 of SEQ ID NO: 10.
A polypeptide having cellulolytic enhancing activity preferably comprises the amino acid sequence of SEQ ID NO: 12 or an allelic variant thereof; or a fragment thereof having cellulolytic enhancing activity. In a preferred aspect, the polypeptide comprises the amino acid sequence of SEQ ID NO: 12. In another preferred aspect, the polypeptide comprises the mature polypeptide of SEQ ID NO: 12. In another preferred aspect, the polypeptide comprises amino acids 16 to 317 of SEQ ID NO: 12, or an allelic variant thereof; or a fragment thereof having cellulolytic enhancing activity. In another preferred aspect, the polypeptide comprises amino acids 16 to 317 of SEQ ID NO: 12. In another preferred aspect, the polypeptide consists of the amino acid sequence of SEQ ID NO: 12 or an allelic variant thereof; or a fragment thereof having cellulolytic enhancing activity. In another preferred aspect, the polypeptide consists of the amino acid sequence of SEQ ID NO: 12. In another preferred aspect, the polypeptide consists of the mature polypeptide of SEQ ID NO: 12. In another preferred aspect, the polypeptide consists of amino acids 16 to 317 of SEQ ID NO: 12 or an allelic variant thereof; or a fragment thereof having cellulolytic enhancing activity. In another preferred aspect, the polypeptide consists of amino acids 16 to 317 of SEQ ID NO: 12.
A polypeptide having cellulolytic enhancing activity preferably comprises the amino acid sequence of SEQ ID NO: 14 or an allelic variant thereof; or a fragment thereof that has cellulolytic enhancing activity. In a preferred aspect, the polypeptide comprises the amino acid sequence of SEQ ID NO: 14. In another preferred aspect, the polypeptide comprises the mature polypeptide of SEQ ID NO: 14. In another preferred aspect, the polypeptide comprises amino acids 23 to 250 of SEQ ID NO: 14, or an allelic variant thereof; or a fragment thereof that has cellulolytic enhancing activity. In another preferred aspect, the polypeptide comprises amino acids 23 to 250 of SEQ ID NO: 14. In another preferred aspect, the polypeptide consists of the amino acid sequence of SEQ ID NO: 14 or an allelic variant thereof; or a fragment thereof that has cellulolytic enhancing activity. In another preferred aspect, the polypeptide consists of the amino acid sequence of SEQ ID NO: 14. In another preferred aspect, the polypeptide consists of the mature polypeptide of SEQ ID NO: 14. In another preferred aspect, the polypeptide consists of amino acids 23 to 250 of SEQ ID NO: 14 or an allelic variant thereof; or a fragment thereof that has cellulolytic enhancing activity. In another preferred aspect, the polypeptide consists of amino acids 23 to 250 of SEQ ID NO: 14.
A polypeptide having cellulolytic enhancing activity preferably comprises the amino acid sequence of SEQ ID NO: 16 or an allelic variant thereof; or a fragment thereof that has cellulolytic enhancing activity. In a preferred aspect, the polypeptide comprises the amino acid sequence of SEQ ID NO: 16. In another preferred aspect, the polypeptide comprises the mature polypeptide of SEQ ID NO: 16. In another preferred aspect, the polypeptide comprises amino acids 20 to 249 of SEQ ID NO: 16, or an allelic variant thereof; or a fragment thereof that has cellulolytic enhancing activity. In another preferred aspect, the polypeptide comprises amino acids 20 to 249 of SEQ ID NO: 16. In another preferred aspect, the polypeptide consists of the amino acid sequence of SEQ ID NO: 16 or an allelic variant thereof; or a fragment thereof that has cellulolytic enhancing activity. In another preferred aspect, the polypeptide consists of the amino acid sequence of SEQ ID NO: 16. In another preferred aspect, the polypeptide consists of the mature polypeptide of SEQ ID NO: 16. In another preferred aspect, the polypeptide consists of amino acids 20 to 249 of SEQ ID NO: 16 or an allelic variant thereof; or a fragment thereof that has cellulolytic enhancing activity. In another preferred aspect, the polypeptide consists of amino acids 20 to 249 of SEQ ID NO: 16.
Preferably, a fragment of the mature polypeptide of SEQ ID NO: 2 contains at least 277 amino acid residues, more preferably at least 287 amino acid residues, and most preferably at least 297 amino acid residues. Preferably, a fragment of the mature polypeptide of SEQ ID NO: 4 contains at least 185 amino acid residues, more preferably at least 195 amino acid residues, and most preferably at least 205 amino acid residues. Preferably, a fragment of the mature polypeptide of SEQ ID NO: 6 contains at least 200 amino acid residues, more preferably at least 212 amino acid residues, and most preferably at least 224 amino acid residues. Preferably, a fragment of the mature polypeptide of SEQ ID NO: 8 contains at least 175 amino acid residues, more preferably at least 185 amino acid residues, and most preferably at least 195 amino acid residues. Preferably, a fragment of the mature polypeptide of SEQ ID NO: 10 contains at least 240 amino acid residues, more preferably at least 255 amino acid residues, and most preferably at least 270 amino acid residues. Preferably, a fragment of the mature polypeptide of SEQ ID NO: 12 contains at least 255 amino acid residues, more preferably at least 270 amino acid residues, and most preferably at least 285 amino acid residues. Preferably, a fragment of the mature polypeptide of SEQ ID NO: 14 contains at least 175 amino acid residues, more preferably at least 190 amino acid residues, and most preferably at least 205 amino acid residues. Preferably, a fragment of the mature polypeptide of SEQ ID NO: 16 contains at least 200 amino acid residues, more preferably at least 210 amino acid residues, and most preferably at least 220 amino acid residues.
Preferably, a subsequence of the mature polypeptide coding sequence of SEQ ID NO: 1 contains at least 831 nucleotides, more preferably at least 861 nucleotides, and most preferably at least 891 nucleotides. Preferably, a subsequence of the mature polypeptide coding sequence of SEQ ID NO: 3 contains at least 555 nucleotides, more preferably at least 585 nucleotides, and most preferably at least 615 nucleotides. Preferably, a subsequence of the mature polypeptide coding sequence of SEQ ID NO: 5 contains at least 600 nucleotides, more preferably at least 636 nucleotides, and most preferably at least 672 nucleotides. Preferably, a subsequence of the mature polypeptide coding sequence of SEQ ID NO: 7 contains at least 525 nucleotides, more preferably at least 555 nucleotides, and most preferably at least 585 nucleotides. Preferably, a subsequence of the mature polypeptide coding sequence of SEQ ID NO: 9 contains at least 720 nucleotides, more preferably at least 765 nucleotides, and most preferably at least 810 nucleotides. Preferably, a subsequence of the mature polypeptide coding sequence of SEQ ID NO: 11 contains at least 765 nucleotides, more preferably at least 810 nucleotides, and most preferably at least 855 nucleotides Preferably, a subsequence of the mature polypeptide coding sequence of nucleotides 67 to 796 of SEQ ID NO: 13 contains at least 525 nucleotides, more preferably at least 570 nucleotides, and most preferably at least 615 nucleotides. Preferably, a subsequence of the mature polypeptide coding sequence of SEQ ID NO: 15 contains at least 600 nucleotides, more preferably at least 630 nucleotides, and most preferably at least 660 nucleotides.
In a fourth aspect, the polypeptide having cellulolytic enhancing activity is encoded by a polynucleotide that hybridizes under at least very low stringency conditions, preferably at least low stringency conditions, more preferably at least medium stringency conditions, more preferably at least medium-high stringency conditions, even more preferably at least high stringency conditions, and most preferably at least very high stringency conditions with (i) the mature polypeptide coding sequence of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7, SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 13, or SEQ ID NO: 15, (ii) the cDNA sequence contained in the mature polypeptide coding sequence of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, or SEQ ID NO: 13, or the genomic DNA sequence comprising the mature polypeptide coding sequence of SEQ ID NO: 7, SEQ ID NO: 9, SEQ ID NO: 11, or SEQ ID NO: 15, (iii) a subsequence of (i) or (ii), or (iv) a full-length complementary strand of (i), (ii), or (iii) (Sambrook et al., 1989, supra). A subsequence of the mature polypeptide coding sequence of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7, SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 13, or SEQ ID NO: 15 contains at least 100 contiguous nucleotides or preferably at least 200 contiguous nucleotides. Moreover, the subsequence may encode a polypeptide fragment that has cellulolytic enhancing activity. In a preferred aspect, the mature polypeptide coding sequence is nucleotides 388 to 1332 of SEQ ID NO: 1, nucleotides 98 to 821 of SEQ ID NO: 3, nucleotides 126 to 978 of SEQ ID NO: 5, nucleotides 55 to 678 of SEQ ID NO: 7, nucleotides 58 to 912 of SEQ ID NO: 9, nucleotides 46 to 951 of SEQ ID NO: 11, nucleotides 67 to 796 of SEQ ID NO: 13, or nucleotides 77 to 766 of SEQ ID NO: 15.
The nucleotide sequence of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7, SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 13, or SEQ ID NO: 15, or a subsequence thereof; as well as the amino acid sequence of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, or SEQ ID NO: 16, or a fragment thereof, may be used to design a nucleic acid probe to identify and clone DNA encoding polypeptides having cellulolytic enhancing activity from strains of different genera or species according to methods well known in the art. In particular, such probes can be used for hybridization with the genomic or cDNA of the genus or species of interest, following standard Southern blotting procedures, in order to identify and isolate the corresponding gene therein. Such probes can be considerably shorter than the entire sequence, but should be at least 14, preferably at least 25, more preferably at least 35, and most preferably at least 70 nucleotides in length. It is, however, preferred that the nucleic acid probe is at least 100 nucleotides in length. For example, the nucleic acid probe may be at least 200 nucleotides, preferably at least 300 nucleotides, more preferably at least 400 nucleotides, or most preferably at least 500 nucleotides in length. Even longer probes may be used, e.g., nucleic acid probes that are preferably at least 600 nucleotides, more preferably at least 700 nucleotides, even more preferably at least 800 nucleotides, or most preferably at least 900 nucleotides in length. Both DNA and RNA probes can be used. The probes are typically labeled for detecting the corresponding gene (for example, with 32P, 3H, 35S, biotin, or avidin). Such probes are encompassed by the present invention.
A genomic DNA or cDNA library prepared from such other strains may, therefore, be screened for DNA that hybridizes with the probes described above and encodes a polypeptide having cellulolytic enhancing activity. Genomic or other DNA from such other strains may be separated by agarose or polyacrylamide gel electrophoresis, or other separation techniques. DNA from the libraries or the separated DNA may be transferred to and immobilized on nitrocellulose or other suitable carrier material. In order to identify a clone or DNA that is homologous with SEQ ID NO: 1, or a subsequence thereof, the carrier material is preferably used in a Southern blot.
For purposes of the present invention, hybridization indicates that the nucleotide sequence hybridizes to a labeled nucleic acid probe corresponding to the mature polypeptide coding sequence of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7, SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 13, or SEQ ID NO: 15 the cDNA sequence contained in the mature polypeptide coding sequence of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, or SEQ ID NO: 13, or the genomic DNA sequence comprising the mature polypeptide coding sequence of SEQ ID NO: 7, SEQ ID NO: 9, SEQ ID NO: 11, or SEQ ID NO: 15, its full-length complementary strand, or a subsequence thereof, under very low to very high stringency conditions, as described supra.
In a preferred aspect, the nucleic acid probe is the mature polypeptide coding sequence of SEQ ID NO: 1. In another preferred aspect, the nucleic acid probe is nucleotides 388 to 1332 of SEQ ID NO: 1. In another preferred aspect, the nucleic acid probe is a polynucleotide sequence that encodes the polypeptide of SEQ ID NO: 2, or a subsequence thereof. In another preferred aspect, the nucleic acid probe is SEQ ID NO: 1. In another preferred aspect, the nucleic acid probe is the polynucleotide sequence contained in plasmid pEJG120 which is contained in E. coli NRRL B-30699, wherein the polynucleotide sequence thereof encodes a polypeptide having cellulolytic enhancing activity. In another preferred aspect, the nucleic acid probe is the mature polypeptide coding sequence contained in plasmid pEJG120 which is contained in E. coli NRRL B-30699.
In another preferred aspect, the nucleic acid probe is the mature polypeptide coding sequence of SEQ ID NO: 3. In another preferred aspect, the nucleic acid probe is nucleotides 98 to 821 of SEQ ID NO: 3. In another preferred aspect, the nucleic acid probe is a polynucleotide sequence that encodes the polypeptide of SEQ ID NO: 4, or a subsequence thereof. In another preferred aspect, the nucleic acid probe is SEQ ID NO: 3. In another preferred aspect, the nucleic acid probe is the polynucleotide sequence contained in plasmid pTter61C which is contained in E. coli NRRL B-30813, wherein the polynucleotide sequence thereof encodes a polypeptide having cellulolytic enhancing activity. In another preferred aspect, the nucleic acid probe is the mature polypeptide coding sequence contained in plasmid pTter61C which is contained in E. coli NRRL B-30813.
In another preferred aspect, the nucleic acid probe is the mature polypeptide coding sequence of SEQ ID NO: 5. In another preferred aspect, the nucleic acid probe is nucleotides 126 to 978 of SEQ ID NO: 5. In another preferred aspect, the nucleic acid probe is a polynucleotide sequence that encodes the polypeptide of SEQ ID NO: 6, or a subsequence thereof. In another preferred aspect, the nucleic acid probe is SEQ ID NO: 5. In another preferred aspect, the nucleic acid probe is the polynucleotide sequence contained in plasmid pTter61D which is contained in E. coli NRRL B-30812, wherein the polynucleotide sequence thereof encodes a polypeptide having cellulolytic enhancing activity. In another preferred aspect, the nucleic acid probe is the mature polypeptide coding sequence contained in plasmid pTter61D which is contained in E. coli NRRL B-30812.
In another preferred aspect, the nucleic acid probe is the mature polypeptide coding sequence of SEQ ID NO: 7. In another preferred aspect, the nucleic acid probe is nucleotides 55 to 678 of SEQ ID NO: 7. In another preferred aspect, the nucleic acid probe is a polynucleotide sequence that encodes the polypeptide of SEQ ID NO: 8, or a subsequence thereof. In another preferred aspect, the nucleic acid probe is SEQ ID NO: 7. In another preferred aspect, the nucleic acid probe is the polynucleotide sequence contained in plasmid pTter61E which is contained in E. coli NRRL B-30814, wherein the polynucleotide sequence thereof encodes a polypeptide having cellulolytic enhancing activity. In another preferred aspect, the nucleic acid probe is the mature polypeptide coding sequence contained in plasmid pTter61E which is contained in E. coli NRRL B-30814.
In another preferred aspect, the nucleic acid probe is the mature polypeptide coding sequence of SEQ ID NO: 9. In another preferred aspect, the nucleic acid probe is nucleotides 58 to 912 of SEQ ID NO: 9 In another preferred aspect, the nucleic acid probe is a polynucleotide sequence that encodes the polypeptide of SEQ ID NO: 10, or a subsequence thereof. In another preferred aspect, the nucleic acid probe is SEQ ID NO: 9. In another preferred aspect, the nucleic acid probe is the polynucleotide sequence contained in plasmid pTter61G which is contained in E. coli NRRL B-30811, wherein the polynucleotide sequence thereof encodes a polypeptide having cellulolytic enhancing activity. In another preferred aspect, the nucleic acid probe is the mature polypeptide coding sequence contained in plasmid pTter61G which is contained in E. coli NRRL B-30811.
In another preferred aspect, the nucleic acid probe is the mature polypeptide coding sequence of SEQ ID NO: 11. In another preferred aspect, the nucleic acid probe is nucleotides 46 to 951 of SEQ ID NO: 11. In another preferred aspect, the nucleic acid probe is a polynucleotide sequence that encodes the polypeptide of SEQ ID NO: 12, or a subsequence thereof. In another preferred aspect, the nucleic acid probe is SEQ ID NO: 11. In another preferred aspect, the nucleic acid probe is the polynucleotide sequence contained in plasmid pTter61F which is contained in E. coli NRRL B-50044, wherein the polynucleotide sequence thereof encodes a polypeptide having cellulolytic enhancing activity. In another preferred aspect, the nucleic acid probe is the mature polypeptide coding region contained in plasmid pTter61F which is contained in E. coli NRRL B-50044.
In another preferred aspect, the nucleic acid probe is the mature polypeptide coding sequence of SEQ ID NO: 13. In another preferred aspect, the nucleic acid probe is nucleotides 67 to 796 of SEQ ID NO: 13. In another preferred aspect, the nucleic acid probe is a polynucleotide sequence that encodes the polypeptide of SEQ ID NO: 14, or a subsequence thereof. In another preferred aspect, the nucleic acid probe is SEQ ID NO: 13. In another preferred aspect, the nucleic acid probe is the polynucleotide sequence contained in plasmid pDZA2-7 which is contained in E. coli NRRL B-30704, wherein the polynucleotide sequence thereof encodes a polypeptide having cellulolytic enhancing activity. In another preferred aspect, the nucleic acid probe is the mature polypeptide coding sequence contained in plasmid pDZA2-7 which is contained in E. coli NRRL B-30704.
In another preferred aspect, the nucleic acid probe is the mature polypeptide coding sequence of SEQ ID NO: 15. In another preferred aspect, the nucleic acid probe is nucleotides 77 to 766 of SEQ ID NO: 15. In another preferred aspect, the nucleic acid probe is a polynucleotide sequence that encodes the polypeptide of SEQ ID NO: 16, or a subsequence thereof. In another preferred aspect, the nucleic acid probe is SEQ ID NO: 15. In another preferred aspect, the nucleic acid probe is the polynucleotide sequence contained in plasmid pTr333 which is contained in E. coli NRRL B-30878, wherein the polynucleotide sequence thereof encodes a polypeptide having cellulolytic enhancing activity. In another preferred aspect, the nucleic acid probe is the mature polypeptide coding sequence contained in plasmid pTr333 which is contained in E. coli NRRL B-30878.
For long probes of at least 100 nucleotides in length, very low to very high stringency conditions are defined as prehybridization and hybridization at 42° C. in 5×SSPE, 0.3% SDS, 200 μg/ml sheared and denatured salmon sperm DNA, and either 25% formamide for very low and low stringencies, 35% formamide for medium and medium-high stringencies, or 50% formamide for high and very high stringencies, following standard Southern blotting procedures for 12 to 24 hours optimally.
For long probes of at least 100 nucleotides in length, the carrier material is finally washed three times each for 15 minutes using 2×SSC, 0.2% SDS preferably at 45° C. (very low stringency), more preferably at 50° C. (low stringency), more preferably at 55° C. (medium stringency), more preferably at 60° C. (medium-high stringency), even more preferably at 65° C. (high stringency), and most preferably at 70° C. (very high stringency).
For short probes of about 15 nucleotides to about 70 nucleotides in length, stringency conditions are defined as prehybridization, hybridization, and washing post-hybridization at about 5° C. to about 10° C. below the calculated Tm using the calculation according to Bolton and McCarthy (1962, Proceedings of the National Academy of Sciences USA 48:1390) in 0.9 M NaCl, 0.09 M Tris-HCl pH 7.6, 6 mM EDTA, 0.5% NP-40, 1× Denhardt's solution, 1 mM sodium pyrophosphate, 1 mM sodium monobasic phosphate, 0.1 mM ATP, and 0.2 mg of yeast RNA per ml following standard Southern blotting procedures for 12 to 24 hours optimally.
For short probes of about 15 nucleotides to about 70 nucleotides in length, the carrier material is washed once in 6×SCC plus 0.1% SDS for 15 minutes and twice each for 15 minutes using 6×SSC at 5° C. to 10° C. below the calculated Tm.
In a fifth aspect, the polypeptide having cellulolytic enhancing activity is encoded by a polynucleotide comprising or consisting of a nucleotide sequence that has a degree of identity to the mature polypeptide coding sequence of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7, SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 13, or SEQ ID NO: 15 of preferably at least 60%, more preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99%.
In a preferred aspect, the mature polypeptide coding sequence is nucleotides 388 to 1332 of SEQ ID NO: 1, nucleotides 98 to 821 of SEQ ID NO: 3, nucleotides 126 to 978 of SEQ ID NO: 5, nucleotides 55 to 678 of SEQ ID NO: 7, nucleotides 58 to 912 of SEQ ID NO: 9, nucleotides 46 to 951 of SEQ ID NO: 11, nucleotides 67 to 796 of SEQ ID NO: 13, or nucleotides 77 to 766 of SEQ ID NO: 15.
In a sixth aspect, the polypeptide having cellulolytic enhancing activity is an artificial variant comprising a substitution, deletion, and/or insertion of one or more (or several) amino acids of the mature polypeptide of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID NO: 10, SEQ ID NO: 12, or SEQ ID NO: 14, or SEQ ID NO: 16; or a homologous sequence thereof. Methods for preparing such an artificial variant is described supra.
The total number of amino acid substitutions, deletions and/or insertions of the mature polypeptide of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID NO: 10, SEQ ID NO: 12, or SEQ ID NO: 14, or SEQ ID NO: 16, is 10, preferably 9, more preferably 8, more preferably 7, more preferably at most 6, more preferably 5, more preferably 4, even more preferably 3, most preferably 2, and even most preferably 1.
A polypeptide having cellulolytic enhancing activity may be obtained from microorganisms of any genus. In a preferred aspect, the polypeptide obtained from a given source is secreted extracellularly.
A polypeptide having cellulolytic enhancing activity may be a bacterial polypeptide. For example, the polypeptide may be a gram positive bacterial polypeptide such as a Bacillus, Streptococcus, Streptomyces, Staphylococcus, Enterococcus, Lactobacillus, Lactococcus, Clostridium, Geobacillus, or Oceanobacillus polypeptide having cellulolytic enhancing activity, or a Gram negative bacterial polypeptide such as an E. coli, Pseudomonas, Salmonella, Campylobacter, Helicobacter, Flavobacterium, Fusobacterium, Ilyobacter, Neisseria, or Ureaplasma polypeptide having cellulolytic enhancing activity.
In a preferred aspect, the polypeptide is a Bacillus alkalophilus, Bacillus amyloliquefaciens, Bacillus brevis, Bacillus circulans, Bacillus clausii, Bacillus coagulans, Bacillus firmus, Bacillus lautus, Bacillus lentus, Bacillus licheniformis, Bacillus megaterium, Bacillus pumilus, Bacillus stearothermophilus, Bacillus subtilis, or Bacillus thuringiensis polypeptide having cellulolytic enhancing activity.
In another preferred aspect, the polypeptide is a Streptococcus equisimilis, Streptococcus pyogenes, Streptococcus uberis, or Streptococcus equi subsp. Zooepidemicus polypeptide having cellulolytic enhancing activity.
In another preferred aspect, the polypeptide is a Streptomyces achromogenes, Streptomyces avermitilis, Streptomyces coelicolor, Streptomyces griseus, or Streptomyces lividans polypeptide having cellulolytic enhancing activity.
The polypeptide having cellulolytic enhancing activity may also be a fungal polypeptide, and more preferably a yeast polypeptide such as a Candida, Kluyveromyces, Pichia, Saccharomyces, Schizosaccharomyces, or Yarrowia polypeptide having cellulolytic enhancing activity; or more preferably a filamentous fungal polypeptide such as an Acremonium, Agaricus, Alternaria, Aspergillus, Aureobasidium, Botryospaeria, Ceriporiopsis, Chaetomidium, Chrysosporium, Claviceps, Cochliobolus, Coprinopsis, Coptotermes, Corynascus, Cryphonectria, Cryptococcus, Diplodia, Exidia, Filibasidium, Fusarium, Gibberella, Holomastigotoides, Humicola, Irpex, Lentinula, Leptospaeria, Magnaporthe, Melanocarpus, Meripilus, Mucor, Myceliophthora, Neocallimastix, Neurospora, Paecilomyces, Penicillium, Phanerochaete, Piromyces, Poitrasia, Pseudoplectania, Pseudotrichonympha, Rhizomucor, Schizophyllum, Scytalidium, Talaromyces, Thermoascus, Thielavia, Tolypocladium, Trichoderma, Trichophaea, Verticillium, Volvariella, or Xylaria polypeptide having cellulolytic enhancing activity.
In a preferred aspect, the polypeptide is a Saccharomyces carlsbergensis, Saccharomyces cerevisiae, Saccharomyces diastaticus, Saccharomyces douglasii, Saccharomyces kluyveri, Saccharomyces norbensis, or Saccharomyces oviformis polypeptide having cellulolytic enhancing activity.
In another preferred aspect, the polypeptide is an Acremonium cellulolyticus, Aspergillus aculeatus, Aspergillus awamori, Aspergillus fumigatus, Aspergillus foetidus, Aspergillus japonicus, Aspergillus nidulans, Aspergillus niger, Aspergillus oryzae, Chrysosporium keratinophilum, Chrysosporium lucknowense, Chrysosporium tropicum, Chrysosporium merdarium, Chrysosporium inops, Chrysosporium pannicola, Chrysosporium queenslandicum, Chrysosporium zonatum, Fusarium bactridioides, Fusarium cerealis, Fusarium crookwellense, Fusarium culmorum, Fusarium graminearum, Fusarium graminum, Fusarium heterosporum, Fusarium negundi, Fusarium oxysporum, Fusarium reticulatum, Fusarium roseum, Fusarium sambucinum, Fusarium sarcochroum, Fusarium sporotrichioides, Fusarium sulphureum, Fusarium torulosum, Fusarium trichothecioides, Fusarium venenatum, Humicola grisea, Humicola insolens, Humicola lanuginosa, Irpex lacteus, Mucor miehei, Myceliophthora thermophila, Neurospora crassa, Penicillium funiculosum, Penicillium purpurogenum, Phanerochaete chrysosporium, Thielavia achromatica, Thielavia albomyces, Thielavia albopilosa, Thielavia australeinsis, Thielavia fimeti, Thielavia microspora, Thielavia ovispora, Thielavia peruviana, Thielavia spededonium, Thielavia setosa, Thielavia subthermophila, Thielavia terrestris, Trichoderma harzianum, Trichoderma koningii, Trichoderma longibrachiatum, Trichoderma reesei, Trichoderma viride, or Trichophaea saccata polypeptide having cellulolytic enhancing activity.
It will be understood that for the aforementioned species the invention encompasses both the perfect and imperfect states, and other taxonomic equivalents, e.g., anamorphs, regardless of the species name by which they are known. Those skilled in the art will readily recognize the identity of appropriate equivalents.
Strains of these species are readily accessible to the public in a number of culture collections, such as the American Type Culture Collection (ATCC), Deutsche Sammlung von Mikroorganismen and Zellkulturen GmbH (DSM), Centraalbureau Voor Schimmelcultures (CBS), and Agricultural Research Service Patent Culture Collection, Northern Regional Research Center (NRRL).
Furthermore, polypeptides having cellulolytic enhancing activity may be identified and obtained from other sources including microorganisms isolated from nature (e.g., soil, composts, water, etc.) using the above-mentioned probes. Techniques for isolating microorganisms from natural habitats are well known in the art. The polynucleotide may then be obtained by similarly screening a genomic or cDNA library of such a microorganism. Once a polynucleotide encoding a polypeptide has been detected with the probe(s), the polynucleotide can be isolated or cloned by utilizing techniques that are well known to those of ordinary skill in the art (see, e.g., Sambrook et al., 1989, supra)
Polynucleotides comprising nucleotide sequences that encode polypeptide having cellulolytic enhancing activity can be isolated and utilized to express the polypeptide having cellulolytic enhancing activity for evaluation in the methods of the present invention, as described herein.
The polynucleotides comprise nucleotide sequences that have a degree of identity to the mature polypeptide coding sequence of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7, SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 13, or SEQ ID NO: 15 of preferably at least 60%, more preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99%, which encode a polypeptide having cellulolytic enhancing activity.
The polynucleotide may also be a polynucleotide encoding a polypeptide having cellulolytic enhancing activity that hybridizes under at least very low stringency conditions, preferably at least low stringency conditions, more preferably at least medium stringency conditions, more preferably at least medium-high stringency conditions, even more preferably at least high stringency conditions, and most preferably at least very high stringency conditions with (i) the mature polypeptide coding sequence of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7, SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 13, or SEQ ID NO: 15, (ii) the cDNA sequence contained in the mature polypeptide coding sequence of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, or SEQ ID NO: 13, or the genomic DNA sequence comprising the mature polypeptide coding sequence of SEQ ID NO: 7, SEQ ID NO: 9, SEQ ID NO: 11, or SEQ ID NO: 15, or (iii) a full-length complementary strand of (i) or (ii); or allelic variants and subsequences thereof (Sambrook et al., 1989, supra), as defined herein. In a preferred aspect, the mature polypeptide coding sequence is nucleotides 388 to 1332 of SEQ ID NO: 1, nucleotides 98 to 821 of SEQ ID NO: 3, nucleotides 126 to 978 of SEQ ID NO: 5, nucleotides 55 to 678 of SEQ ID NO: 7, nucleotides 58 to 912 of SEQ ID NO: 9, nucleotides 46 to 951 of SEQ ID NO: 11, nucleotides 67 to 796 of SEQ ID NO: 13, or nucleotides 77 to 766 of SEQ ID NO: 15.
As described earlier, the techniques used to isolate or clone a polynucleotide encoding a polypeptide are known in the art and include isolation from genomic DNA, preparation from cDNA, or a combination thereof.
A peroxidase is present or added during the method for degrading pretreated cellulosic material of the invention together with a cellulolytic enzyme composition; a polypeptide having cellulolytic enhancing activity; and a nonionic surfactant and/or a cationic surfactant.
In the methods of the present invention, the polypeptide having peroxidase activity can be any polypeptide having peroxidase activity. The peroxidase may be present as an enzyme activity in the enzyme composition and/or as one or more (several) protein components added to the composition. In a preferred aspect, the polypeptide having peroxidase activity is foreign to one or more (several) components of the cellulolytic enzyme composition.
Examples of peroxidases are peroxidase and peroxide-decomposing enzymes including, but are not limited to, the following:
E.C. 1.11.1.1 NADH peroxidase;
E.C. 1.11.1.2 NADPH peroxidase;
E.C. 1.11.1.3 fatty-acid peroxidase;
E.C. 1.11.1.5 cytochrome-c peroxidase;
E.C. 1.11.1.6 catalase;
E.C. 1.11.1.7 peroxidase;
E.C. 1.11.1.8 iodide peroxidase;
E.C. 1.11.1.9 glutathione peroxidase;
E.C. 1.11.1.10 chloride peroxidase;
E.C. 1.11.1.11 L-ascorbate peroxidase;
E.C. 1.11.1.12 phospholipid-hydroperoxide glutathione peroxidase;
E.C. 1.11.1.13 manganese peroxidase;
E.C. 1.11.1.14 lignin peroxidase;
E.C. 1.11.1.15 peroxiredoxin;
E.C. 1.11.1.16 versatile peroxidase;
E.C. 1.11.1.B2 chloride peroxidase;
E.C. 1.11.1.B6 iodide peroxidase;
E.C. 1.11.1.B7 bromide peroxidase;
E.C. 1.11.1.B8 iodide peroxidase:
EC numbers and names can be found, e.g., at www.brenda-enzymes.org.
In one aspect, the peroxidase is an NADH peroxidase. In another aspect, the peroxidase is an NADPH peroxidase. In another aspect, the peroxidase is a fatty acid peroxidase. In another aspect, the peroxidase is a cytochrome-c peroxidase. In another aspect, the peroxidase is a catalase. In another aspect, the peroxidase is a peroxidase. In another aspect, the peroxidase is an iodide peroxidase. In another aspect, the peroxidase is a glutathione peroxidase. In another aspect, the peroxidase is a chloride peroxidase. In another aspect, the peroxidase is an L-ascorbate peroxidase. In another aspect, the peroxidase is a phospholipid-hydroperoxide glutathione peroxidase. In another aspect, the peroxidase is a manganese peroxidase. In another aspect, the peroxidase is a lignin peroxidase. In another aspect, the peroxidase is a peroxiredoxin. In another aspect, the peroxidase is a versatile peroxidase. In another aspect, the peroxidase is a chloride peroxidase. In another aspect, the peroxidase is an iodide peroxidase. In another aspect, the peroxidase is a bromide peroxidase. In another aspect, the peroxidase is an iodide peroxidase.
In a preferred embodiment the peroxidase is an E.C. 1.11.1.7 peroxidase.
Examples of peroxidases include, but are not limited to, Coprinus cinereus peroxidase (Baunsgaard et al., 1993, Amino acid sequence of Coprinus macrorhizus peroxidase and cDNA sequence encoding Coprinus cinereus peroxidase. A new family of fungal peroxidases, Eur. J. Biochem. 213(1): 605-611 (Accession number P28314) or SEQ ID NO: 71 herein); horseradish peroxidase (Fujiyama et al., 1988, Structure of the horseradish peroxidase isozyme C genes, Eur. J. Biochem. 173(3): 681-687 (Accession number P15232)); peroxiredoxin (Singh and Shichi, 1998, A novel glutathione peroxidase in bovine eye. Sequence analysis, mRNA level, and translation, J. Biol. Chem. 273(40): 26171-26178 (Accession number 077834)); lactoperoxidase (Dull et al., 1990, Molecular cloning of cDNAs encoding bovine and human lactoperoxidase, DNA Cell Biol. 9(7): 499-509 (Accession number P80025)); Eosinophil peroxidase (Fornhem et al., 1996, Isolation and characterization of porcine cationic eosinophilgranule proteins, Int. Arch. Allergy Immunol. 110(2): 132-142 (Accession number P80550)); versatile peroxidase (Ruiz-Duenas et al., 1999, Molecular characterization of a novel peroxidase isolated from the ligninolytic fungus Pleurotus eryngii, Mol. Microbiol. 31(1): 223-235 (Accession number O94753)); turnip peroxidase (Mazza and Welinder, 1980, Covalent structure of turnip peroxidase 7. Cyanogen bromide fragments, complete structure and comparison to horseradish peroxidase C, Eur. J. Biochem. 108(2): 481-489 (Accession number P00434)); myeloperoxidase (Morishita et al., 1987, Chromosomal gene structure of human myeloperoxidase and regulation of its expression by granulocyte colony-stimulating factor, J. Biol. Chem. 262(31): 15208-15213 (Accession number P05164)); peroxidasin and peroxidasin homologs (Horikoshi et al., 1999, Isolation of differentially expressed cDNAs from p53-dependent apoptotic cells: activation of the human homologue of the Drosophila peroxidasin gene, Biochem. Biophys. Res. Commun. 261(3): 864-869 (Accession number Q92626)); lignin peroxidase (Tien and Tu, 1987, Cloning and sequencing of a cDNA for a ligninase from Phanerochaete chrysosporium, Nature 326(6112): 520-523 (Accession number P06181)); Manganese peroxidase (Orth et al., 1994, Characterization of a cDNA encoding a manganese peroxidase from Phanerochaete chrysosporium: genomic organization of lignin and manganese peroxidase-encoding genes, Gene 148(1): 161-165 (Accession number P78733)); alpha-dioxygenase, dual oxidase, peroxidasin, invertebrate peroxinectin, short peroxidockerin, lactoperoxidase, myeloperoxidase, non-mammalian vertebrate peroxidase, catalase, catalase-lipoxygenase fusion, di-heme cytochrome c peroxidase, methylamine utilization protein, DyP-type peroxidase, haloperoxidase, ascorbate peroxidase, catalase peroxidase, hybrid ascorbate-cytochrome c peroxidase, lignin peroxidase, manganese peroxidase, versatile peroxidase, other class II peroxidase, class III peroxidase, alkylhydroperoxidase D, other alkylhydroperoxidases, no-heme, no metal haloperoxidase, no-heme vanadium haloperoxidase, manganese catalase, NADH peroxidase, glutathione peroxidase, cysteine peroxiredoxin, thioredoxin-dependent thiol peroxidase, and AhpE-like peroxiredoxin (Passard et al., 2007, Phytochemistry 68:1605-1611).
The peroxidase activity may be obtained from microorganisms of any genus. In one aspect, the polypeptide obtained from a given source is secreted extracellularly.
The peroxidase activity may be a bacterial polypeptide. For example, the polypeptide may be a Gram positive bacterial polypeptide such as a Bacillus, Streptococcus, Streptomyces, Staphylococcus, Enterococcus, Lactobacillus, Lactococcus, Clostridium, Geobacillus, or Oceanobacillus polypeptide having peroxidase activity, or a Gram negative bacterial polypeptide such as an E. coli, Pseudomonas, Salmonella, Campylobacter, Helicobacter, Flavobacterium, Fusobacterium, Ilyobacter, Neisseria, or Ureaplasma polypeptide having peroxidase activity.
In an embodiment the peroxidase is derived from a strain of Bacillus alkalophilus, Bacillus amyloliquefaciens, Bacillus brevis, Bacillus circulans, Bacillus clausii, Bacillus coagulans, Bacillus firmus, Bacillus lautus, Bacillus lentus, Bacillus licheniformis, Bacillus megaterium, Bacillus pumilus, Bacillus stearothermophilus, Bacillus subtilis, or Bacillus thuringiensis.
In another embodiment the peroxidase is derived from a strain of Streptococcus equisimilis, Streptococcus pyogenes, Streptococcus uberis, or Streptococcus equi subsp. Zooepidemicus.
In another aspect, the peroxidase is derived from a strain of Streptomyces achromogenes, Streptomyces avermitilis, Streptomyces coelicolor, Streptomyces griseus, or Streptomyces lividans.
The peroxidase activity may also be a fungal polypeptide, and more preferably a yeast polypeptide such as one derived from a strain of a Candida, Kluyveromyces, Pichia, Saccharomyces, Schizosaccharomyces, or Yarrowia polypeptide having peroxidase activity; or more preferably a filamentous fungal polypeptide such as an Acremonium, Agaricus, Alternaria, Aspergillus, Aureobasidium, Botryospaeria, Ceriporiopsis, Chaetomidium, Chrysosporium, Claviceps, Cochliobolus, Coprinopsis, Coptotermes, Corynascus, Cryphonectria, Cryptococcus, Diplodia, Exidia, Filibasidium, Fusarium, Gibberella, Holomastigotoides, Humicola, Irpex, Lentinula, Leptospaeria, Magnaporthe, Melanocarpus, Meripilus, Mucor, Myceliophthora, Neocallimastix, Neurospora, Paecilomyces, Penicillium, Phanerochaete, Piromyces, Poitrasia, Pseudoplectania, Pseudotrichonympha, Rhizomucor, Schizophyllum, Scytalidium, Talaromyces, Thermoascus, Thielavia, Tolypocladium, Trichoderma, Trichophaea, Verticillium, Volvariella, or Xylaria.
In another aspect, the peroxidase is derived from a strain of Saccharomyces carlsbergensis, Saccharomyces cerevisiae, Saccharomyces diastaticus, Saccharomyces douglasii, Saccharomyces kluyveri, Saccharomyces norbensis, or Saccharomyces oviformis.
In another aspect, the peroxidase is derived from a strain of Acremonium cellulolyticus, Aspergillus aculeatus, Aspergillus awamori, Aspergillus fumigatus, Aspergillus foetidus, Aspergillus japonicus, Aspergillus nidulans, Aspergillus niger, Aspergillus oryzae, Chrysosporium keratinophilum, Chrysosporium lucknowense, Chrysosporium tropicum, Chrysosporium merdarium, Chrysosporium inops, Chrysosporium pannicola, Chrysosporium queenslandicum, Chrysosporium zonatum, Fusarium bactridioides, Fusarium cerealis, Fusarium crookwellense, Fusarium culmorum, Fusarium graminearum, Fusarium graminum, Fusarium heterosporum, Fusarium negundi, Fusarium oxysporum, Fusarium reticulatum, Fusarium roseum, Fusarium sambucinum, Fusarium sarcochroum, Fusarium sporotrichioides, Fusarium sulphureum, Fusarium torulosum, Fusarium trichothecioides, Fusarium venenatum, Humicola grisea, Humicola insolens, Humicola lanuginosa, Irpex lacteus, Mucor miehei, Myceliophthora thermophila, Neurospora crassa, Penicillium funiculosum, Penicillium purpurogenum, Phanerochaete chrysosporium, Thielavia achromatica, Thielavia albomyces, Thielavia albopilosa, Thielavia australeinsis, Thielavia fimeti, Thielavia microspora, Thielavia ovispora, Thielavia peruviana, Thielavia spededonium, Thielavia setosa, Thielavia subthermophila, Thielavia terrestris, Trichoderma harzianum, Trichoderma koningii, Trichoderma longibrachiatum, Trichoderma reesei, or Trichoderma viride.
In another aspect, the peroxidase is horseradish peroxidase. In another aspect, the peroxidase is Coprinus cinereus peroxidase, such as the one shown in SEQ ID NO: 71 herein In an embodiment the peroxidase has at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 71 herein (i.e., CiP).
Techniques used to isolate or clone a polynucleotide encoding a polypeptide having peroxidase activity are known in the art and include isolation from genomic DNA, preparation from cDNA, or a combination thereof. The cloning of the polynucleotides of the present invention from such genomic DNA can be effected, e.g., by using the well known polymerase chain reaction (PCR) or antibody screening of expression libraries to detect cloned DNA fragments with shared structural features. See, e.g., Innis et al., 1990, PCR: A Guide to Methods and Application, Academic Press, New York. Other nucleic acid amplification procedures such as ligase chain reaction (LCR), ligation activated transcription (LAT) and nucleotide sequence-based amplification (NASBA) may be used.
In the methods or processes of the present invention, the cellulolytic enzyme composition may comprise any protein involved in the processing of a pretreated cellulosic material to glucose and/or cellobiose, or hemicellulose to xylose, mannose, galactose, and/or arabinose.
The cellulolytic enzyme composition typically comprises enzymes having cellulolytic activity. In one aspect, the cellulolytic enzyme composition comprises one or more (several) cellulolytic enzymes. In an aspect, the cellulolytic enzyme composition further comprises one or more (several) xylan degrading enzymes. In another aspect, the cellulolytic enzyme composition comprises one or more (several) cellulolytic enzymes and one or more (several) xylan degrading enzymes.
The one or more (several) cellulolytic enzymes are preferably selected from the group consisting of an endoglucanase, a cellobiohydrolase, and a beta-glucosidase. The one or more (several) xylan degrading enzymes are preferably selected from the group consisting of a xylanase, an acetyxylan esterase, a feruloyl esterase, an arabinofuranosidase, a xylosidase, and a glucuronidase.
In another aspect, the cellulolytic enzyme composition may further or even further comprise one or more (several) additional enzyme activities to improve the degradation of the cellulose-containing material. Preferred additional enzymes are hemicellulases (e.g., alpha-D-glucuronidases, alpha-L-arabinofuranosidases, endo-mannanases, beta-mannosidases, alpha-galactosidases, endo-alpha-L-arabinanases, beta-galactosidases), carbohydrate-esterases (e.g., acetyl-xylan esterases, acetyl-mannan esterases, ferulic acid esterases, coumaric acid esterases, glucuronoyl esterases), pectinases, proteases, ligninolytic enzymes (e.g., laccases, manganese peroxidases, lignin peroxidases, H2O2-producing enzymes, oxidoreductases), expansins, swollenins, or mixtures thereof. In the methods of the present invention, the additional enzyme(s) can be added prior to or during fermentation, e.g., during saccharification or during or after propagation of the fermenting microorganism(s).
One or more (several) components of the cellulolytic enzyme composition may be wild-type proteins, recombinant proteins, or a combination of wild-type proteins and recombinant proteins. For example, one or more (several) components may be native proteins of a cell, which is used as a host cell to express recombinantly one or more (several) other components of the enzyme composition. One or more (several) components of the enzyme composition may be produced as monocomponents, which are then combined to form the enzyme composition. The cellulolytic enzyme composition may be a combination of multicomponent and monocomponent protein preparations.
The enzymes used in the methods or process of the present invention may be in any form suitable for use in the methods or processes described herein, such as, for example, a crude fermentation broth with or without cells removed, a cell lysate with or without cellular debris, a semi-purified or purified enzyme preparation, or a host cell as a source of the enzymes. The cellulolytic enzyme composition may be a dry powder or granulate, a non-dusting granulate, a liquid, a stabilized liquid, or a stabilized protected enzyme. Liquid enzyme preparations may, for instance, be stabilized by adding stabilizers such as a sugar, a sugar alcohol or another polyol, and/or lactic acid or another organic acid according to established processes.
A polypeptide having cellulolytic enzyme activity or xylan degrading activity may be a bacterial polypeptide. For example, the polypeptide may be a gram positive bacterial polypeptide such as a Bacillus, Streptococcus, Streptomyces, Staphylococcus, Enterococcus, Lactobacillus, Lactococcus, Clostridium, Geobacillus, or Oceanobacillus polypeptide having cellulolytic enzyme activity or xylan degrading activity, or a Gram negative bacterial polypeptide such as an E. coli, Pseudomonas, Salmonella, Campylobacter, Helicobacter, Flavobacterium, Fusobacterium, Ilyobacter, Neisseria, or Ureaplasma polypeptide having cellulolytic enzyme activity or xylan degrading activity.
In a preferred aspect, the polypeptide is a Bacillus alkalophilus, Bacillus amyloliquefaciens, Bacillus brevis, Bacillus circulans, Bacillus clausii, Bacillus coagulans, Bacillus firmus, Bacillus lautus, Bacillus lentus, Bacillus licheniformis, Bacillus megaterium, Bacillus pumilus, Bacillus stearothermophilus, Bacillus subtilis, or Bacillus thuringiensis polypeptide having cellulolytic enzyme activity or xylan degrading activity.
In another preferred aspect, the polypeptide is a Streptococcus equisimilis, Streptococcus pyogenes, Streptococcus uberis, or Streptococcus equi subsp. Zooepidemicus polypeptide having cellulolytic enzyme activity or xylan degrading activity.
In another preferred aspect, the polypeptide is a Streptomyces achromogenes, Streptomyces avermitilis, Streptomyces coelicolor, Streptomyces griseus, or Streptomyces lividans polypeptide having cellulolytic enzyme activity or xylan degrading activity.
The polypeptide having cellulolytic enzyme activity or xylan degrading activity may also be a fungal polypeptide, and more preferably a yeast polypeptide such as a Candida, Kluyveromyces, Pichia, Saccharomyces, Schizosaccharomyces, or Yarrowia polypeptide having cellulolytic enzyme activity or xylan degrading activity; or more preferably a filamentous fungal polypeptide such as an Acremonium, Agaricus, Alternaria, Aspergillus, Aureobasidium, Botryospaeria, Ceriporiopsis, Chaetomidium, Chrysosporium, Claviceps, Cochliobolus, Coprinopsis, Coptotermes, Corynascus, Cryphonectria, Cryptococcus, Diplodia, Exidia, Filibasidium, Fusarium, Gibberella, Holomastigotoides, Humicola, Irpex, Lentinula, Leptospaeria, Magnaporthe, Melanocarpus, Meripilus, Mucor, Myceliophthora, Neocallimastix, Neurospora, Paecilomyces, Penicillium, Phanerochaete, Piromyces, Poitrasia, Pseudoplectania, Pseudotrichonympha, Rhizomucor, Schizophyllum, Scytalidium, Talaromyces, Thermoascus, Thielavia, Tolypocladium, Trichoderma, Trichophaea, Verticillium, Volvariella, or Xylaria polypeptide having cellulolytic enzyme activity or xylan degrading activity.
In a preferred aspect, the polypeptide is a Saccharomyces carlsbergensis, Saccharomyces cerevisiae, Saccharomyces diastaticus, Saccharomyces douglasii, Saccharomyces kluyveri, Saccharomyces norbensis, or Saccharomyces oviformis polypeptide having cellulolytic enzyme activity or xylan degrading activity.
In another preferred aspect, the polypeptide is an Acremonium cellulolyticus, Aspergillus aculeatus, Aspergillus awamori, Aspergillus fumigatus, Aspergillus foetidus, Aspergillus japonicus, Aspergillus nidulans, Aspergillus niger, Aspergillus oryzae, Chrysosporium keratinophilum, Chrysosporium lucknowense, Chrysosporium tropicum, Chrysosporium merdarium, Chrysosporium inops, Chrysosporium pannicola, Chrysosporium queenslandicum, Chrysosporium zonatum, Fusarium bactridioides, Fusarium cerealis, Fusarium crookwellense, Fusarium culmorum, Fusarium graminearum, Fusarium graminum, Fusarium heterosporum, Fusarium negundi, Fusarium oxysporum, Fusarium reticulatum, Fusarium roseum, Fusarium sambucinum, Fusarium sarcochroum, Fusarium sporotrichioides, Fusarium sulphureum, Fusarium torulosum, Fusarium trichothecioides, Fusarium venenatum, Humicola grisea, Humicola insolens, Humicola lanuginosa, Irpex lacteus, Mucor miehei, Myceliophthora thermophila, Neurospora crassa, Penicillium funiculosum, Penicillium purpurogenum, Phanerochaete chrysosporium, Thielavia achromatica, Thielavia albomyces, Thielavia albopilosa, Thielavia australeinsis, Thielavia fimeti, Thielavia microspora, Thielavia ovispora, Thielavia peruviana, Thielavia spededonium, Thielavia setosa, Thielavia subthermophila, Thielavia terrestris, Trichoderma harzianum, Trichoderma koningii, Trichoderma longibrachiatum, Trichoderma reesei, Trichoderma viride, or Trichophaea saccata polypeptide having cellulolytic enzyme activity or xylan degrading activity.
Chemically modified or protein engineered mutants of polypeptides having cellulolytic enzyme activity or xylan degrading activity may also be used.
One or more (several) components of the enzyme composition may be a recombinant component, i.e., produced by cloning of a DNA sequence encoding the single component and subsequent cell transformed with the DNA sequence and expressed in a host (see, for example, WO 91/17243 and WO 91/17244). The host is preferably a heterologous host (enzyme is foreign to host), but the host may under certain conditions also be a homologous host (enzyme is native to host). Monocomponent cellulolytic proteins may also be prepared by purifying such a protein from a fermentation broth.
Examples of commercial cellulolytic enzyme composition suitable for use in the present invention include, for example, CELLIC™ Ctec (Novozymes A/S), CELLIC™ Ctec2 (Novozymes A/S) CELLIC™ Ctec3 (Novozymes A/S); CELLUCLAST™ (Novozymes A/S), NOVOZYM™ 188 (Novozymes A/S), CELLUZYME™ (Novozymes A/S), CEREFLO™ (Novozymes A/S), and ULTRAFLO™ (Novozymes A/S), ACCELERASE™ (Genencor Int.), LAMINEX™ (Genencor Int.), SPEZYME™ CP (Genencor Int.); ROHAMENT™ 7069 W (Röhm GmbH), FIBREZYME® LDI (Dyadic International, Inc.), FIBREZYME® LBR (Dyadic International, Inc.), VISCOSTAR® 150L (Dyadic International, Inc.) or AlternaFuel® CMAX3™ (Dyadic International, Inc). The cellulolytic enzyme compositions are added in amounts effective from about 0.001 to about 5.0 wt. % of total solids, more preferably from about 0.025 to about 4.0 wt. % of total solids, and most preferably from about 0.005 to about 2.0 wt % of total solids. The cellulolytic enzyme compositions are added in amounts effective from about 0.001 to about 5.0 wt. % of total solids, more preferably from about 0.025 to about 4.0 wt % of total solids, and most preferably from about 0.005 to about 2.0 wt. % of total solids.
The cellulolytic enzyme composition used in a method or process of the invention may comprise any endoglucanase. Examples of bacterial endoglucanases that can be used in the methods of the present invention, include, but are not limited to, an Acidothermus cellulolyticus endoglucanase (WO 91/05039; WO 93/15186; U.S. Pat. No. 5,275,944; WO 96/02551; U.S. Pat. No. 5,536,655, WO 00/70031, WO 2005/093050); Thermobifida fusca endoglucanase III (WO 2005/093050); and Thermobifida fusca endoglucanase V (WO 2005/093050).
Examples of fungal endoglucanases that can be used in the methods of the present invention, include, but are not limited to, a Trichoderma reesei endoglucanase I (Penttila et al., 1986, Gene 45: 253-263; GENBANK™ accession no. M15665); Trichoderma reesei endoglucanase II (Saloheimo, et al., 1988, Gene 63:11-22; GENBANK™ accession no. M19373); Trichoderma reesei endoglucanase III (Okada et al., 1988, Appl. Environ. Microbiol. 64: 555-563; GENBANK™ accession no. AB003694); Aspergillus aculeatus endoglucanase (Ooi et al., 1990, Nucleic Acids Research 18: 5884); Aspergillus kawachii endoglucanase (Sakamoto et al., 1995, Current Genetics 27: 435-439); Erwinia carotovara endoglucanase (Saarilahti et al., 1990, Gene 90: 9-14); Fusarium oxysporum endoglucanase (GENBANK™ accession no. L29381); Humicola grisea var. thermoidea endoglucanase (GENBANK™ accession no. AB003107); Melanocarpus albomyces endoglucanase (GENBANK™ accession no. MAL515703); Neurospora crassa endoglucanase (GENBANK™ accession no. XM—324477); Humicola insolens endoglucanase V (SEQ ID NO: 20); Humicola insolens endoglucanase V core (Schulein, 1997, J. Biotechnology 57:71-81-213 amino acids) (i.e., EG V core); Myceliophthora thermophila CBS 117.65 endoglucanase (SEQ ID NO: 22); basidiomycete CBS 495.95 endoglucanase (SEQ ID NO: 24); basidiomycete CBS 494.95 endoglucanase (SEQ ID NO: 26); Thielavia terrestris NRRL 8126 CEL6B endoglucanase (SEQ ID NO: 28); Thielavia terrestris NRRL 8126 CEL6C endoglucanase (SEQ ID NO: 30); Thielavia terrestris NRRL 8126 CEL7C endoglucanase (SEQ ID NO: 32); Thielavia terrestris NRRL 8126 CEL7E endoglucanase (SEQ ID NO: 34); Thielavia terrestris NRRL 8126 CEL7F endoglucanase (SEQ ID NO: 36); Cladorrhinum foecundissimum ATCC 62373 CEL7A endoglucanase (SEQ ID NO: 38); and Trichoderma reesei strain No. VTT-D-80133 endoglucanase (SEQ ID NO: 40; GENBANK™ accession no. M15665). The endoglucanases of SEQ ID NO: 20, SEQ ID NO: 22, SEQ ID NO: 24, SEQ ID NO: 26, SEQ ID NO: 28, SEQ ID NO: 30, SEQ ID NO: 32, SEQ ID NO: 34, SEQ ID NO: 36, SEQ ID NO: 38, and SEQ ID NO: 40 described above are encoded by the mature polypeptide coding sequence of SEQ ID NO: 19, SEQ ID NO: 21, SEQ ID NO: 23, SEQ ID NO: 25, SEQ ID NO: 27, SEQ ID NO: 29, SEQ ID NO: 31, SEQ ID NO: 33, SEQ ID NO: 35, SEQ ID NO: 37, SEQ ID NO: 39, respectively.
The cellulolytic enzyme composition used in a method or process of the invention may comprise any cellobiohydrolase.
Examples of cellobiohydrolases useful in the methods of the present invention include, but are not limited to, Trichoderma reesei cellobiohydrolase I (SEQ ID NO: 42); Trichoderma reesei cellobiohydrolase II (SEQ ID NO: 44); Humicola insolens cellobiohydrolase I (SEQ ID NO: 46), Myceliophthora thermophila cellobiohydrolase II (SEQ ID NO: 48 and SEQ ID NO: 50), Thielavia terrestris cellobiohydrolase II (CEL6A) (SEQ ID NO: 52), Chaetomium thermophilum cellobiohydrolase I (SEQ ID NO: 54), and Chaetomium thermophilum cellobiohydrolase II (SEQ ID NO: 56). The cellobiohydrolases of SEQ ID NO: 40, SEQ ID NO: 42, SEQ ID NO: 44, SEQ ID NO: 46, SEQ ID NO: 48, SEQ ID NO: 50, SEQ ID NO: 52, and SEQ ID NO: 54 described above are encoded by the mature polypeptide coding sequence of SEQ ID NO: 41, SEQ ID NO: 43, SEQ ID NO: 45, SEQ ID NO: 47, SEQ ID NO: 49, SEQ ID NO: 51, SEQ ID NO: 53, and SEQ ID NO: 55, respectively.
The cellulolytic enzyme composition used in a method or process of the invention may comprise any beta-glucosidase.
Examples of beta-glucosidases useful in the methods of the present invention include, but are not limited to, Aspergillus oryzae beta-glucosidase (SEQ ID NO: 58); Aspergillus fumigatus beta-glucosidase (SEQ ID NO: 60); Penicillium brasilianum IBT 20888 beta-glucosidase (SEQ ID NO: 62); Aspergillus niger beta-glucosidase (SEQ ID NO: 64); and Aspergillus aculeatus beta-glucosidase (SEQ ID NO: 66). The beta-glucosidases of SEQ ID NO: 58, SEQ ID NO: 60, SEQ ID NO: 62, SEQ ID NO: 64, and SEQ ID NO: 66 described above are encoded by the mature polypeptide coding sequence of SEQ ID NO: 57, SEQ ID NO: 59, SEQ ID NO: 61, SEQ ID NO: 63, and SEQ ID NO: 65, respectively.
The Aspergillus oryzae polypeptide having beta-glucosidase activity can be obtained according to WO 02/095014. The Aspergillus fumigatus polypeptide having beta-glucosidase activity can be obtained according to WO 2005/047499. The Penicillium brasilianum polypeptide having beta-glucosidase activity can be obtained according to WO 2007/019442 or SEQ ID NO: 62 herein. The Aspergillus niger polypeptide having beta-glucosidase activity can be obtained according to Dan et al., 2000, J. Biol. Chem. 275: 4973-4980. The Aspergillus aculeatus polypeptide having beta-glucosidase activity can be obtained according to Kawaguchi et al., 1996, Gene 173: 287-288. In an embodiment the beta-glucosidase may be an Aspergillus aculeatus beta-glucosidase, such as the one disclosed in SEQ ID NO: 66 herein.
In an embodiment beta-glucosidase fusion protein is one having at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 66 herein.
The beta-glucosidase may be a fusion protein. In one aspect, the beta-glucosidase is the Aspergillus oryzae beta-glucosidase variant BG fusion protein of SEQ ID NO: 68 herein or the Aspergillus oryzae beta-glucosidase fusion protein of SEQ ID NO: 70 herein. In another aspect, the Aspergillus oryzae beta-glucosidase variant BG fusion protein is encoded by the polynucleotide of SEQ ID NO: 67 herein or the Aspergillus oryzae beta-glucosidase fusion protein is encoded by the polynucleotide of SEQ ID NO: 69 herein.
In an embodiment beta-glucosidase fusion proteain is one having at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 68 of 70 herein.
In another embodiment the beta-glucosidase may be one derived from Aspergillus fumigatus, e.g., the one shown in SEQ ID NO: 5 in WO 2005/047499 or SEQ ID NO: 78 herein or a variant thereof, e.g., with the following substitutions: F100D, S283G, N456E, F512Y using SEQ ID NO: 78 for numbering.
In an embodiment the beta-glucosidase is from a strain of Aspergillus, such as a strain of Aspergillus fumigatus, such as Aspergillus fumigatus beta-glucosidase (SEQ ID NO: 78 herein), which comprises one or more substitutions selected from the group consisting of L89M, G91L, F100D, I140V, I186V, S283G, N456E, and F512Y; such as a variant thereof with the following substitutions:
F100D+S283G+N456E+F512Y;
L89M+G91L+I186V+I140V;
I186V+L89M+G91L+I140V+F100D+S283G+N456E+F512Y (using SEQ ID NO: 78 herein for numbering.
In an embodiment the number of substitutions is between 1 and 10, such as between 1 and 8, such as between 1 and 6, such as between 1 and 4, such as 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10 substitutions.
In an embodiment the beta-glucosidase is one having at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 78 herein.
In an embodiment the beta-glucosidase variant is one having at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 78 herein.
Other endoglucanases, cellobiohydrolases, and beta-glucosidases are disclosed in numerous Glycosyl Hydrolase families using the classification according to Henrissat, 1991, A classification of glycosyl hydrolases based on amino-acid sequence similarities, Biochem. J. 280: 309-316, and Henrissat and Bairoch, 1996, Updating the sequence-based classification of glycosyl hydrolases, Biochem. J. 316: 695-696.
Other cellulolytic enzymes that may be used in the present invention are described in EP 495,257, EP 531,315, EP 531,372, WO 89/09259, WO 94/07998, WO 95/24471, WO 96/11262, WO 96/29397, WO 96/034108, WO 97/14804, WO 98/08940, WO 98/12307, WO 98/13465, WO 98/15619, WO 98/15633, WO 98/28411, WO 99/06574, WO 99/10481, WO 99/25846, WO 99/25847, WO 99/31255, WO 00/09707, WO 02/050245, WO 02/076792, WO 02/101078, WO 03/027306, WO 03/052054, WO 03/052055, WO 03/052056, WO 03/052057, WO 03/052118, WO 2004/016760, WO 2004/043980, WO 2004/048592, WO 2005/001065, WO 2005/028636, WO 2005/093050, WO 2005/093073, WO 2006/074005, WO 2006/117432, WO 2007/071818, WO 2007/071820, WO 2008/008070, WO 2008/008793, U.S. Pat. No. 4,435,307, U.S. Pat. No. 5,457,046, U.S. Pat. No. 5,648,263, U.S. Pat. No. 5,686,593, U.S. Pat. No. 5,691,178, U.S. Pat. No. 5,763,254, and U.S. Pat. No. 5,776,757.
The cellulolytic enzyme composition used in a method or process of the invention may comprise any xylanase.
Examples of commercial xylan degrading enzyme preparations suitable for use in the present invention include, for example, SHEARZYME™ (Novozymes A/S), CELLIC™ Htec (Novozymes A/S), VISCOZYME® (Novozymes A/S), ULTRAFLO® (Novozymes A/S), PULPZYME® HC (Novozymes A/S), MULTIFECT® Xylanase (Genencor), ECOPULP® TX-200A (AB Enzymes), HSP 6000 Xylanase (DSM), DEPOL™ 333P (Biocatalysts Limit, Wales, UK), DEPOL™ 740L. (Biocatalysts Limit, Wales, UK), and DEPOL™ 762P (Biocatalysts Limit, Wales, UK).
Examples of xylanases useful in the methods of the present invention include, but are not limited to, Aspergillus aculeatus xylanase (GeneSeqP:AAR63790; WO 94/21785), Aspergillus fumigatus xylanases (e.g., Xyl III shown as SEQ ID NO: 6 in WO 2006/078256 or SEQ ID NO: 75 herein), and Thielavia terrestris NRRL 8126 xylanases (WO 2009/079210).
The cellulolytic enzyme composition used in a method or process of the invention may comprise any beta-xylosidase.
Examples of beta-xylosidases useful in the methods of the present invention include, but are not limited to, Trichoderma reesei beta-xylosidase (UniProtKB/TrEMBL accession number Q92458), Talaromyces emersonii (SwissProt accession number Q8X212), and Neurospora crassa (SwissProt accession number Q7SOW4).
The cellulolytic enzyme composition used in a method or process of the invention may comprise any acetylxylan esterase.
Examples of acetylxylan esterases useful in the methods of the present invention include, but are not limited to, Hypocrea jecorina acetylxylan esterase (WO 2005/001036), Neurospora crassa acetylxylan esterase (UniProt accession number q7s259), Thielavia terrestris NRRL 8126 acetylxylan esterase (WO 2009/042846), Chaetomium globosum acetylxylan esterase (Uniprot accession number Q2GWX4), Chaetomium gracile acetylxylan esterase (GeneSeqP accession number AAB82124), Phaeosphaeria nodorum acetylxylan esterase (Uniprot accession number Q0UHJ1), and Humicola insolens DSM 1800 acetylxylan esterase (WO 2009/073709).
The cellulolytic enzyme composition used in a method or process of the invention may comprise any ferulic acid esterase.
Examples of ferulic acid esterases useful in the methods of the present invention include, but are not limited to, Humicola insolens DSM 1800 feruloyl esterase (WO 2009/076122), Neurospora crassa feruloyl esterase (UniProt accession number Q9HGR3), and Neosartorya fischeri feruloyl esterase (UniProt Accession number A1D9T4).
The cellulolytic enzyme composition used in a method or process of the invention may comprise any arabinofuranosidase.
Examples of arabinofuranosidases useful in the methods of the present invention include, but are not limited to, Humicola insolens DSM 1800 arabinofuranosidase (WO 2009/073383) and Aspergillus niger arabinofuranosidase (GeneSeqP accession number AAR94170).
The cellulolytic enzyme composition used in a method or process of the invention may comprise any alpha-glucuronidase.
Examples of alpha-glucuronidases useful in the methods of the present invention include, but are not limited to, Aspergillus clavatus alpha-glucuronidase (UniProt accession number alcc12), Trichoderma reesei alpha-glucuronidase (Uniprot accession number Q99024), Talaromyces emersonii alpha-glucuronidase (UniProt accession number Q8X211), Aspergillus niger alpha-glucuronidase (Uniprot accession number Q96WX9), Aspergillus terreus alpha-glucuronidase (SwissProt accession number Q0CJP9), and Aspergillus fumigatus alpha-glucuronidase (SwissProt accession number Q4WW45).
The enzymes and proteins used in the methods of the present invention may be produced by fermentation of the above-noted microbial strains on a nutrient medium containing suitable carbon and nitrogen sources and inorganic salts, using procedures known in the art (see, e.g., Bennett, J. W. and LaSure, L. (eds.), More Gene Manipulations in Fungi, Academic Press, CA, 1991). Suitable media are available from commercial suppliers or may be prepared according to published compositions (e.g., in catalogues of the American Type Culture Collection). Temperature ranges and other conditions suitable for growth and enzyme production are known in the art (see, e.g., Bailey, J. E., and Ollis, D. F., Biochemical Engineering Fundamentals, McGraw-Hill Book Company, NY, 1986).
In a final aspect, the present invention relates to a composition. The composition is a blend or mixture of at least three components. The composition may be added before and/or during hydrolysis done in accordance with methods or processes of the present invention. In embodiments where the composition of the invention does not include a cellulolytic enzyme composition as defined herein, it may be added to hydrolysis together with a cellulolytic enzyme composition. It is typically added simultaneously with and/or after the cellulolytic enzyme composition, but may also be added before hydrolysis.
More specifically the composition of the invention comprises or consists of:
i) a polypeptide having cellulolytic enhancing activity;
ii) a peroxidase;
iii) a nonionic surfactant and/or a cationic surfactant.
Polypeptides having cellulytic enhancing activity may be one disclosed in the “Polypeptide having cellulolytic enhancing activity”-section above.
The peroxidase may be one disclosed in the “Peroxidases” section above.
The nonionic and cationic surfactants may be one disclosed in the “Nonionic surfactants” or “Cationic surfactants” section above.
In an embodiment polypeptide having cellulolytic enhancing activity is a GH61 polypeptide. In an embodiment the polypeptide having cellulolytic enhancing activity is one derived from the genus Thermoascus, such as a strain of Thermoascus aurantiacus, e.g., the one described in WO 2005/074656 as SEQ ID NO: 2 or SEQ ID NO: 14 herein.
In an embodiment the polypeptide having cellulolytic enhancing activity has at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 14 herein.
In an embodiment the polypeptide having cellulolytic enhancing activity is one derived from the genus Thielavia, such as a strain of Thielavia terrestris, such as the one described in WO 2005/074647 as SEQ ID NO: 7 and SEQ ID NO: 8. In an embodiment the polypeptide having cellulolytic enhancing activity is one derived from a strain of Aspergillus, such as a strain of Aspergillus fumigatus, such as the one described in WO 2010/138754 as SEQ ID NO: 1 and SEQ ID NO: 2. In an embodiment the polypeptide having cellulolytic enhancing activity is one derived from a strain derived from Penicillium, such as a strain of Penicillium emersonii, such as the one disclosed in WO 2011/041397 as SEQ ID NO: 2 or SEQ ID NO: 72 herein.
In an embodiment the peroxidase is selected from the group comprising peroxidase or peroxide-decomposing enzymes include, but are not limited to, the following: E.C. 1.11.1.1 NADH peroxidase; E.C. 1.11.1.2 NADPH peroxidase; E.C. 1.11.1.3 fatty-acid peroxidase; E.C. 1.11.1.5 cytochrome-c peroxidase; E.C. 1.11.1.5; E.C. 1.11.1.6 catalase; E.C. 1.11.1.7 peroxidase; E.C. 1.11.1.8 iodide peroxidase; E.C. 1.11.1.9 glutathione peroxidase; E.C. 1.11.1.10 chloride peroxidase; E.C. 1.11.1.11 L-ascorbate peroxidase; E.C. 1.11.1.12 phospholipid-hydroperoxide glutathione peroxidase; E.C. 1.11.1.13 manganese peroxidase; E.C. 1.11.1.14 lignin peroxidase; E.C. 1.11.1.15 peroxiredoxin; E.C. 1.11.1.16 versatile peroxidase; E.C. 1.11.1.B2 chloride peroxidase; E.C. 1.11.1.B6 iodide peroxidase (vanadium-containing); E.C. 1.11.1.B7 bromide peroxidase; E.C. 1.11.1.B8 iodide peroxidase.
In a preferred embodiment the peroxidase is an EC 1.11.1.7 peroxidase.
In an embodiment the peroxidase is derived from a microorganism, such as a fungal organism, such a yeast or filamentous fungi, or bacteria; or plant.
In an embodiment the peroxidase is derived from a strain of Coprinus, such as strain of Coprinus cinereus, such as one classified as EC 1.11.1.7, such as the one shown in SEQ ID NO: 71 herein (i.e., CiP). In an embodiment the peroxidase has at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 71 herein.
In an embodiment the nonionic surfactant is alkyl or aryl. In an embodiment the nonionic surfactant is selected from the group of glycerol ethers, glycol ethers, ethanolamides, sulfoanylamides, alcohols, amides, alcohol ethoxylates, glycerol esters, glycol esters, ethoxylates of glycerol ester and glycol esters, sugar-based alkyl polyglycosides, polyoxyethylenated fatty acids, alkanolamine condensates, alkanolamides, tertiary acetylenic glycols, polyoxyethylenated mercaptans, carboxylic acid esters, and polyoxyethylenated polyoxyproylene glycols, such as EO/PO block copolymers (EO is ethylene oxide, PO is propylene oxide), EO polymers and copolymers, polyamines, and polyvinylpynolidones.
In an embodiment the nonionic surfactant is a linear primary, or secondary or branched alcohol ethoxylate having the formula: RO(CH2CH2O)nH, wherein R is the hydrocarbon chain length and n is the average number of moles of ethylene oxide, such as where R is linear primary or branched secondary hydrocarbon chain length in the range from C9 to C16 and n ranges from 6 to 13, such as alcohol ethoxylate where R is linear C9-C11 hydrocarbon chain length, and n is 6.
In an embodiment the cationic surfactant is selected from the group of primary, secondary, or tertiary amines, such as octenidine dihydrochloride; alkyltrimethylammonium salts, such as cetyl trimethylammonium bromide (CTAB) a.k.a. hexadecyl trimethyl ammonium bromide, cetyl trimethylammonium chloride (CTAC), cetylpyridinium chloride (CPC), benzalkonium chloride (BAC), benzethonium chloride (BZT), 5-bromo-5-nitro-1,3-dioxane, dimethyldioctadecylammonium chloride, dioctadecyldimethylammonium bromide (DODAB).
In an embodiment the composition of the invention further comprises a cellulolytic enzyme composition.
In an embodiment the composition of the invention comprises a beta-glucosidase.
In an embodiment the cellulolytic enzyme composition comprises a beta-glucosidase, preferably one derived from a strain of the genus Aspergillus, such as Aspergillus oryzae, such as the one disclosed in WO 02/095014 or the fusion protein having beta-glucosidase activity disclosed in WO 2008/057637, or Aspergillus fumigatus, such as such as one disclosed in WO 2005/047499, e.g., SEQ ID NO: 78 herein, or an Aspergillus fumigatus beta-glucosidase variant disclosed in WO 2012/044915 (see variants above); or a strain of the genus a strain Penicillium, such as a strain of the Penicillium brasilianum disclosed in WO 2007/019442 or SEQ ID NO: 62 herein, or a strain of the genus Trichoderma, such as a strain of Trichoderma reesei.
In an embodiment the cellulolytic enzyme composition is derived from Trichoderma reesei, Humicola insolens, or Chrysosporium lucknowense, or Myceliophthora thermophila.
In a more specific embodiment the composition of the invention comprises or consists of:
i) a polypeptide having cellulolytic enhancing activity, preferably the one derived from Thermoascus aurantiacus shown as SEQ ID NO: 14 herein, and/or the one derived from Penicillium emersonii shown in SEQ ID NO: 72 herein, or a polypeptide having cellulolytic enhancing activity having at least 60%, at least 70%, at least 80%, at least 90%, at least 95%, at least 97%, at least 99% sequence identity to SEQ ID NO: 14 herein or SEQ ID NO: 72 herein:
ii) a peroxidase classified as EC 1.11.1.7 peroxidase, preferably the one derived from Coprinus cinereus shown in SEQ ID NO: 71 herein; or a polypeptide having peroxidase activity having at least 60%, at least 70%, at least 80%, at least 90%, at least 95%, at least 97%, at least 99% identity to SEQ ID NO: 71 herein:
iii) a nonionic surfactant and/or a cationic surfactant.
In an embodiment the composition also comprises a cellulolytic enzyme composition, especially one defined herein.
The present invention is further described by the following examples that should not be construed as limiting the scope of the invention.
Hemicellulase 3 (“HEMI 3”) is hemicellulase enzyme composition produced recombinantly by a strain of Trichoderma reesei and contains a thermostable xylanase derived from Aspergillus fumigatus GH10 and an Aspergillus fumigatus beta-xylosidase.
Cellulolytic enzyme composition is produced by a strain of Trichoderma reesei.
Cellulolytic enzyme composition 2 (“Tr Cel 2”): Trichoderma reesei with Af CBHI and Af CBHII
Horseradish peroxidase (“HrP”) purchased from SIGMA (P2088-10KU) (254 units/mg solids)
Sigma Unit Definition for HrP
One pyrogallol unit will form 1.0 mg purpurogallin from pyrogallol in 20 sec at pH 6.0 at 20° C.
Lignin peroxidase (“LiP”) purchased from SIGMA (42603-10MG-F) (0.1 units/mg solids)
Sigma Unit Definition for LiP
One unit corresponds to the amount of enzyme, which oxidizes 1 μmole 3.4-dimethoxybenzyl alcohol per minute at pH 3.0 and 30° C.
Soybean peroxidase (“Soy P”)
Royal palm peroxidase (“RpP”) shown in SEQ ID NO: 79.
Humicola insolens
Aspergillus fumigatus
Aspergillus fumigatus
Penicillium emersonii
Thermoascus aurantiacus
Aspergillus aculeatus
Aspergillus fumigatus
Coprinus cinereus
Corn stover was pretreated at the U.S. Department of Energy National Renewable Energy Laboratory (NREL) using dilute sulfuric acid. The following conditions were used for the pretreatment: 5% sulfuric acid (w/w on dry corn stover basis) at 180° C. for 4 minutes. Composition and the fraction of insoluble solid (FIS) of the pretreated corn stover (PCS) were determined by following the Standard Analytical Procedures developed by NREL (Sluiter et al., 2008a, Determination of Total Solids in Biomass and Total Dissolved Solids in Liquid Process Samples. NREL/TP-510-42621. National Renewable Research Laboratory, Golden, Colo. www.nrel.gov/biomass/pdfs/42621.pdf. Sluiter et al. 2008b, Determination of structural carbohydrates and lignin in biomass. Laboratory Analytical Procedures. NREL/TP-510-42618. National Renewable Research Laboratory, Golden, Colo. www.nrel.gov/biomass/pdfs/42618.pdf. Sluiter et al, 2008c, Determination of Total Solids in Biomass and Total Dissolved Solids in Liquid Process Samples. Laboratory Analytical Procedures. NREL/TP-510-42621. National Renewable Research Laboratory, Golden, Colo. www.nrel.gov/biomass/pdfs/42621.pdf).
The water insoluble solids in the PCS contained 62% glucan, 2% xylan, and 29.7% acid insoluble lignin. The FIS of the PCS was found to be 56%.
Batch enzymatic hydrolysis was performed in 50 mL Nalgene polycarbonate centrifuge tubes (Thermo Scientific, Pittsburgh, Pa.). PCS was mixed with 50 mM sodium acetate buffer (pH 5.0) supplemented with enzymes, surfactants (as needed), as well as 2.5 mg/L lactrol to prevent microbial growth. All enzymes and surfactants used in this study are summarized in Tables 1 and 2. The final total solid concentration was 20% (w/w on a dry weight basis) unless otherwise specified. The reaction mixtures (20 g) were agitated in a hybridization incubator (Combi-D24, FINEPCR®, Yang-Chung, Seoul, Korea) at 50° C. for 120 hours. At the end of hydrolysis, 600 μL of hydrolysate were transferred to a Costar Spin-X centrifuge filter tube (Cole-Parmer, Vernon Hills, Ill.) and filtered through 0.2 μm nylon filter during centrifugation (14,000 rpm, 20 minutes). Supernatant was acidified with 5 μL of 40% (w/v) sulfuric acid to deactivate residual enzyme activity and analyzed by high performance liquid chromatography (HPLC) for sugar concentrations.
Sugars released from hydrolysis of PCS was analyzed with an HPLC system (1200 Series LC System, Agilent Technologies Inc., Palo Alto, Calif.) equipped with a Rezex ROA-Organic acid H+ column (8%) (7.8 ×300 mm) (Phenomenex Inc., Torrance, Calif.), 0.2 μm in line filter, an automated sampler, a gradient pump, and a refractive index detector. The mobile phase used was 5 mM sulfuric acid at a flow rate of 0.9 ml/min. Monomeric sugars at concentrations of 0, 10, 30, and 50 mg/L were used as standards. The overall glucan/xylan conversions from pretreatment and hydrolysis were calculated based on sugars in enzyme hydrolysis supernatant and biomass composition of the raw feedstock using a method similar to that published by Zhu et al., 2011, Calculating sugar yields in high solids hydrolysis of biomass, Bioresour Technol 102(3): 2897-2903.
Enhanced Production of Sugars from Pretreated Corn Stover (PCS) Using Peroxidase and Nonionic Surfactant
Hydrolysis of PCS was carried out at 50° C., pH 5, at 20% (w/w on a dry weight basis) total solid loading. Three enzyme mixtures were used: cellulolytic enzyme composition, a cellulase mixture containing 10% EG V core, 40% AfCBHI, 30% AfCBHII, 5% AfBG 4M, 10% TaGH61a, and 5% hemicellulases, and a cellulase mixture containing 10% EG, 40% AfCBHI, 30% AfCBHII, 5% AaBG, 10% TaGH61a, and 5% hemicellulase. Total protein dosage of GH61, cellulases and hemicellulases were 4 mg/g PCS cellulose. Samples were also supplemented with CiP (120 μg/g PCS cellulose), Levapon nonionic surfactant (2% w/w on a dry PCS basis), and the combination of peroxidase and nonionic surfactant at similar doses as outlined in Table 3. Samples were taken at 72 and 120 hours and analyzed as described by a HPLC.
The results as shown in
Hydrolysis of PCS was carried out at 50° C., pH 5, at 20% (w/w on a dry weight basis) total solid loading. The hydrolytic enzymes were combinations of EG V core, AfCBHI, AfCBHII, AaBG, and hemicellulases at different ratio. The concentration of TaGH61a varied between 0-20% as summarized in Table 4. Total protein dosage of GH61, cellulases and hemicellulases were 4 mg/g PCS cellulose. Samples were also supplemented with CiP (120 μg/g PCS cellulose), Levapon nonionic surfactant (2% w/w on a dry PCS basis), and the combination of peroxidase and nonionic surfactant at similar doses (Table 4). Samples were taken at 72 and 120 hours and analyzed as described by HPLC.
The results as shown in
Hydrolysis of PCS was carried out at 50° C., pH 5, out at 20% (w/w on a dry weight basis) total solid loading. The hydrolytic enzymes were combinations of EG V core, AfCBHI, AfCBHII, AaBG, hemicellulase, and GH61a from Thermoascus aurantiacus or Penicillium emersonii at the ratio shown in Table 5. Total protein dosage of GH61, cellulases and hemicellulases were 3 mg/g PCS cellulose. Samples were also supplemented with CiP (90 μg/g PCS cellulose), Levapon nonionic surfactant (2% w/w on a dry PCS basis), and the combination of peroxidase and nonionic surfactant at similar doses (Table 5). Samples were taken at 72 and 120 hours and analyzed as described by HPLC.
Hydrolysis of PCS was carried at 50° C., pH 5, out at 20% (w/w on a dry weight basis) total solid loading. For nonionic surfactants, 4 mg/g cellulose of cellulolytic enzymes were used. Samples were also supplemented with CiP (120 μg/g PCS cellulose), nonionic surfactants (2% w/w on a dry PCS basis) (Table 2), and the combination of peroxidase and nonionic surfactant at similar doses (Table 6). For cationic surfactants, the hydrolytic enzymes were a combination of EG V core, AfCBHI, AfCBHII, AaBG, TaGH61a, and hemicellulase (Table 7). Total enzyme dose was maintained at 3 mg/g cellulose. Samples were also supplemented with CiP (90 μg/g PCS cellulose), cationic surfactants (2% w/w on a dry PCS basis) (Table 2), and the combination of peroxidase and cationic surfactant at similar doses (Table 7). Samples were taken at 72 and 120 hours and analyzed as described by HPLC.
The results showed that the synergistic effect existed between all nonionic surfactants and peroxidase (
Hydrolysis of PCS was carried out at 50° C., pH 5, at 20% (w/w on a dry weight basis) total solid loading. The hydrolytic enzymes containing EG V core, AfCBHI, AfCBHII, AaBG, TaGH61a, and hemicellulase at 4 mg/g cellulose were used (Table 8). Samples were also supplemented with CiP (120 μg/g PCS cellulose), Levapon nonionic surfactants (0-2% w/w on a dry PCS basis), and the combination of peroxidase and nonionic surfactant at similar doses (Table 8). Samples were taken at 72 and 120 hours and analyzed as described by HPLC.
The results (
Hydrolysis was carried out at 50° C., pH 5, with cellulase mono-components mixture containing EG V core, AfCBH, AaBG, TaGH61a, and hemicellulases. Total CBH dose was maintained at 70% of the total cellulases and hemicellulases dose (3 mg/g cellulose). The ratio of CBHI to CBHII varied from 0:70 to 70:0 (Table 9). Samples were also supplemented with CiP (90 μg/g PCS cellulose), Levapon nonionic surfactant (2% w/w on a dry PCS basis), and the combination of peroxidase and nonionic surfactant at similar doses. Samples were taken at 72 and 120 hours and analyzed as described by HPLC.
Table 10 summarizes the pretreatment method and composition of the lignocellulosic substrates tested in this study. No washing of substrates was performed between pretreatment and hydrolysis. Hydrolysis of various substrates was carried out with 5 mg/g cellulose of cellulolytic enzyme at different solid loading (Table 11). The 5 mg/g cellulose of enzyme was based on cellulose in pretreated substrate for Arundo and mixed wood, while in hot water and dilute acid pretreated corn stover, it was based on cellulose in raw corn stover (38%). Samples were also supplemented with CiP (150 μg/g PCS cellulose), nonionic surfactant (2% w/w on a dry substrate basis), and the combination of peroxidase and nonionic surfactant at similar doses (Table 11). Samples were taken at 72 and 120 hours and analyzed as described by HPLC.
Hydrolysis of PCS was carried out at 50° C., pH 5, at 20% (w/w on a dry weight basis) total solid loading. The enzymes used were combinations of Trichoderma reesei cellulase 2 (Tr Cel 2), Aspergillus aculeatus beta-glucosidase (AaBG), Hemicellulase 3 (Hemi 3), Thermoascus aurantiacus GH61 polypeptide (TaGH61a), Coprinus cinereus peroxidase (CiP), Soybean peroxidase (Soy P), Royal palm peroxidase (RpP), Lignin peroxidase (LiP) and horseradish peroxidase (HrP) at different ratio as summarized in Table 12. Total protein dosage of GH61, cellulases and hemicellulases were 3 mg/g PCS cellulose, Levapon nonionic surfactant (1% w/w on a dry PCS basis), and the combination of peroxidase and nonionic surfactant at similar doses (Table 12). Samples were taken at 72 and 144 hours and analyzed as described by HPLC.
The results are shown in
The invention described and claimed herein is not to be limited in scope by the specific aspects herein disclosed, since these aspects are intended as illustrations of several aspects of the invention. Any equivalent aspects are intended to be within the scope of this invention. Indeed, various modifications of the invention in addition to those shown and described herein will become apparent to those skilled in the art from the foregoing description. Such modifications are also intended to fall within the scope of the appended claims. In the case of conflict, the present disclosure including definitions will control.
The present invention is further described in the following numbered paragraphs:
1. A method for degrading/hydrolyzing a pretreated cellulosic material comprising subjecting the pretreated cellulosic material to:
a cellulolytic enzyme composition;
a polypeptide having cellulolytic enhancing activity;
a peroxidase; and
a nonionic surfactant and/or a cationic surfactant,
at conditions suitable for hydrolyzing the pretreated lignocellulosic material.
2. The method of paragraph 1, wherein the hydrolysis is carried out at 10-50% TS, such as 15-40% TS, such as 15-30% TS, such as around 20% TS.
3. The method of paragraph 1 or 2, wherein the hydrolysis is done for 12-240 hours, such as 24-192 hours, such as 48-144, such as around 96 hours.
4. The method of any of paragraphs 1-3, wherein the temperature during hydrolysis is between 30-70° C., such as 40-60° C., such as 45-55° C., such as around 50° C.
5. The method of any of paragraphs 1-4, wherein the pH during hydrolysis is between 4-7, such as 4.5-6, such as around pH 5.
6. The method of any of paragraphs 1-5, wherein the cellulolytic enzyme composition loading during hydrolysis is between about 0.1 to about 25 mg, such as about 1-10 mg, such as about 2 to about 8 mg, such as around 4 mg protein per g cellulosic material.
7. The method of any of paragraphs 1-6, wherein the cellulolytic enzyme composition comprises one or more (several) enzymes selected from the group consisting of endoglucanase, cellobiohydrolase (CBH), and beta-glucosidase.
8. The method of any of paragraphs 1-7, wherein the cellulolytic enzyme composition is derived from Chrysosporium lucknowense, Humicola insolens, Myceliophthora thermophila, or Trichoderma reesei.
9. The method of any of paragraphs 1-8, wherein the polypeptide having cellulolytic enhancing activity is a GH61 polypeptide such as one derived from the genus Thermoascus, such as a strain of Thermoascus aurantiacus, such as the one described in WO 2005/074656 as SEQ ID NO: 2 or SEQ ID NO: 14 herein; or one derived from the genus Thielavia, such as a strain of Thielavia terrestris, such as the ones described in WO 2005/074647 as SEQ ID NO: 7 and SEQ ID NO: 8; or one derived from a strain of Aspergillus, such as a strain of Aspergillus fumigatus, such as the ones described in WO 2010/138754 as SEQ ID NO: 1 and SEQ ID NO: 2; or one derived from a strain derived from Penicillium, such as a strain of Penicillium emersonii, such as the one disclosed in WO 2011/041397 as SEQ ID NO: 2 or SEQ ID NO: 72 herein.
10. The method of any of paragraphs 1-9, wherein the polypeptide having cellulolytic enhancing activity is one having at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 14 herein.
11. The method of any of paragraphs 1-9, wherein the polypeptide having cellulolytic enhancing activity is one having at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 72 herein.
12. The method of any of paragraphs 1-11, wherein the cellulolytic enzyme composition comprises a beta-glucosidase, preferably one derived from a strain of the genus Aspergillus, such as Aspergillus oryzae, such as the one disclosed in WO 02/095014 or the fusion protein having beta-glucosidase activity disclosed in WO 2008/057637, e.g., SEQ ID NO: 68 or 70 herein; Aspergillus aculeatus, such as the one disclosed in SEQ ID NO: 66 herein, or Aspergillus fumigatus, such as such as one disclosed in WO 2005/047499, e.g., SEQ ID NO: 78 herein; or an Aspergillus fumigatus beta-glucosidase variant (e.g., F100D, S283G, N456E, F512Y) disclosed in WO 2012/044915; or a strain of the genus a strain Penicillium, such as a strain of the Penicillium brasilianum disclosed in WO 2007/019442 or SEQ ID NO: 62 herein, or a strain of the genus Trichoderma, such as a strain of Trichoderma reesei.
13. The method of paragraph 12, wherein the beta-glucosidase variant is from a strain of Aspergillus, such as a strain of Aspergillus fumigatus, such as Aspergillus fumigatus beta-glucosidase (SEQ ID NO: 78 herein), which comprises one or more substitutions selected from the group consisting of L89M, G91L, F100D, I140V, I186V, S283G, N456E, and F512Y.
14. The method of paragraph 13, wherein the beta-glucosidase variant has the following substitutions:
F100D+S283G+N456E+F512Y;
L89M+G91L+I186V+I140V;
I186V+L89M+G91L+I140V+F100D+S283G+N456E+F512Y (using SEQ ID NO: 78 herein for numbering.
15. The method of any of paragraphs 12-14, wherein the beta-glucosidase variant has a number of substitutions between 1 and 10, such as between 1 and 8, such as between 1 and 6, such as between 1 and 4, such as 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10 substitutions.
16. The method of any of paragraphs 12-15, wherein beta-glucosidase is one having at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 78 herein.
17. The method of any of paragraphs 12-16, wherein the beta-glucosidase variant is one having at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 78 herein.
18. The method of any of paragraphs 1-17, wherein the cellulolytic enzyme composition comprises a xylanase, preferably a GH10 xylanase, such as one derived from a strain of the genus Aspergillus, such as a strain from Aspergillus fumigatus, such as the one disclosed as SEQ ID NO: 6 (Xyl III) in WO 2006/078256 or SEQ ID NO: 75 herein, or Aspergillus aculeatus, such as the one disclosed in WO 94/21785 as SEQ ID NO: 5 (Xyl II) or SEQ ID NO: 74 herein.
19. The method of paragraph 18, wherein the xylanase is one having at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 74 herein.
20. The method of paragraph 18, wherein the xylanase is one having at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 75 herein.
21. The method of any of paragraphs 1-20, wherein the cellulolytic enzyme composition comprises a beta-xylosidase, such as one derived from a strain of the genus Aspergillus, such as a strain of Aspergillus fumigatus, such as the one disclosed in co-pending U.S. provisional No. 61/526,833 or WO 2013/028928 (Examples 16 and 17) or SEQ ID NO: 73 herein, or derived from a strain of Trichoderma, such as a strain of Trichoderma reesei, such as the mature polypeptide of SEQ ID NO: 58 in WO 2011/057140.
22. The method of paragraph 21, wherein the beta-xylosidase is one having at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 73 herein.
23. The method of any of paragraphs 1-22, wherein the cellulolytic enzyme composition comprises a cellobiohydrolase I (CBH I), such as one derived from a strain of the genus Aspergillus, such as a strain of Aspergillus fumigatus, such as the Cel7a CBH I disclosed in SEQ ID NO: 6 in WO 2011/057140 or SEQ ID NO: 76 herein, or a strain of the genus Trichoderma, such as a strain of Trichoderma reesei.
24. The method of paragraph 23, wherein the CBH I is one having at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 76 herein.
25. The method of any of paragraphs 1-24, wherein the cellulolytic enzyme composition comprises a cellobiohydrolase II (CBH II), such as one derived from a strain of the genus Aspergillus, such as a strain of Aspergillus fumigatus, such as the one shown as SEQ ID NO: 18 in WO 2011/057140 or SEQ ID NO: 77 herein; or a strain of the genus Trichoderma, such as Trichoderma reesei, or a strain of the genus Thielavia, such as a strain of Thielavia terrestris, such as cellobiohydrolase II CEL6A from Thielavia terrestris.
26. The method of paragraph 25, wherein the CBH II is one having at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 77 herein.
27. The method of any of paragraphs 1-26, wherein the cellulolytic enzyme composition is a Trichoderma reesei cellulolytic enzyme composition and the polypeptide having cellulolytic enhancing activity is Thermoascus aurantiacus GH61A (SEQ ID NO: 2 in WO 2005/074656 or SEQ ID NO: 14 herein), such as one having at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 14 herein.
28. The method of paragraph 27, further wherein a beta-glucosidase is present or added, such as Aspergillus oryzae beta-glucosidase fusion protein shown as SEQ ID NO: 74 or 76 in WO 2008/057637 or SEQ ID NO: 68 or 70 herein.
29. The method of paragraph 28, wherein the beta-glucosidase is one having at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 68 of 70 herein.
30. The method of any of paragraphs 1-29, wherein the cellulolytic enzyme composition is a Trichoderma reesei cellulolytic enzyme composition and the polypeptide having cellulolytic enhancing activity is Penicillium emersonii GH61A polypeptide disclosed in WO 2011/041397 as SEQ ID NO: 2, such as one having at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 72 herein.
31. The method of paragraph 30, further wherein a beta-glucosidase is present or added, such as Aspergillus fumigatus beta-glucosidase (SEQ ID NO: 2 of WO 2005/047499 or SEQ ID NO: 76 herein) or a variant thereof with the following substitutions: F100D, S283G, N456E, F512Y (WO 2012/044915).
32. The method of any of paragraphs 1-31, wherein the cellulolytic enzyme composition is a Trichoderma reesei cellulolytic enzyme composition and wherein one or more of the following components are present or added:
(i) an Aspergillus fumigatus cellobiohydrolase I;
(ii) an Aspergillus fumigatus cellobiohydrolase II;
(iii) an Aspergillus fumigatus beta-glucosidase or variant thereof, e.g., with one or more of the following substitutions: F100D, S283G, N456E, F512Y (using SEQ ID NO: 78 herein for numbering); and
(iv) a Penicillium sp. GH61 polypeptide having cellulolytic enhancing activity; or homologs thereof.
33. The method of any of paragraphs 1-32, wherein the cellulytic enzyme composition further comprises one or more (several) enzymes selected from the group consisting of a hemicellulase, an esterase, a protease, and a laccase.
34. The method of any of paragraphs 1-33, wherein the cellulolytic enzyme composition further comprises one or more (several) enzymes selected from the group consisting of a xylanase, an acetylxylan esterase, a feruloyl esterase, an arabinofuranosidase, a xylosidase, a glucuronidase, and a combination thereof.
35. The method of any of paragraphs 1-34, wherein the peroxidase is selected from the group comprising peroxidase or peroxide-decomposing enzymes include, but are not limited to, the following: E.C. 1.11.1.1 NADH peroxidase; E.C. 1.11.1.2 NADPH peroxidase; E.C. 1.11.1.3 fatty-acid peroxidase; E.C. 1.11.1.5 cytochrome-c peroxidase; E.C. 1.11.1.5; E.C. 1.11.1.6 catalase; E.C. 1.11.1.7 peroxidase; E.C. 1.11.1.8 iodide peroxidase; E.C. 1.11.1.9 glutathione peroxidase; E.C. 1.11.1.10 chloride peroxidase; E.C. 1.11.1.11 L-ascorbate peroxidase; E.C. 1.11.1.12 Phospholipid-hydroperoxide glutathione peroxidase; E.C. 1.11.1.13 manganese peroxidase; E.C. 1.11.1.14 lignin peroxidase; E.C. 1.11.1.15 peroxiredoxin; E.C. 1.11.1.16 versatile peroxidase; E.C. 1.11.1.B2 chloride peroxidase; E.C. 1.11.1.B6 iodide peroxidase (vanadium-containing); E.C. 1.11.1.B7 bromide peroxidase; E.C. 1.11.1.B8 iodide peroxidase.
36. The method of any of paragraphs 1-35, wherein the peroxidase is derived from a microorganism, such as a fungal organism, such a yeast or filamentous fungi, or bacteria; or plant.
37. The method of any of paragraphs 1-36, wherein the peroxidase is derived from a strain of Coprinus, such as strain of Coprinus cinereus, such as the one shown in SEQ ID NO: 71 herein (i.e., CiP), or one having at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 71 herein.
38. The method of any of paragraphs 1-37, wherein the nonionic surfactant is alkyl or aryl: glycerol ethers, glycol ethers, ethanolamides, sulfoanylamides, alcohols, amides, alcohol ethoxylates, glycerol esters, glycol esters, ethoxylates of glycerol ester and glycol esters, sugar-based alkyl polyglycosides, polyoxyethylenated fatty acids, alkanolamine condensates, alkanolamides, tertiary acetylenic glycols, polyoxyethylenated mercaptans, carboxylic acid esters, and polyoxyethylenated polyoxyproylene glycols, such as EO/PO block copolymers (EO is ethylene oxide, PO is propylene oxide), EO polymers and copolymers, polyamines, and polyvinylpynolidones.
39. The method of any of paragraphs 1-38, wherein the nonionic surfactant is a linear primary, or secondary or branched alcohol ethoxylate having the formula: RO(CH2CH2O)nH, wherein R is the hydrocarbon chain length and n is the average number of moles of ethylene oxide, such as where R is linear primary or branched secondary hydrocarbon chain length in the range from C9 to C16 and n ranges from 6 to 13, such as alcohol ethoxylate where R is linear C9-C11 hydrocarbon chain length, and n is 6.
40. The method of any of paragraphs 1-39, wherein the cationic surfactant is a primary, secondary, or tertiary amines, such as octenidine dihydrochloride; alkyltrimethylammonium salts, such as cetyl trimethylammonium bromide (CTAB) a.k.a. hexadecyl trimethyl ammonium bromide, cetyl trimethylammonium chloride (CTAC), cetylpyridinium chloride (CPC), benzalkonium chloride (BAC), benzethonium chloride (BZT), 5-bromo-5-nitro-1,3-dioxane, dimethyldioctadecylammonium chloride, dioctadecyldimethylammonium bromide (DODAB).
41. The method of any of paragraphs 1-40, wherein the hydrolyzed pretreated cellulosic material is a sugar.
42. The method of any of paragraphs 1-41, wherein the pretreated cellulosic material is agricultural residue, herbaceous material (including energy crops), municipal solid waste, pulp and paper mill residue, waste paper, or wood (including forestry residue), or arundo, bagasse, bamboo, corn cob, corn fiber, corn stover, miscanthus, orange peel, rice straw, switchgrass or wheat straw.
43. The method of any of paragraphs 1-42, wherein the sugars are fermented into a fermentation product by a fermenting microorganism.
44. The method of any of paragraphs 1-43, further comprising recovering the hydrolyzed cellulosic material, such as sugars or fermentation product.
45. The method of paragraph 44, wherein the sugar is selected from the group consisting of glucose, xylose, mannose, galactose, and arabinose.
46. The method of any of paragraphs 43-45, wherein the fermentation product is an alcohol, such as ethanol, an organic acid, a ketone, an amino acid, or a gas.
47. The method of any of paragraphs 1-46, wherein the Km of the polypeptide having peroxidase activity is in the range of preferably 0.0001 to 50 mM, more preferably 0.001 to 10 mM, even more preferably 0.005 to 1 mM, and most preferably 0.01 to 0.1 mM.
48. The method of any of paragraphs 1-47, wherein the pretreated cellulosic material is pretreated by chemical pretreatment, a physical pretreatment, or a chemical pretreatment and a physical pretreatment.
49. The method of any of paragraphs 1-48, wherein the pretreatment is alkaline pretreatment, such as ammonium pretreatment, such as mild ammonium pretreatment.
50. The method of any of paragraphs 1-49, wherein the cellulosic material is thermomechemically pretreated.
51. The method of any of paragraphs 1-50, wherein pretreating the cellulosic material includes pretreatment with an acid, such as dilute acid pretreatment.
52. The method of any of paragraphs 1-51, wherein the pretreated cellulosic material is prepared by pretreating the cellulosic material at high temperature, high pressure with an acid, such as dilute acid.
53. The method of paragraph 51 or 52, wherein acid pretreatment is carried out using acetic acid.
54. The method of any of paragraphs 1-53, wherein the pretreated cellulosic material has been prepared by pretreating cellulosic material using organosolv pretreatment, such as Acetosolv and Acetocell processes.
55. A process for producing a fermentation product, comprising
(a) hydrolyzing/degrading the pretreated cellulosic material as defined in any of paragraphs 1-54;
(b) fermenting the material with one or more (several) fermenting microorganisms to produce the fermentation product; and
(c) optionally recovering the fermentation product from the fermentation.
56. The process of paragraph 55, wherein hydrolysis step (a) and fermentation step (b) are carried out sequentially or simultaneously; as separate hydrolysis and fermentation (SHF); simultaneous saccharification and fermentation (SSF); simultaneous saccharification and co-fermentation (SSCF); hybrid hydrolysis and fermentation (HHF); separate hydrolysis and co-fermentation (SHCF); hybrid hydrolysis and co-fermentation (HHCF); or direct microbial conversion (DMC), also sometimes called consolidated bioprocessing (CBP).
57. The process of paragraph 55 or 56, wherein fermentation is carried out using a yeast or bacterium.
58. The process of any of paragraphs 55-57, wherein the fermenting microorganism is capable of fermenting hexose and/or pentose into a desired fermentation product.
59. The process of paragraph 58, wherein the fermenting microorganism is a yeast, such as strain of the genus Saccharomyces, such as a strain of Saccharomyces cerevisiae.
60. The process of any of paragraphs 55-59, wherein the fermentation is carried out at a temperature between about 26° C. to about 60° C., e.g., about 32° C. or 50° C., and about pH 3 to about pH 8, e.g., pH 4-5, 6, or 7.
61. The process of any of paragraphs 55-60, wherein the fermentation is carried out at a temperature from 20-40° C., e.g., 26-34° C., preferably around 32° C., when the fermentation microorganism is yeast, such as a strain of the genus Saccharomyces, in particular a strain of Saccharomyces cerevisiae, especially when the fermentation product is ethanol.
62. The process of any of paragraphs 55-61, wherein the fermentation is carried out at pH 3-7, e.g., pH 4-6.
63. The process of any of paragraphs 55-62, wherein the fermentation is performed for about 12 to about 96 hours, such as typically 24-60 hours.
64. The process of any of paragraphs 55-63, wherein the fermentation product is ethanol.
65. A composition comprising or consisting of:
i) a polypeptide having cellulolytic enhancing activity;
ii) a peroxidase;
iii) a nonionic surfactant and/or a cationic surfactant.
66. The composition of paragraph 65, wherein the polypeptide having cellulolytic enhancing activity is a GH61 polypeptide such as one derived from the genus Thermoascus, such as a strain of Thermoascus aurantiacus, such as the one described in WO 2005/074656 as SEQ ID NO: 2 or SEQ ID NO: 14 herein; or one derived from the genus Thielavia, such as a strain of Thielavia terrestris, such as the one described in WO 2005/074647 as SEQ ID NO: 8 or SEQ ID NO: 8 herein; or one derived from a strain of Aspergillus, such as a strain of Aspergillus fumigatus, such as the one described in WO 2010/138754 as SEQ ID NO: 1 and SEQ ID NO: 2; or one derived from a strain derived from Penicillium, such as a strain of Penicillium emersonii, such as the one disclosed in WO 2011/041397 as SEQ ID NO: 2 or SEQ ID NO: 72 herein.
67. The composition of paragraph 65 or 66, wherein the polypeptide having cellulolytic enhancing activity has at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 14 herein.
68. The composition of any of paragraphs 65-67, wherein the polypeptide having cellulolytic enhancing activity has at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 72 herein.
69. The composition of any of paragraphs 65-68, wherein the peroxidase is selected from the group comprising peroxidase or peroxide-decomposing enzymes include, but are not limited to, the following: E.C. 1.11.1.1 NADH peroxidase; E.C. 1.11.1.2 NADPH peroxidase; E.C. 1.11.1.3 fatty-acid peroxidase; E.C. 1.11.1.5 cytochrome-c peroxidase; E.C. 1.11.1.5; E.C. 1.11.1.6 catalase; E.C. 1.11.1.7 peroxidase; E.C. 1.11.1.8 iodide peroxidase; E.C. 1.11.1.9 glutathione peroxidase; E.C. 1.11.1.10 chloride peroxidase; E.C. 1.11.1.11 L-ascorbate peroxidase; E.C. 1.11.1.12 phospholipid-hydroperoxide glutathione peroxidase; E.C. 1.11.1.13 manganese peroxidase; E.C. 1.11.1.14 lignin peroxidase; E.C. 1.11.1.15 peroxiredoxin; E.C. 1.11.1.16 versatile peroxidase; E.C. 1.11.1.82 chloride peroxidase; E.C. 1.11.1.B6 iodide peroxidase (vanadium-containing); E.C. 1.11.1.B7 bromide peroxidase; E.C. 1.11.1.B8 iodide peroxidase.
70. The composition of any of paragraphs 65-69, wherein the peroxidase is derived from a microorganism, such as a fungal organism, such a yeast or filamentous fungi, or bacteria; or plant.
71. The composition of any of paragraphs 65-70, wherein the peroxidase is derived from a strain of Coprinus, such as strain of Coprinus cinereus.
72. The composition of any of paragraphs 65-71, wherein the peroxidase is the one shown in SEQ ID NO: 71 herein or one having at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 71 herein.
73. The composition of any of paragraphs 65-72, wherein the nonionic surfactant is alkyl or aryl: glycerol ethers, glycol ethers, ethanolamides, sulfoanylamides, alcohols, amides, alcohol ethoxylates, glycerol esters, glycol esters, ethoxylates of glycerol ester and glycol esters, sugar-based alkyl polyglycosides, polyoxyethylenated fatty acids, alkanolamine condensates, alkanolamides, tertiary acetylenic glycols, polyoxyethylenated mercaptans, carboxylic acid esters, and polyoxyethylenated polyoxyproylene glycols, such as EO/PO block copolymers (EO is ethylene oxide, PO is propylene oxide), EO polymers and copolymers, polyamines, and polyvinylpynolidones.
74. The composition of any of paragraphs 65-73, wherein the nonionic surfactant is a linear primary, or secondary or branched alcohol ethoxylate having the formula: RO(CH2CH2O)nH, wherein R is the hydrocarbon chain length and n is the average number of moles of ethylene oxide, such as where R is linear primary or branched secondary hydrocarbon chain length in the range from C9 to C16 and n ranges from 6 to 13, such as alcohol ethoxylate where R is linear C9-C11 hydrocarbon chain length, and n is 6.
75. The composition of any of paragraphs 65-74, wherein the cationic surfactant is a primary, secondary, or tertiary amines, such as octenidine dihydrochloride; alkyltrimethylammonium salts, such as cetyl trimethylammonium bromide (CTAB) a.k.a. hexadecyl trimethyl ammonium bromide, cetyl trimethylammonium chloride (CTAC), cetylpyridinium chloride (CPC), benzalkonium chloride (BAC), benzethonium chloride (BZT), 5-bromo-5-nitro-1,3-dioxane, dimethyldioctadecylammonium chloride, dioctadecyldimethylammonium bromide (DODAB).
76. The composition of any of paragraphs 65-75, further comprising a cellulolytic enzyme composition.
77. The composition of paragraph 76, comprising a beta-glucosidase.
78. The composition of any of paragraphs 65-77, wherein the cellulolytic enzyme composition comprises a beta-glucosidase, preferably one derived from a strain of the genus Aspergillus, such as Aspergillus oryzae, such as the one disclosed in WO 02/095014 or the fusion protein having beta-glucosidase activity disclosed in WO 2008/057637 or SEQ ID NO: 68 or 70 herein, or Aspergillus fumigatus, such as such as one disclosed as SEQ ID NO: 2 in WO 2005/047499 or SEQ ID NO: 78 herein, or an Aspergillus fumigatus beta-glucosidase variant disclosed in WO 2012/044915 (e.g., e.g., F100D, S283G, N456E, F512Y); or a strain of the genus a strain Penicillium, such as a strain of the Penicillium brasilianum disclosed in WO 2007/019442 shown in SEQ ID NO: 62 herein, or a strain of the genus Trichoderma, such as a strain of Trichoderma reesei.
79. The composition of paragraph 78, wherein the beta-glucosidase variant is from a strain of Aspergillus, such as a strain of Aspergillus fumigatus, such as Aspergillus fumigatus beta-glucosidase (SEQ ID NO: 78 herein), which comprises one or more substitutions selected from the group consisting of L89M, G91L, F100D, I140V, I186V, S283G, N456E, and F512Y.
80. The composition of any of paragraphs 77-79, wherein the beta-glucosidase variant has the following substitutions:
F100D+S283G+N456E+F512Y;
L89M+G91L+I186V+I140V;
I186V+L89M+G91L+I140V+F100D+S283G+N456E+F512Y (using SEQ ID NO: 78 herein for numbering.
81. The composition of any of paragraphs 77-80, wherein the beta-glucosidase variant has a number of substitutions between 1 and 10, such 1 and 8, such as 1 and 6, such as 1 and 4, such as 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10 substitutions.
82. The composition of any of paragraphs 77-81, wherein beta-glucosidase is one having at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 78 herein.
83. The composition of any of paragraphs 77-82, wherein the beta-glucosidase variant is one having at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 78 herein.
84. The composition of any of paragraphs 77-83, wherein the cellulolytic enzyme composition is derived from Trichoderma reesei, Humicola insolens, or Chrysosporium lucknowense, or Myceliophthora thermophila.
85. The composition of any of paragraphs 65-84, comprising:
i) a polypeptide having cellulolytic enhancing activity having at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 14 herein or SEQ ID NO: 72 herein;
ii) a peroxidase having at least 60%, preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to SEQ ID NO: 71 herein;
iii) a nonionic surfactant and/or a cationic surfactant.
86. The composition of paragraph 85, wherein the nonionic surfactant is alkyl or aryl: glycerol ethers, glycol ethers, ethanolamides, sulfoanylamides, alcohols, amides, alcohol ethoxylates, glycerol esters, glycol esters, ethoxylates of glycerol ester and glycol esters, sugar-based alkyl polyglycosides, polyoxyethylenated fatty acids, alkanolamine condensates, alkanolamides, tertiary acetylenic glycols, polyoxyethylenated mercaptans, carboxylic acid esters, and polyoxyethylenated polyoxyproylene glycols, such as EO/PO block copolymers (EO is ethylene oxide, PO is propylene oxide), EO polymers and copolymers, polyamines, and polyvinylpynolidones.
87. The composition of paragraph 85 or 86, wherein the nonionic surfactant is a linear primary, or secondary or branched alcohol ethoxylate having the formula: RO(CH2CH2O)nH, wherein R is the hydrocarbon chain length and n is the average number of moles of ethylene oxide, such as where R is linear primary or branched secondary hydrocarbon chain length in the range from C9 to C16 and n ranges from 6 to 13, such as alcohol ethoxylate where R is linear C9-C11 hydrocarbon chain length, and n is 6.
88. The composition of any of paragraphs 85-87, wherein the cationic surfactant is a primary, secondary, or tertiary amines, such as octenidine dihydrochloride; alkyltrimethylammonium salts, such as cetyl trimethylammonium bromide (CTAB) a.k.a. hexadecyl trimethyl ammonium bromide, cetyl trimethylammonium chloride (CTAC), cetylpyridinium chloride (CPC), benzalkonium chloride (BAC), benzethonium chloride (BZT), 5-bromo-5-nitro-1,3-dioxane, dimethyldioctadecylammonium chloride, dioctadecyldimethylammonium bromide (DODAB).
89. The composition of any of paragraphs 85-88, wherein the nonionic surfactant is selected from the group of nonylphenol ethoxylate; C14H22O(C2H4O)n; C13-alcohol polyethylene glycol ethers (10 EO); EO, PO copolymer; alkylpolyglycolether; RO(EO)5H; HOCH2(EO)nCH2OH; and HOCH2(EO)nCH2OH.
90. The composition of any of paragraphs 85-89, wherein the cationic surfactant is selected from the group of C21H38NCl and CH3(CH2)15N(CH3)3Br.
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/US2013/051084 | 7/18/2013 | WO | 00 |
| Number | Date | Country | |
|---|---|---|---|
| 61673556 | Jul 2012 | US |
